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ABSTRACT 
The free radical theory of ageing proposes ageing is the result of macromolecules, 
damaged by free radicals, accumulating in cells over time. Mitochondria are critical to 
this theory as they are the primary source of the free radical superoxide. This thesis 
aims to understand the effect of age and dietary restriction (DR) with regard to 
mitochondrial protein abundance and superoxide generation.  
Superoxide production and protein composition was studied from multiple ages in 
isolated mitochondria from both ad libitum (AL) and DR mice. Superoxide production 
was assessed by measuring hydrogen peroxide release from multiple electron 
transport chain (ETC) sites. Mass spectrometry was used to determine the 
mitochondrial protein composition from mouse liver tissue. 
Older mice have increased hydrogen peroxide release from ETC complexes I and III. DR 
has decreased complex I hydrogen peroxide release in brain, skeletal muscle and liver 
mitochondria analysed at 15 and 24 months old. DR doesn’t prevent but delays the age 
associated hydrogen peroxide release. Hydrogen peroxide release at the same survival 
point is not significantly different between AL and DR mice.  
The liver mitochondrial proteome is affected by age and DR. Fatty acid metabolism 
protein abundance increases with age whereas amino acid metabolism protein 
abundance decreased. Superoxide clearance protein abundance is increased in older 
and DR liver mitochondria. Catalase had increased abundance in DR mitochondria at 
15 and 24 months than at 3 or 36 months old.  
In conclusion hydrogen peroxide release, superoxide clearance protein abundance and 
fatty acid metabolism protein abundance are increased with ageing. The age 
associated increase in hydrogen peroxide release is delayed in DR mitochondria 
possibly due to increased abundance of catalase.  
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CHAPTER 1: INTRODUCTION 
1.1. THE FREE RADICAL THEORY OF AGEING 
The mechanism by which ageing occurs is still undetermined. Multiple factors have 
been shown to change with age. Increased age has been associated with impaired 
protein turnover (Ryazanov and Nefsky, 2002), shortened telomeres (Kim Sh et al., 
2002) and increased reactive oxygen species (ROS) levels (Lass et al., 1998).  
The free radical theory of ageing was proposed over 60 years ago and remains a 
popular theory.  This theory proposes the constant generation of reactive oxygen 
species (ROS) and free radicals continually causes molecular damage. The 
accumulation of molecular damage over time, causing detrimental effects on the 
function of the cells and therefore the organism as a whole (Harman, 1956). ROS have 
been linked to carcinogenesis, ageing and other age-related disorders (Andersen, 
2004; Trachootham et al., 2009; Shukla et al., 2011)(Haigis and Yankner, 2010)(Mates 
et al., 1999) 
There are multiple sites of ROS production in the cell. (Quinlan et al., 2012)Gross et al 
showed the endoplasmic reticulum contained enzymes which produce ROS (Gross et 
al., 2006). The cytochrome P450 catalytic cycle produces ROS, even without substrate 
(Gonzalez, 2005)(Mari and Cederbaum, 2000). Peroxisomes are an important 
intracellular source of ROS production as they are the site of beta fatty acid oxidation 
and D-amino acid oxidation (Boveris et al., 1972; Mueller et al., 2002). NADPH oxidases 
in the plasma membrane are well documented to be another cellular source of ROS 
(Lambeth, 2004; Dikalov, 2011; Coso et al., 2012)(Kowaltowski et al., 2009)  
The free radical theory of ageing was refined to the mitochondrial theory of ageing in 
1972. Mitochondria produce ROS from three complexes; CI, CII and CIII as well as 
monoamine oxidase and α-ketoglutarate have been shown to produce superoxide 
(Starkov et al., 2004; Tretter and Adam-Vizi, 2005; Starkov, 2008; Quinlan et al., 2012). 
Mitochondria are a major source of ROS in the cell with the superoxide produced a by-
product of ATP generation when producing energy. The theory suggests that the role 
mitochondria play in ageing is critical as they are the primary sites of ROS production 
(Harman, 1956; Harman, 1972).  
2 
 
1.2. STRUCTURE AND FUNCTION OF THE MITOCHONDRIA 
Mitochondrial have an unusual structure comprising two membranes, an outer 
membrane and folded inner membrane which produces cristae. These membranes 
create two internal compartments, the intermembrane space and the matrix (figure 
1.1).  
1.2.1. DIFFERENT POPULATIONS OF MITOCHONDRIA EXIST WITHIN 
TISSUES 
Mitochondrial populations from different tissues don’t respond in the same way. 
Tahara et al (2009) show differences in mitochondrial function in mitochondria from 
different tissues. The oxygen consumption rates, respiration control ratios and 
hydrogen peroxide release rates are shown to be different between mitochondria 
isolated from brain, liver, heart, kidney and muscle tissues (Tahara et al., 2009).  
The murine brain comprises different cell type and regions. Studying the different 
regions of the brain has shown different oxygen consumption rates seen in the cortex, 
straitum and the ventral midbrain (Subramaniam et al., 2014). Liver and muscle 
mitochondria have been shown to have subpopulations within individual cells (Lanni et 
al., 1996; Kuznetsov et al., 2006; Hagopian et al., 2013). Liver mitochondria have been 
divided into three sub-populations based on differential centrifugation force. The 
heavier mitochondria are larger and have a higher respiration rate than those found in 
the lighter sub-populations. These populations are possibly a reflection of 
mitochondrial maturation with the heavier population containing the older and 
damaged mitochondria (Lanni et al., 1996)(Hagopian et al., 2013).  
1.2.2. MITOCHONDRIA HAVE MULTIPLE CELLULAR FUNCTIONS 
Mitochondria are essential in energy production for the cell. The complete metabolism 
of sugars, fatty acids and amino acids all occur within the mitochondria. Mitochondria 
contain the krebs cycle and the ETC which allow the cell to extract  15 times the energy 
of glycolysis alone. (McBride et al., 2006).  
Multiple signalling pathways are linked to mitochondria. The mitochondria are a 
primary site of metabolism. The regulation of metabolic processes can occur by 
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phosphatases, calcium signalling and the continual fission fusion events between 
mitochondria themselves (Chen and Chan, 2005; Hill and Van Remmen, 2014). The cell 
cycle and apoptosis have signalling cascades which are affected by signalling from the 
mitochondria (Alberts et al., 2008). 
Mitochondria contain their own circular DNA. A mitochondrion can have multiple 
copies of DNA within its matrix. Transcription and translation of the mitochondrial DNA 
occurs within the mitochondria. Mutations within the mitochondrial DNA have been 
linked to multiple diseases (Alberts et al., 2008).  
1.2.3. CHANGES IN CELLULAR ENVIRONMENT HAVE AFFECTS ON THE 
MITOCHONDRIA 
Mitochondrial biogenesis is affected by calcium levels, nitric oxide, oxidative stress, 
energy requirements and caloric restriction. The differences in the amount of 
mitochondria can alter the abundance of mitochondrial proteins (Kowaltowski et al., 
2009). Calcium content effects mitochondrial ROS release in both directions. The 
uptake of calcium can reduce ROS production by increasing electron transport due to a 
lower electron potential. Calcium can however change the citric acid cycle activity, and 
the formation of NADH increasing ROS (Kowaltowski et al., 2009). Exercise has been 
shown to increase heat shock protein abundance in muscle cells in mice (McArdle et 
al., 2001). Heat shock proteins protect against oxidative stress by aiding the 
localisation of newly synthesised proteins (McArdle et al., 2002).  
1.3. REACTIVE OXYGEN SPECIES PRODUCTION IN THE ELECTRON 
TRANSPORT CHAIN 
The electron transport chain (ETC) is the final stage of aerobic respiration and the 
major site of superoxide production (Vendelbo and Nair, 2011). Figure 1-1 and figure 
1-2 shows there are four complexes in the ETC which pump protons into the inner 
membrane space. Superoxide is the primary product produced at complex I, II (Quinlan 
et al., 2012) and III in the ETC (St-Pierre et al., 2002; Barja, 2004; Miwa and Brand, 
2005). Complex I produced superoxide is released into the matrix, whereas the 
superoxide produced from complex III is released into the matrix as well as the inter 
membrane space (St-Pierre et al., 2002; Miwa and Brand, 2003). 
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Other mechanisms can affect the mitochondria and superoxide production. Fatty acids 
and uncoupling proteins (UCPs) can alter membrane potential which has been shown 
to have an effect of ROS production in drosophila (Miwa and Brand, 2003). Membrane 
potential is affected by uncoupling proteins which increase the proton leak and reduce 
the protomotive force, and the membrane potential. These uncoupling proteins can be 
activated by fatty acids (Beck et al., 2007). The production of superoxide from complex 
I by reverse electron flow is greatly reduced following a small decrease in membrane 
potential due to mild uncoupling (Miwa and Brand, 2003). Therefore the amount and 
role of uncoupling proteins could have large effects on the production of ROS and 
therefore oxidative damage.  
The driving of electron transport in the ETC begins with the addition of a substrate 
which can enter at either complex I or II. Complex I superoxide production can occur 
from two locations within the complex depending on the substrate present (Treberg et 
al., 2011). Pyruvate Malate (PM), a complex I linked substrate, produces NADH which 
is converted to NAD+ by complex I (Murphy, 2009; Costa et al., 2011). The reaction 
results in forward electron flow through the ETC producing small amounts of 
superoxide. The production of superoxide is increased with the addition of rotenone, a 
complex I inhibitor, which blocks the transfer of electrons causing a ‘traffic jam’ of 
electrons. These electrons leak and react with oxygen to produce superoxide which is 
released into the mitochondrial matrix (figure 1-2A).  
Succinate is a complex II linked substrate, which produces FADH2 and results in both 
forward and reverse flow of electrons in the ETC (Murphy, 2009; Costa et al., 2011). 
The superoxide production in the presence of a complex II linked substrate is high and 
originates from complex I via reverse electron flow (Murphy, 2009; Tahara et al., 2009) 
(figure 1-1B).  
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A:   
B:  
Figure 1-1: Superoxide production from complex I can occur in the presence of both a 
complex I and a complex II linked substrate. The panels show a simplified diagram of 
the five complexes of the ETC. In panel A there is a complex I linked substrate present, 
and a complex I blocker (rotenone). The complex I blockage by rotenone in the 
presence of forward flowing electrons from the complex I linked substrate causes 
maximum complex I superoxide production. Panel B has a complex II linked substrate 
present. Complex II linked substrates produce reverse electron flow causing 
superoxide release from complex I. Superoxide is released from complex I into the 
matrix of the mitochondria (Tahara et al., 2009).  
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Succinate is a complex II linked substrate. In the presence of a complex II linked 
substrate electrons in the ETC can move in two directions. The electrons can move 
backwards from complex II to complex I causing reverse flow of electrons and complex 
I superoxide production.  In the presence of succinate and rotenone the electron flow 
is forward through the ETC. The remaining superoxide production after rotenone block 
comes from complex III; production can be increased to maximum levels with the 
addition of Antimycin A (AA), a complex III inhibitor of the o site (Miwa and Brand, 
2005; Murphy, 2009). Complex III superoxide is released to both sides of the inner 
mitochondrial membrane (Muller et al., 2004) (figure 1-2A). 
Complex II produces superoxide from the flavin site. Production is higher in complex I 
and II (St-Pierre et al., 2002). Measuring complex II production requires low 
concentrations of substrate compared to those added to measure complex I and III 
(Quinlan et al., 2012) (figure 1-2B). 
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A:  
B:  
Figure 1-2: In the presence of complex II linked substrates and rotenone complex II 
and III release superoxide. Two sites of superoxide production are outlined in the 
above diagrams. A complex II linked substrate and rotenone are present in both 
panels. In panel A antimycin A blocks complex II producing maximum production of 
superoxide from complex III. Complex III releases superoxide into the matrix and 
intermembrane space. Panel B shows the superoxide release from complex II. This can 
occur in two sites. Site F is the dominant location of superoxide production. Atpenin A5 
blocks siteQ and malonate blocks siteF (Tahara et al., 2009).   
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1.3.1. METHODS AVAILABLE TO MEASURE REACTIVE OXYGEN SPECIES  
There are many methods used for the detection of ROS. Reactive oxygen species are 
normally superoxide, hydrogen peroxide or peroxynitrile. These are transient in nature 
lasting less than a few seconds and antioxidant mechanisms are well developed to 
remove them. The short lifespan result in very low levels of steady-state ROS in the cell 
(Dikalov and Harrison, 2014). Spin traps are one of the earliest methods made 
available to measure superoxide, these covalently bind the radical to detect it 
(Finkelstein et al., 1980). These probes are oxidised without binding but have a slow 
kinetic rate which is less likely to compete effectively with SOD. Spin probes are newer 
method to detect superoxide which have a quicker kinetic rate and will compete with 
SOD more effectively (Dikalov et al., 1997; Dikalov and Harrison, 2014).  
ROS detection methods were reviewed in Dikalov and Harrison (2014). 
Chemiluminescent probes including lucigenin, luminol, MCLA and coelenterazine can 
be used to detect superoxide however none of these are specific to the mitochondria. 
Dihydroethidium and mitoSOX fluorescent probes have been shown to detect 
superoxide in the cell and mitochondria respectively. Other fluorescent probes detect 
hydrogen peroxide which is more stable. Amplex red, dichlorodihydrofluorescein 
diacetate and other probe which are boronate based can be used to detect hydrogen 
peroxide (Dikalov and Harrison, 2014). This thesis uses amplex red to detect hydrogen 
peroxide changes in isolated mitochondria.  
Superoxide reacts with superoxide dismutase to produce hydrogen peroxide (McCord 
and Fridovich, 1969a; McCord and Fridovich, 1969b). Hydrogen peroxide release can 
be measured to infer superoxide production. Hydrogen peroxide release from isolated 
mitochondria can be measured effectively by Amplex red (10-acetyl-3,7-
dihydroxyphenoxazine). Amplex red reacts in the presence of horseradish peroxidase 
with hydrogen peroxide in a 1:1 stoichiometry to produce resorufin (Zhou et al., 1997). 
Resorufin has absorption and fluorescence emission maxima of approximately 571 nm 
and 585 nm, respectively (Zhou et al., 1997). Monitoring the accumulation of 
fluorescence resorufin product we can determine the rate of hydrogen peroxide (H2O2) 
release under different conditions.  
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There are limitations of amplex red as a method of superoxide detection. Superoxide is 
not directly detected. Superoxide is only detected after conversion to hydrogen 
peroxide outside of the mitochondria as amplex red cannot cross the mitochondrial 
membrane (Zhou et al., 1997). Endogenous SOD present within the mitochondrial 
matrix ensures the conversion of superoxide to H2O2 which can then cross the 
mitochondrial membranes (Galley, 2011).  
Mitochondria contain antioxidants. The antioxidants including catalase and glutathione 
peroxidase convert hydrogen peroxide to water (Beckman and Ames, 1998). Hydrogen 
peroxide could be cleared by these antioxidants and would not be measured. 
Hydrogen peroxide would also not be detected is it did not cross the membrane but 
stayed in the matrix of the mitochondria (Zhou et al., 1997). 
1.3.2. REACTIVE OXYGEN SPECIES HAVE BEEN SHOWN TO INCREASE 
WITH AGE. DIETARY RESTRICTION EXTENDS LIFESPAN AND 
DECREASES REACTIVE OXYGEN SPECIES 
Dietary Restriction (DR) has been shown to increase lifespan, in mammalian models 
including mice and monkeys (Lass et al., 1998; Colman et al., 2009; Ash and Merry, 
2011). A decreased body weight and organ mass in mice has been shown with DR 
(Drew and Leeuwenburgh, 2003; Drew et al., 2003). ROS production has been shown 
to increase with age (Lass et al., 1998). Many groups show reduced ROS production in 
DR mice tissues (Lass et al., 1998; Sanz et al., 2004; Ash and Merry, 2011) This 
reduction in the rate of oxidative stress has been linked to a reduction in oxidative 
damage e.g. reduced mtDNA damage, although direct manipulation of oxidative stress 
has resulted in conflicting results. This has been the mechanism hypothesised as the 
reason that animals live longer under DR. ROS has been shown to be sensitive to 
membrane potential (Hansford et al., 1997). Ash and Merry suggested that a reduced 
membrane potential due to an increased proton leak across the mitochondrial 
membrane could be the cause of reduced ROS in DR rats (Ash and Merry, 2011). This is 
consistent which the uncoupling to survive hypothesis proposed by Brand (Brand, 
2000). The uncoupling to survive theory has been supported in separate cases. 
Mitochondria isolated from skeletal muscle the longest living mice had increased 
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uncoupling and ROS reduction (Harper et al., 2004; Speakman et al., 2004), suggesting 
an importance of uncoupling in reducing ROS. 
1.3.3. RAPAMYCIN TREATMENT AS A DIETARY RESTRICTION MIMETIC 
Rapamycin feeding has been shown to increase lifespan under both long-term 
treatment (Miller et al., 2011) and late-onset treatment (Harrison et al., 2009). 
Rapamycin inhibits mTOR part of a nutrient sensing pathway activated by growth 
factor stimuli (Ma and Blenis, 2009). mTORC1 and mTORC2 are both complexes 
formed by mTOR. mTORC1 appears to be more sensitive to rapamycin. The activation 
of mTOR has been shown to increase protein synthesis and cell growth while causing a 
reduction in autophagy (Thomson et al., 2009). The inhibition of the kinase decreases 
lipid synthesis and promotes the inhibition of growth factors (Clohessy et al., 2012; Fok 
et al., 2012).  
It is thought that rapamycin treatment could be a DR mimetic as both increase lifespan 
(Kaeberlein and Kennedy, 2009). It has been shown that both rapamycin and DR act 
through the same mammalian target (Fok et al., 2012). Rapamycin treatment and 
dietary restriction both cause a decrease in phosphorylation of the ribosomal protein 
S6 kinase is decreased in both. Reactive oxygen species are shown to decrease in 
dietary restriction and rapamycin (Ash and Merry, 2011; Shin et al., 2011). There are 
indications that not all characteristics between rapamycin treatment and dietary 
restriction are the same. Insulin sensitivity is higher in DR mice a response which is not 
replicated in rapamycin treated mice (Fok et al., 2012). Fok et al look at differences 
between mRNA levels of cell cycle proteins none of these are changed, in the same 
direction, significantly from AL expression (Fok et al., 2012). The release of hydrogen 
peroxide measured from specific ETC sites would be mirrored between DR and 
rapamycin treatment if they responded via the same pathways.  
1.3.4. TELOMERASE AND MITOCHONDRIAL REACTIVE OXYGEN SPECIES 
PRODUCTION  
Telomeres are tandem repeats at the end of chromosomes, which play an important 
role in protecting the chromosome (Suh et al., 2002). Normal cell division makes copies 
of the chromosomes and results in shorter telomeres (Harley et al., 1990). Telomerase 
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elongates the telomeres to prevent chromosomal instabilities in dividing cells 
(Haendeler et al., 2003; Haendeler et al., 2009).  The lagging strand is replicated during 
chromosomal replication by initiation using a primer. The final step in chromosomal 
replication requires removal of the primers. Ligase fills the gaps left by the primer, a 
process which can’t be completed where final primer is attached resulting in 
shortening the telomeres (Suh et al., 2002).  
Telomerase reverse transcriptase protein (TERT) is the catalytic unit of the telomerase 
enzyme. Telomerase can immortalize cells by maintaining telomere length resulting in 
continuing growth (Bodnar et al., 1998). Senescence is triggered in response to DNA 
damage which includes uncapped telomeres. Telomeres are more susceptible to 
oxidative damage and the repair mechanisms aren’t as efficient. Telomeres 
accumulate damage easily and increase the speed at which they shorten resulting in 
senescence {Ahmed, 2008 #999}(Passos et al., 2007a; Passos et al., 2007b). 
The TERT sequence contains an N-terminal leader sequence which allows for the 
localisation of telomerase to the mitochondria (Santos et al., 2004). The increase of 
hydrogen peroxide levels causes an export of telomerase from the nuclei and co-
localisation between telomerase and mitochondria (Haendeler et al., 2004; Ahmed et 
al., 2008; Singhapol et al., 2013). TERT has been shown to have a protective effect in 
response to oxidative stress in cultured cells. Stress results in the exclusion of 
telomerase from the nucleus in a reversible manner. Telomerase co-localises with the 
mitochondria when excluded from the nucleus (Ahmed et al., 2008; Haendeler et al., 
2009; Spilsbury et al., 2015). Telomerase expression protects the mitochondria when 
increased in MRC5 cells. This increased telomerase expression prevents mtDNA 
damage, reduces superoxide levels and increases antioxidant defences (Ahmed et al., 
2008; Haendeler et al., 2009; Spilsbury et al., 2015).  
Telomerase is also involved in protecting the activity of the ETC complexes (Haendeler 
et al., 2009).Mice with mutated TERT has lower respiration and lower complex I 
activity (Haendeler et al., 2009). Complex I of the ETC is a primary source of superoxide 
production. Hydrogen peroxide release is measured from specific sites of the electron 
transport chain will allow us to discover the complexes involved in reduced 
superoxide. 
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1.4. THE IMPORTANCE OF QUANTITATIVE PROTEOMICS IN 
RESEARCH 
Proteins are the basis for all cellular processes. Proteins have many functions as 
enzymes, transporters, signal transducers and structure forming molecules. The 
versatility in their structure, folding and modification results in a complex and dynamic 
network of functional proteins. This makes them a desirable target in biological studies 
to monitor changes in abundance of proteins and modifications within them (Berg et 
al., 2007). 
High-throughput protein identification using automated techniques gave us the ability 
to study the proteome from an organelle, cell, or tissue. These large scale studies allow 
for the discovery of multiple pathway changes which interact with each other. High-
throughput techniques gave remove the constraints of focusing on a limited number of 
targets due to elaborate and time-consuming techniques like chromatography and 
electrophoresis (Reinders and Sickmann, 2009).  
1.4.1. DIFFERENT METHODS USED TO QUANTIFY PROTEINS 
Quantitative proteomics requires a label on the individual proteins so a comparison 
can be made to determine changes between samples. Mass spectrometry samples can 
be labelled using different methods. TMT labelling tags each sample’s individual 
peptides with differently weighted labels. Multiple samples are directly analysed in 
parallel and separated out by their different tagging with computer analysis after 
measuring (Okuda et al., 2002; Thompson et al., 2003).  
Stable Isotope Labelling with Amino Acids in Cell Culture (SILAC) was developed in the 
centre for Experimental Bioinformatics. This method requires metabolic labelling of 
the proteins, prior to digestion of the protein for peptides. This is a different method 
to TMT labelling which labels the peptides prior to measurements, but similarly 
directly compares samples in one parallel measurement (Steen and Mann, 2004). 
Spike-in SILAC method has only one labelled sample, a standard, to which all others are 
compared. This standard is always the same the protein change in each sample is 
determined in relation to the standard and then each other (Kim et al., 2002; Geiger et 
al., 2011).  
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1.5. MITOCHONDRIAL PROTEOME IS CHANGED WITH AGE AND 
DIETARY RESTRICTION 
ETC complex activity was measured in the gastrocnemus mouse muscle at 10 and 20 
months of age. The activity of the four complexes was affected by age and dietary 
restriction. Complex I, III and IV activity is decreased with age and in 10 month DR. The 
activity of complexes IV in DR mice became higher than AL at 20 months (Desai et al., 
1996).  
Comparing three different tissue proteome changes in female rat liver had the highest 
number of altered proteins (Chang et al., 2007). Bonferroni correction limited the 
number of significant changes in protein abundance with age and dietary restriction. 
There were 76% of significantly changed proteins increased with age. These increased 
proteins included an increase in amino acid metabolism, TCA and respiration proteins 
suggesting an increase in the need for energy with age. Additional proteins increased 
with age were chaperone proteins prohibitin and heat shock protein 60. The heat 
shock protein 60 has been shown to protect against oxidative damage (Chang et al., 
2007). However prohibitin stabilises unassembled complex I subunits which causes an 
oxidative stress increase (Miwa et al., 2014). In the same study dietary restricted 
mitochondria have a decrease in complex I protein abundance (Miwa et al., 2014). 
Novel approaches are continually produced. Complexome profiling is a novel approach 
using blue native gels to separate large protein complexes (Huang et al., 2009; Heide et 
al., 2012; Wessels et al., 2013; Miwa et al., 2014; Giese et al., 2015). The mitochondrial 
ETC complexes are the primary site of superoxide release. Heide et al confirm that 
these ETC complexes and flavoproteins cluster closely in 2D BN gel electrophoresis 
(Heide et al., 2012). Complexome profiling allows for the discovery of proteins which 
are involved in assembling protein complexes. PhB, STOML2 are seen to co-migrate 
with 28S and 39S mitoribsomal complexes suggesting a role in complex I assembly 
(Wessels et al., 2013).  
Superoxide clearance proteins have been targeted as possible lifespan extension 
treatments. Overexpression of catalase targeted to the mitochondria caused lifespan 
extension and attenuation of hydrogen peroxide release in transgenic mice (Schriner et 
al., 2005). Catalase is increased with age in the brain and dietary restriction has a 
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higher catalase activity than AL tissues  (Sohal et al., 1994). Overexpression of 
superoxide dismutase has also reduced ROS in cellular models  (Lee et al., 2009).  
1.5.1. PROTEIN QUALITY CONTROL DETERIATES WITH AGE 
Oxidative stress causes protein damage resulting in mitochondrial dysfunction. The 
maintenance systems which repair protein damage are critical to protect against the 
ageing process. The increase in free radicals and oxidative stress with age can create 
mitochondrial dysfunction. The increased oxidative stress increases the likelihood of 
protein damage leading to mitochondrial function changes (Hamon et al., 2015).  
Long-lived mice have a preference for correct ETC complex I matrix arm assembly. The 
assembly is more efficient in mice with longer lifespan. Correct assembly decreases 
reactive oxygen species (ROS). In ageing the assembly becomes compromised 
increasing ROS (Miwa et al., 2014). 
Liver protein replacement is reduced in 12 months dietary restriction. Price et al shows 
an increase in the half-life 85% of liver proteins. The replacement rate is decreased in 
proteins of the tricarboxylic acid, fatty acid and ATP synthesis metabolism pathways 
(Price et al., 2012).  
1.5.2. MITOCHONDRIAL PROTEIN DEGRADATION PATHWAYS. 
Mitochondrial proteins are likely targets for oxidative damage due to the ROS 
produced by the ETC into the matrix. It is considered that the mitochondrial proteins 
are degraded internally. This degradation produces free amino acids available for 
transcription of proteins encoded for in the mitochondrial DNA. Mitochondrial 
proteins which are moderately damaged can be degraded via the Lon protease 
pathway {Johnson, 2013 #1230}. Lon protease has been shown to degrade proteins 
damaged by oxidative stress {Bota, 2002 #1231}. Knockdown of the Lon protease has 
also been shown to protect against senescence and tumorigenesis {Quiros, 2014 
#1233}.  
Severe oxidative damage to mitochondrial proteins can cause a decrease in the 
mitochondrial membrane potential. If the membrane potential of the mitochondria 
decreases fission of the mitochondria can occur and target the protein for the 
15 
 
lysosome and degradation {Johnson, 2013 #1230}{Twig, 2008 #1234}. Twig et al 
determined fission events were important for mitophagy. Fission would produce 
mitochondria which were depolarised and unable to undergo fusion therefore they 
would be targeted for mitophagy {Twig, 2008 #1235}. The degradation of damaged 
proteins and mitochondria is important to protect against dysfunction. 
1.6. AIMS AND OBJECTIVES OF THE STUDY 
The aims of this study were to determine detailed effects of ageing and dietary 
restriction on changes in hydrogen peroxide production and mitochondrial protein 
abundance. ROS in the cell is generally a biological derivative of hydrogen peroxide or 
superoxide (Brown and Borutaite, 2012). Hydrogen peroxide release is examined at 
multiple ages in addition to the comparison of AL and DR treatments. AL mitochondria 
were collected at 3, 15, 24 and 30 months with DR collected at 15, 24, 30 and 36 
months. 30 month AL mitochondria and 36 month DR mitochondria compares the 
function at the same survival point (35%) in the mouse lifespan. This timescale is much 
more detailed than anything previously reported. Lifespan extension mechanisms for 
example the effect of rapamycin and mechanism which protect against ROS like 
telomerase were also investigated.  
Mitochondria are the primary site of superoxide production and therefore oxidative 
damage. This suggests the mitochondrial proteome would have the greatest source of 
proteomic changes to explain the mechanisms of ageing.  
The objectives of this thesis is to study the changes in hydrogen peroxide release from 
different sites of the electron transport chain including:  
o Multiple ages in three tissues (Brain, Liver and Skeletal Muscle) 
o Long term dietary restriction (DR) in three tissues (Brain, Liver and 
Skeletal Muscle) 
o Dietary restricted mitochondria from three tissues (Brain, Liver and 
Skeletal Muscle) at multiple ages. 
o Dietary restricted mitochondria in three tissues (Brain, Liver and 
Skeletal Muscle) at two collection times, DR (24hrs after feeding) and 
postprandial DR (6hrs after feeding)  
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o A late 35% survival point of AL and DR fed mice in three tissues (Brain, 
Liver and Skeletal Muscle). 
o Short term rapamycin feeding in three tissues (Brain, Liver and Skeletal 
Muscle) 
 A comparison of short term dietary restriction with short 
term rapamycin  
o The absence of telomerase 
I also studied the changes seen in the liver proteome abundance under different 
conditions including: 
 Multiple ages in three tissues (Brain, Liver and Skeletal Muscle) 
 Long term dietary restriction (DR) in three tissues (Brain, Liver and 
Skeletal Muscle) 
 Dietary restricted mitochondria from three tissues (Brain, Liver and 
Skeletal Muscle) at multiple ages. 
 Dietary restricted mitochondria in three tissues (Brain, Liver and 
Skeletal Muscle) at two timepoints, DR (24hrs after feeding) and 
postprandial DR (6hrs after feeding)  
 Late survival points of 35% of AL and DR fed mice in three tissues 
(Brain, Liver and Skeletal Muscle). 
The outline of the proteomics study has male mitochondria of comparable age and 
treatment studied for their hydrogen peroxide release. A sun diagram depicting the 
experimental plan is shown in figure 1-3. 
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Figure 1-3: The experimental plan for the proteomics study. These are the factors 
compared in the proteomics study and amplex red study in males only. There are four 
factors considered (Sex, Nutrition, Age and Time of Culling) each with at least two 
parameters. 
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CHAPTER 2: MATERIALS AND METHODS 
2.1. ANIMALS 
All the work in this thesis complied with the guiding principles for the care and use of 
laboratory animals and was licensed by the UK Home Office (PPL60/3864). Mice of the 
same sex were housed in cages (56 cm × 38 cm × 18 cm, North Kent Plastics, Kent, UK) 
of groups of four to six with an identifying ear notch. Mice were provided with 
unlimited water, sawdust and paper bedding. Mice were housed at 20 ± 2 C under a 
12h light/12h dark cycle with lights on at 7:00 am. Dissections of the mice were carried 
out in a team this included: Kerry Cameron; Satomi Miwa; Amy Johnson; Rafal 
Czapiewski; Laura Wiley; Hannah Gautrey; Claire Kolenda; Craig Parker; Carmen 
Martin-Ruiz; Clara Correia Melo; Joanna Gorniak; Sabine Langie; Sofia Lisanti. 
All chemicals are included in table 6-5 in appendix A. 
2.1.1. MICE FROM THE DIETARY RESTRICTION STUDY USED FOR 
MITOCHONDRIAL HYDROGEN PEROXIDE RELEASE ASSAY 
A total of 48 C57Bl/6 male mice were purchased from Harlan (Blackthorn, UK) for use 
in the study focusing on age and dietary restriction. Mice were fed AL diet (CRM (P); 
Special Diets Services, Witham, UK) until 3 months of age then divided into AL and DR 
groups. DR mice were fed a 40% restricted diet based on the AL food intake (Cameron, 
K et al. Longevity & Healthspan 2012). Mice fed an AL diet had tissues collected from 3, 
15, 24 and 30 months. Mice fed a DR diet had tissues collected from 15, 24, 30 and 36 
months. Brain tissue was collected from mice at all age points. Liver tissue was 
collected from mice at 3, 24, 30 and 36 months. Skeletal muscle mitochondria were 
collected from mice at 3, 15, 30 and 36 months. Brain, liver and skeletal muscles from 
the hind legs were collected and used to obtain mitochondria at these ages for 
functional hydrogen peroxide release studies as a mark of superoxide and therefore 
ROS production.  Table 6-1  in appendix A summarises additional information on these 
mice. Pathology, dissection and tissue isolation problems are also detailed in table 6.1. 
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Figure 2-1: Experimental Plan for the long-term dietary restricted study. Mice were 
culled at 3 months in AL fed mice only; 15, 24 and 30months in both AL and DR mice; 
and 36 months from DR mice only. The age and dietary treatment is denoted by the 
coloured lines. AL treated mice are on the red line and DR treated mice are in blue. DR 
treatment starts at 3 months at this age there is only AL treated mice culled. AL mice 
have a shorter lifespan so at 36 months only DR mice were available for tissue 
collection. Amplex red experiments were carried out on tissues collected at each age, 
the data shown is detailed in the boxes below the time point in the figure. 
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2.1.2. MICE MITOCHONDRIA OBTAINED FOR HYDROGEN PEROXIDE 
RELEASE IN TERT KNOCKOUTS AND RAPAMYCIN STUDIES 
This study compared the effect of short-term dietary restriction treatment in WT and 
TERT knockout mice on hydrogen peroxide release from brain mitochondria (strain 
B6.129S-Tert tm1Yjc/J, Jackson Laboratories) There were four groups of four male 12 
month old mice compared. The groups comprised two treatments, ad libitum (AL) fed 
and 40% dietary restricted (DR) fed groups, for two genotypes, WT and TERT-/-. The 
dietary restriction was introduced at nine months and  maintained for three months 
until mice were culled, tissues were collected and mitochondria were isolated. 
2.1.3. MICE USED TO OBTAIN HYDROGEN PEROXIDE RELEASE FROM 
SHORT-TERM DIETARY STUDIES 
Short-term dietary studies were focused on two areas, dietary restriction was studied 
including the effects of culling six hours post feeding, and short-term rapamycin 
treatment. The short-term studies used a mouse strain backcrossed from TERC+/− 
mice (strain B6.Cg-Terctm1Rdp/J, Jackson Laboratories). The onset of DR treatments in 
female mitochondria occurred at 12 months and continued until culling at 15 months. 
Start controls were mice culled at 12 months obtaining the tissue prior to dietary 
changes. The short term dietary restriction study had three treatment types for three 
months, AL, DR and PMDR (Afternoon collected dietary restricted). In AL and DR mice 
the tissues were collected directly prior to feeding. In PMDR mice the tissues were 
collected in the afternoon six hours after feeding. DR and PMDR groups were fed a 
40% restricted diet compared to the intake of the AL diet. The rapamycin experiment 
had two treatments control and rapamycin feeding. Rapamycin treatment was studied 
in two separate experiments. It was started in males at 9 months, and females at 12 
months. Control mice had a variation of the AL diet and rapamycin diet has the same 
basis of the control mice with the addition of 0.067mg rapamycin (Miller et al., 2011; 
Wilkinson et al., 2012). 
2.1.4. MICE USED IN THE LARGE PROTEOMICS STUDY 
There were a total of 60 mice used in the large dataset looking at sex, age and dietary 
restriction. They were from the same strain as those in section 2.1.1 and husbandry 
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was the same for these mice. The sex, age and treatment for each mouse are detailed 
in Table 6-3 (appendix A). 
2.2. ISOLATION OF MITOCHONDRIA 
Mitochondria were isolated by tissue-specific methods as outlined below. The  
mitochondria for the amplex red assay were immediately resuspended in 200µl of the 
corresponding isolation medium (detailed below). The mitochondria were used within 
less than 4h storing them during this period at 4°C. The mitochondrial pellet obtained 
at the end of the isolation process was snap frozen in liquid nitrogen before storage at 
-80oC before use for proteomics studies. Mitochondria were isolated by Satomi Miwa 
unless otherwise stated. 
2.2.1. ISOLATION OF MITOCHONDRIA FROM MOUSE BRAIN TISSUE 
The mouse brain was dissected and placed in brain isolation medium (250mM Sucrose, 
10mM Tris, 0.5mM EDTA pH 7.4 @ 4oC) within 15 seconds of the death of the mouse. 
The brain was homogenised using a glass homogeniser (Wheaton 15ml Douce tissue 
grinder) using eight strokes with a loose-fit pestle and centrifuged for 3 minutes at 
2000g. The supernatant was centrifuged for 10 minutes at 11400g. The pellet was 
resuspended in 0.5ml of 3% Ficoll medium (240mM mannitol, 60mM sucrose, 50µM 
EDTA, 10mM Tris, pH 7.4 @ 4oC, and 6% (w/w) Ficoll (Sigma-Aldrich). This suspension is 
layered onto 10ml of 6% Ficoll medium and centrifuged at 12500g for 15 minutes. The 
resultant brown pellet was resuspended in 10ml isolation medium and spun at 12500g 
for 10 minutes to remove the ficoll.  
2.2.2. ISOLATION OF MITOCHONDRIA FROM MOUSE LIVER TISSUE 
The liver was dissected from the mouse and cut into smaller pieces. This was washed 
with liver isolation medium (STE (250mM Sucrose, 5mM Tris, 2mM EGTA pH 7.4 @ 4C, 
Sigma)) and homogenised, six strokes with the loose pestle of the glass tissue grinder. 
The homogenate is centrifuged at 1,050g for 3 minutes. The supernatant is then 
centrifuged at 11,630g for 10 minutes. This pellet is further purified using density 
gradient centrifugation (Pagliarini et al., 2008). The pellet is resuspended in 0.5ml 
isolation medium and carefully layered on top of a stepwise density gradient of 2ml 
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80%, 6ml 52%, and 6ml 26% Percoll (Sigma). This was centrifuged at 41,100g for 45 
min. Mitochondria were collected from the 26%/52% interface, diluted to capacity in a 
2ml eppendorf tube with STE, and centrifuged at 11600g for 10 minutes. The 
supernatant was carefully discarded, and the mitochondria were washed with an 
additional 2ml STE and re-spun. The resulting pellet was purified mitochondria.  
2.2.3. ISOLATION OF MITOCHONDRIA FROM MOUSE SKELETAL MUSCLE 
TISSUE 
Skeletal muscle from the hind legs (quadriceps, biceps femoralis, gastrocnemius) was 
added to CP1 isolation medium (100mM KCl, 50mM Tris, 2mM EGTA, pH 7.4 @ 4C, 
Sigma). It was then minced and chopped then added to CP2 medium [(CP1 isolation 
medium plus 1mM ATP, 5mM MgCl2, 0.5% fatty acid free BSA (Sigma A3803), Protease 
(Type VIII Subtilisin A; Sigma, P5380), ph 7.4 @ 4C] using about 10ml medium per 1g 
tissue. The muscle CP2 mix is stirred for 1 minute. The tissue was homogenised with a 
loose pestle in a glass homogeniser and centrifuged for seven minutes at 490g.  The 
supernatant was filtered through two layers of muslin into a new tube and spun for 10 
minutes at 10368g.  The pellet is resuspended in CP1 and spun for 10 minutes at 
11368g. The pellet was flash frozen in liquid nitrogen for proteomics digestion or 
resuspended in CP1 for hydrogen peroxide production. 
2.3. AMPLEX RED ASSAY  
Amplex red (Thermo Fisher Scientific) is a non-fluorescent compound which oxidises in 
the presence of hydrogen peroxide and horseradish peroxidase. The oxidised 
compound created in the amplex red assay is resorufin which is excited at 450nm and 
then fluoresces at 490nm. Amplex red reacts with horseradish peroxidase in a 1:1 
stoichiometry so as more hydrogen peroxide is made more resorufin is produced and 
more fluorescence is detected. The volume of hydrogen peroxide can then be 
calculated from the fluorescence intensity changes when a standard is added.  
2.3.1. STANDARD ASSAY CONDITIONS 
The release of hydrogen peroxide from isolated mitochondria was determined using an 
amplex red assay using an Omega FLUOstar using a 96 well black plate. A final 
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concentration of 0.6mg/ml brain, liver or muscle mitochondria were incubated at 37oC 
in the assay buffer; 200µl comprising KHE (100mM KCl, 10mM Hepes (pH 7.0), 0.1mM 
EDTA (pH 7.4 @ 37oC) 1% BSA, All chemical from Sigma), 2U/ml horseradish peroxidase 
, Sigma, 50µM Amplex Red, 15U/ml SOD, Sigma and 1ug/ml oligomycin, Sigma. The 
machine was set at an excitation of 544nm and an emission of 590nm to read resorufin 
fluorescence every 10 seconds. Experimental wells contain the isolation medium and 
mitochondria. Blank wells contain no mitochondria. Blank wells were used to produce 
a standard. The standard is an addition made during the assay which comprises of 
29.4pmoles of hydrogen peroxide (Sigma). The standard allows for the conversion of 
resorufin fluorescence to hydrogen peroxide release. 
To measure hydrogen peroxide production originating from specific complexes in the 
ETC, various activators and inhibitors were sequentially added to the reaction mix. The 
assay, maintained at 37oC, was interrupted after at least two minutes of stable 
measurements to add these activators and inhibitors and restarted immediately after. 
These additions can take up to two minutes, this can cause fluctuations in the 
temperature of the assay. Measurements taken directly after the addition of activators 
and inhibitors were not used for calculations. Two minutes of incubation at 37oC 
stabilises the temperature in the wells. Measurements were taken at a stable 
temperature using consistent rates of fluorescence. 
Different methods were used to measure complex II compared to I and III. To measure 
Complex I and III hydrogen peroxide release, two respiratory substrates were used. 
Complex I hydrogen peroxide release is determined using 5mM Pyruvate and 5mM 
Malate (PM, complex I-linked substrate). Rotenone addition (2.5µM, in DMSO 
Dimethyl Sulfoxide) in the presence of PM inhibits complex I, and stimulates maximum 
complex I superoxide production. Addition of 4mM Succinate (complex II-linked 
substrate) gives data on both complex I and III superoxide production. The addition of 
succinate and rotenone means the electron flow is forward through the ETC. Complex 
III maximal production is shown by addition of Antimycin A (2.5µM). A further addition 
of myxothiazol (2.5µM) was made to wells containing succinate, rotenone and 
antimycin A (all chemicals Sigma).  
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To measure complex II-linked hydrogen peroxide production (Quinlan et al 2012), 
mitochondria were incubated with four separate assay buffers. All assay buffers 
contained an additional 2.5uM rotenone to that outlined in section 2.2.2.1 as a basal 
buffer. The assay buffers comprised: basal buffer, basal buffer with the addition of 
0.4mM Succinate; basal buffer with the addition of 0.4mM Succinate and 1uM Atpenin 
A5; basal buffer with the addition of 0.4mM Succinate, 1uM Atpenin A5 and 500uM 
Malonate (all chemicals Sigma). No further additions were made to the assay as it 
progressed. 
Experiments were completed in triplicate for each sample as well as two wells without 
any mitochondrial suspension which act as a blank control. Results were calculated 
using fluorescence values, produced after a constant rate has been established from 
measurements performed every 10 sec over at least two minutes. The SLOPE function 
in Microsoft Excel was used on each kinetic measurement. This calculation gives us the 
rate of fluorescence increase. The rate results from the blank wells were subtracted 
from the rate results from the wells containing mitochondria to remove background 
fluorescence. 
 
b = rate of fluorescence 
increase            per minute 
 
?̅? = 𝑚𝑒𝑎𝑛 𝑡𝑖𝑚𝑒𝑝𝑜𝑖𝑛𝑡𝑠     
  x = timepoints  
?̅? = 𝑚𝑒𝑎𝑛 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒 
               y = fluorescence values 
 
A hydrogen peroxide standard was created by adding known amounts of hydrogen 
peroxide to blank wells. The change in fluorescence was determined in the wells with 
standard addition. This standard allows for the conversion of the rate of mitochondrial 
fluorescence values to the rate of moles of hydrogen peroxide released.  
The fluorescence rate was first determined before substrate addition. This describes 
the basal release of hydrogen peroxide. All hydrogen peroxide release rates are 
determined in the presence of PM and PM + Rotenone as well as Succinate, Succinate 
+ Rotenone, Succinate + Rotenone + Antimycin A and Succinate + Rotenone + 
25 
 
Antimycin A + Myxathiozol. The rates of production are determined separately for 
each substrate and displayed graphically as such. The difference between succinate 
and succinate + rotenone is calculated to show the reverse flow hydrogen peroxide 
release from complex I. The rates were calculated for individual wells (technical 
replicates) any background fluorescence (blank wells) was deducted.  Technical 
replicates were averaged  give a value for each mouse. 
Complex II hydrogen peroxide release is calculated differently than complex I and III. 
The mitochondria don’t have the activators and inhibitors added in succession. The 
mitochondria are incubated with the activators and inhibitors from the start of the 
assay. The different incubation assays are detailed in 2.2.2.1. The results are calculated 
as rate of hydrogen peroxide release for each well as with complex I and III. The blank 
results and basal buffer results are subtracted as with complex I and III. The release of 
hydrogen peroxide is then determined from site IIq and site IIf. Complex IIq release 
was calculated as the difference between succinate only and succinate + atpenin A5. 
Complex IIf was calculated as (succinate + atpenin a5) minus (succinate + atpenin a5 + 
malonate). 
Hydrogen peroxide release from liver mitochondria is calculated differently than brain 
and muscle. The measurements are made in the presence and absence of HRP. The 
final calculation is the difference between the values in the presence and absence of 
HRP.  
2.3.2. RESORUFIN AS THE TARGET OF THE AMPLEX RED ASSAY 
There were problems seen in the detection method used on liver mitochondria. This 
complication was clouded by the decrease in hydrogen peroxide release after the 
addition of substrate and other chemicals. Resorufin changes were monitored as a 
result. The fluorescence of resorufin in the presence of isolated mitochondria was 
determined using a modified amplex red assay using an Omega FLUOstar 
spectrophotometer using a 96 well black plate. Firstly incubated at 37oC and 
monitored was the assay buffer: 200µl of KHE (100mM KCl, 10mM Hepes (pH 7.0), 
0.1mM EDTA (pH 7.4 @ 37oC) 1% BSA), 2U/ml horseradish peroxidase, and 200µM 
Resorufin (Invitrogen).  The machine was set at an excitation of 544nm and an 
emission of 590nm to read fluorescence every 10 seconds. Additions of 0.6mg/ml 
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brain, liver or muscle mitochondria were incubated with the assay buffer after 
consistent results were produced. The addition of substrates, hydrogen peroxide and 
HRP were made as labelled in each experiment separately. 
2.3.3. STATISTICAL ANALYSIS 
Values are given as either mean ± standard error mean, in cases where n>3, with n 
being the number of individual experiments, or as mean ± standard deviation if n≤3. 
Percentage variation is the standard deviation of the values when compared to the 
mean. Statistical analysis was carried out using the standard t-test in Microsoft Excel 
2010 after checking the normality of distribution. The t-test was used to directly 
compare two separate conditions. Significant values were determined to be P < 0.05. 
ANOVA tests were carried out in sigma plot on data sets involving multiple 
comparisons, e.g. those related to age. Sigma plot checks for normal distribution and 
comparable variance. In the case that these conditions were not fulfilled, the ANOVA 
by ranks was used.  
2.4. RESORUFIN ABSORBANCE 
Amplex red assay relies on the detection of resorufin fluorescence. The product in the 
amplex red assay which fluoresces in response to hydrogen peroxide is resorufin. 
Resorufin absorbs light at 544nM. Absorbance of the reaction medium across the 
wavelengths 400-700nM was measured using Omega FLUOstar spectrophotometer. 
Wells were loaded with the same experimental media as in the amplex red assay 
(2.2.2.1). This reaction media was incubated with either brain mitochondria, liver 
mitochondria, or no mitochondria. Several conditions were used including substrate, 
excluding HRP or amplex red. Background levels were determined without 
mitochondria. Area under the curve was calculated and statistics performed on these 
numbers. 
2.5. PROTEIN CONCENTRATION ASSAY 
Protein concentration was determined using the BioRad DC protein concentration 
assay kit (BioRad). Standards of known protein concentrations (0mg/ml, 0.06mg/ml, 
0.125mg/ml, 0.25mg/ml, 0.5mg/ml, 1mg/ml, 2mg/ml) were made using BSA (Sigma). 
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Mitochondria were measured in a 5% dilution. The standard and the mitochondrial 
dilutions were combined with reagents A, S and B. The absorbance was read at 750nM 
after 15 minutes incubation at room temperature. A standard curve was created 
(figure 2-1). The mitochondrial sample absorbance was compared to the standard 
curve to determine the protein concentration of the diluted mitochondria. The 
concentration was then deduced for the mitochondrial sample from its dilution.  
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Figure 2-2: An example standard curve produced from the BSA standards with an r2 
value of 0.9971. This standard curve is produced from two replicates of known protein 
concentrations (0mg/ml, 0.06mg/ml, 0.125mg/ml, 0.25mg/ml, 0.5mg/ml, 1mg/ml, 
2mg/ml BSA). A trendline is added with its equation. The curve is used to then obtain 
accurate protein concentration from the sample absorbance measured.  
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2.6. ISOLATION OF MITOCHONDRIA FROM MOUSE AML 12 CELLS FOR 
PROTEOMICS STUDY 
Cells were AML12 mouse liver cells (http://www.atcc.org/products/all/CRL-
2254.aspx#documentation) and maintained in DMEM/F12 media in 1:1 ratio with the 
following supplements: 5µl/ml insulin, 5µg/ml transferrin, 5ng/ml selenium and 
40ng/ml dexamethasone. Cells were switched to the same type of supplemented 
media with replacement of FBS with dialyzed FCS (Biowest, France) lysine and arginine 
labelled with C14 and N13 for SILAC incorporation. SILAC labelled amino acids used 
were lysine (K8, L-Lysine-2HCl (U13C6, 98%; 15N2, 98%) Cambridge Isotope Lab, 
Hampshire) and Arginine (R10, L-Arginine; HCl (U-13C6, 98%; 15N4, 98%) Cambridge 
Isotope Lab). The cells were harvested at 80% confluence and mitochondria were 
isolated from them using the QuadroMACs separation kit (Miltenyi Biotec). 20 million 
cells were harvested and resuspended in 2ml of lysis buffer. The cells were lysed using 
a 27G needle in 5million batches. The mitochondria were labelled with 
superparamagnetic MACs MicroBeads supplied as part of the kit. The MACs column is 
attached to a strong magnet this retains all magnetically labelled mitochondria when 
passed through the column. Removing the column from the magnet allows for elution 
of the mitochondria (Hornig-Do et al., 2009). Approximately 100µg protein per 107 
cells was obtained and 3mg isolated mitochondrial protein was collected in total. 
2.7. SEPARATION AND DIGESTION OF PROTEINS 
2.7.1. ACETONE PRECIPITATION 
Mitochondria comprise more than just proteins, to ensure a pure preparation of 
proteins was used for mass spectrometer analysis acetone precipitation was used 
(Sigma).  100%  acetone stored at -20 oC is added in a 6:1 ratio with the volume of 
isolated mitochondria. This was incubated at -20oC overnight. The mixture was 
centrifuged for 15 minutes at 15,000g at 4oC to remove the acetone. the pellet was 
allowed to dry before use. 
2.7.2. IN SOLUTION DIGEST 
30 
 
Proteins were precipitated from the isolated liver mitochondrial samples were 
dissolved in 250µl 6M urea (Sigma), 100mM Tris/50mM Ammonium bicarbonate 
(Sigma). 50µl of this solution was reduced with 2.5µl of reducing agent for 1 hr. The 
samples were then alkylated in the dark for 1 hour with 10µl of alkylating agent. To 
consume unreacted iodoacetamide after an hour 10µl of reducing agent was added. 
240µl of 50mM ammonium bicarbonate was added to decrease the urea 
concentration to 1M. 2µg of trypsin was added to each sample and incubated at 37oC 
overnight. The digest was stopped by adding 100µl of 5% TFA. The samples were 
cleaned using stagetips. 20µl of each digested sample was combined with 10µl of 
digested standard. LC-MS/MS analysis was performed at FingerPrints Proteomics 
laboratories (University of Dundee) and RAW data was returned (performed by Dougie 
Lamont, Kenny Beattie and FingerPrints Proteomics Staff). 
2.7.3. STAGE TIPS 
STAGE tips were created with a C18 Empore filter (Sigma) placed in a 10µl pipette tip 
(Eppendorf). The tip was then used to filter the sample. The sample is filtered using 
several steps. The STAGE tip has the buffer or sample loaded into the top and a syringe 
is used to push the buffer over the Empore filter.  
The STAGE tip is equilibrated with 10µl acetonitrile then 10µl 0.1% TFA. The sample is 
then loaded through the STAGE tip twice. The STAGE tip is washed with 0.1% TFA. To 
elute the sample 10µl of elution buffer (65% Acetonitrile in 0.1% TFA) is added to the 
STAGE tip to elute the sample into a clean Eppendorf tube. 
2.8. INCORPORATION OF HEAVY LABELLED AMINO ACIDS INTO 
AML12 CELLULAR PROTEINS 
2.8.1. 1-DIMENSIONAL GEL ELECTROPHORESIS 
To assess the incorporation of heavy labelled isotopes into the AML12 mitochondria, a 
LC-MS/MS experiment was carried out with a single band from a mitochondrial protein 
1-dimensional gel. Isolated liver mitochondria from 2.2.2 were flash frozen in liquid 
nitrogen and thawed on ice for five repetitions. Acetone precipitation was carried out 
on the mitochondria to further purify the protins. The dried precipitate was 
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redissolved in SDS sample buffer, NuPAGE reducing agent, water, 5:1:4 (10µl total 
volume, Invitrogen), heated to 85oC for five minutes and sonicated for 3 minutes. 
Samples were separated on a pre-cast 4-12% Bis-Tris gel (NuPAGE) at 180 volts for 90 
minutes. Gel was stained using Coomassie Blue (EZBlue, Sigma). 
2.8.2. IN GEL DIGEST 
 To determine SILAC incorporation only a small amount of the gel was needed so only 
one band was used for an in gel digestion. Gel sections/bands were cut and destained. 
The gel pieces were then reduced using 10mM DTT (AppliChem) and alkylated in the 
dark using 50mM Iodoacetamide (Applichem). After washing with ammonium 
bicarbonate and acetonitrile (Sigma), the gel pieces were incubated at 37oC with 0.2µg 
trypsin (Promega) in 60µl of 50mM NH4HCO3 and 1mM CaCl2 for 18h to digest the 
proteins. Trypsin was stopped by the addition of 10µl 5% TFA (Trifluoroacetic acid, 
Sigma). The digested peptides are now in the solution. Further hydrophobic peptides 
were obtained from the gel by the addition of 20µl 2% TFA/ 60% acetonitrile. 20µl of 
100% acetonitrile was added to the gel pieces to elute any remaining peptides. The 
total solution was then concentrated in a speedvac. The samples were stage tipped to 
clean the sample. The samples were then acidified using 1% TFA and transferred to MS 
vials for mass spectrometer analysis. LC-MS/MS analysis was performed, using a 1 hour 
gradient, on an LTQ XL orbitrap mass spectrometer coupled to an Ultimate 3000 nano 
HPLC system (Thermo Scientific). 
 
The incorporation of the SILAC label into the standard above a threshold value is 
fundamental to this method. Unlabelled standard would count as part of the 
unlabelled sample therefore affecting the quantification of proteins. Therefore 
determining the incorporation of SILAC into the standard’s proteins is vital. 
Confirmation of fully labelled protein of greater than 95% within the sample is an 
accepted amount for a spike-in standard (Kim et al., 2002; Geiger et al., 2011). As the 
heavy labelled amino acids are the only source for new proteins, during mitosis the 
proteins made in the new cells will contain only heavy labelled amino acids. Therefore 
mitosis halves the quantity of unlabelled protein. This produces the equation: 
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 1/(2n) = proteins unlabelled. Where n = number of population doubling  
According to the equation after seven population doublings there should be only 
1/128 (0.78%) of the cellular protein unlabelled. This is when the incorporation 
analysis was carried out to ensure more than 95% of the amino acids were labelled. 
Incorporation was determined by mass spectrometer analysis of a digested protein 
sample from the cells. The sample was of isolated mitochondria from these cells, as 
will be used as the standard.  
Two protein lists were generated from the one AML12 protein sample. A list containing 
the SILAC labelled proteins and another of proteins which weren’t labelled with SILAC. 
There were 158 significant proteins found to be fully labelled with SILAC, and 21 which 
weren’t fully labelled. Examining the produced lists can only show which proteins were 
found with each query result. These lists are more effective in determining SILAC 
incorporation when analysing the raw data. SILAC incorporation required growing the 
AML12 cells in media with heavy labelled amino acids which in this case were K8 and 
R10 (Geiger et al., 2011). Looking in the raw data and using The GPM list as a guide we 
can find the peak relating to that of the unlabelled peptide. Adding the mass of the 
heavy labels we can then find the corresponding peak of the peptide containing the 
labelled protein in this heavier mass range (Craig et al., 2004). Acceptable levels of this 
unlabelled protein are <5%. The level of incorporation is determined by comparing the 
mass of the heavy weighted protein with that of the unlabelled protein. Setting the 
mass spectrometer viewer to monitor the labelled protein at 100%, the percentage of 
unlabelled protein is calculated as a percentage of the heavy labelled protein. In the 
analysis performed on the SILAC incorporated samples the levels of labelled protein 
found in the SILAC labelled mitochondrial proteins were 3% which is well within the 
threshold for labelling. As further population doubling will further decrease the 
amount of unlabelled protein the sample is sufficiently labelled to act as a standard for 
spike in SILAC analysis. 
The more divisions that occur more amino acids are incorporated so all mitochondrial 
protein will be labelled to this standard minimum. 2.5mg of protein will need to be 
isolated for these experiments to produce enough standard to be spiked in to each 
sample. 
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2.8.3. DATA PROCESSING IN MAXQUANT 
The raw data files were processed using Max Quant version 1.3.1.5 using the mouse 
fasta file from May 2013 (www.uniprot.com (Geiger et al., 2013; The UniProt, 2014; 
UniProt, 2014)). Protein lists were generated using intermediate files produced by 
MaxQuant. Determination of quantification of the SILAC was also completed in the 
MaxQuant program.  
The proteinGroups.txt file was imported into Microsoft Excel 2010. The data was 
transformed in Microsoft Excel 2010. The data was logged, then filtered to include only 
the data present in over 66.6% of samples. The H/L ratio data from the proteins which 
meet these criteria were transformed in the first transformation step. This resulted in 
a subtraction of the sample median value from each protein H/L ratio to remove 
technical variation seen across the dataset. The second transformation step takes the 
median value of each protein across the samples and subtracts this value from each 
samples H/L ratio. The resultant value is a comparative amount which can be 
compared across samples. This comparative value was termed RAAT. 
Data is deposited to the ProteomeXchange Consortium 
(http://proteomecentral.proteomexchange.org) via the PRIDE Partner repository 
(Vizcaino et al., 2013). MaxQuant parameters (table 6-4) and template files (table 6-2) 
were attached in appendix A. 
2.9. STATISCAL ANALYSIS IN PERSEUS 
The transformed data was imported into Perseus a statistical program built to work 
with large multi-sample SILAC data (Geiger et al., 2013).  This program was used to 
produce random missing values for the mouse samples based on their normal 
distribution (Geiger et al., 2013). Data program R and Microsoft Excel were both used 
to produce the figures in section 5.  
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CHAPTER 3: MITOCHONDRIAL HYDROGEN PEROXIDE 
RELEASE CHANGES WITH AGE AND DIETARY 
INTERVENTION 
3.1. EXAMINING THREE TISSUES FROM MULTIPLE AGES AND 
CONDITION REQUIRES AN OPTIMISED METHOD 
3.1.1. TECHNICAL VARIATION IS MINIMISED IN THE PROTOCOL 
The fluorescence variation in response to the addition of a hydrogen peroxide 
standard was calculated over three separate days using four wells in five individual 
amplex red assays. All wells begin as blanks containing reaction medium only. The 
assay took a measurement every ten seconds, this was paused to add a standard of 
29.4pmoles H2O2 (3l) separately into two wells. The increase in fluorescence with the 
standard addition was measured. Any fluorescence change which occurred due to 
opening the machine in the blank wells when no addition of hydrogen peroxide was 
subtracted from the standard. This standard was used to estimate and minimize 
technical variation.  
The mitochondrial experiments carried out in the dietary restriction and ageing study 
take four hours. Five separate assays of three technical replicates were carried out 
over four hours. The fluorescence of a standard was checked over a four hour time 
period to ensure no degradation of either the chemicals used in the reaction medium 
or the hydrogen peroxide standard. 
On day 1 all reagents including hydrogen peroxide were diluted by KHE, for use as a 
comparable standard, these were used for the full four hours without rediluting the 
reagents. The high error bars were thought to be a result of poor pipetting technique 
this was improved on day two reducing the error bars. After the error bars were still 
high it was considered that hydrogen peroxide may not be stable when diluted in KHE. 
On day three the hydrogen peroxide was re-diluted between assays. Re-diluting the 
hydrogen peroxide standard for each experiment reduced the variation over the day’s 
experiments. The coefficient of variation between independent wells decreased from 
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34% on day 1 to 10% on day 3 (Figure 3-1). This level of technical variation was 
deemed acceptable and was maintained in all further experiments. 
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Figure 3-1: Technical variation in fluorescence intensity of a hydrogen peroxide 
standard. 3µl hydrogen peroxide (29.4pmoles) was added separately to two separate 
reaction wells in five separate experiments. These experiments were repeated on 
subsequent days. Data are mean ± standard deviation n=10. Reproducing the usable 
solutions between experiments and reducing human error decreased technical 
variation to 10%.  
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3.1.2. THE TECHNICAL VARIATION USING A BIOLOGICAL SAMPLE 
Biological variation exists between mice of the same treatment, age and strain. 
Technical variation is seen within earlier experiments as shown in Figure 3-2. The 
mitochondria are re-suspended in isolation medium for use in the amplex red assay. 
The technical variation obtained from five separate assays with three replicates for 
each mouse. Figure 3-2 shows the average hydrogen peroxide release from n=5 mice 
using the assay’s averages. The technical variation is higher in biological samples than 
in the standard as seen in Figure 3-2. This could be due to uneven suspensions in 
mitochondrial preparations. The disparity in density can re-occur between assays if the 
mitochondria are kept on ice and stable. Re-suspending the mitochondria between 
assays is the best way to reduce this. Figure 3-2 also displays the standard deviation 
from the three mice (biological variation). The standard deviation from biological 
variation is comparable to the technical variation for each mouse. Progressing with this 
amount of variation is acceptable. To reduce the variation more replicates are 
required. Limitations in the amount of mitochondria obtained from the tissues results 
in optimum technical variation. Minimising the biological variation could be achieved 
by increasing the number of mice. 
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Figure 3-2: Technical Variation is maintained with the use of a mitochondrial sample. 
Brain mitochondria were incubated with PM (A) and succinate (B) as a substrate. Each 
bar is a separate mouse, of the same age, treatment and strain, carried out on a 
separate day. The separate mice are denoted by a lighter purple colour. The separate 
mice had three technical replicates. The data is displayed as mean ± standard 
deviation.  
  
0
5
10
15
20
25
Basal Pyruvate
Malate
Rotenone
p
m
o
le
sH
2
O
2
p
ro
d
u
ce
d
 p
er
 m
g 
p
ro
te
in
A
0
5
10
15
20
25
30
35
Basal Succinate Rotenone
p
m
o
le
sH
2
O
2
p
ro
d
u
ce
d
 p
er
 m
g 
p
ro
te
in
B
39 
 
3.1.3. OTHER CONTROL EXPERIMENTS TO CONFIRM REACTION 
MEDIUM COMPOSITION 
Rotenone is diluted to concentration in DMSO. DMSO is commonly used to solubilise 
rotenone and amplex red. DMSO has been shown to preserve plant mitochondria from 
freezing damage (Dickinson DB, Science 1967). Figure 3-3 confirms that DMSO does 
not affect the hydrogen peroxide release from the mitochondria. 50uM DMSO was 
added to the wells after substrate addition to determine whether this would have an 
effect on hydrogen peroxide production. Figure 3-3 shows 50uM DMSO has no effect 
on the rate of H2O2 production from brain mitochondria. 
Mitochondria can be contaminated by free fatty acids from the cytoplasm during the 
preparation. Free fatty acids play a role in altering the mitochondrial membrane 
potential. They are known to activate uncoupling proteins (UCP) (Weigle et al., 1998) 
which can lower the membrane potential of the mitochondria decreasing superoxide 
production (Miwa and Brand, 2003). Bovine Serum Albumin (BSA) binds free fatty acids 
preventing UCP activation.  
It was shown in figure 3-4 that without BSA there is a statistically significant lower 
hydrogen peroxide release. The reduced release seen from complex I without BSA is 
significant in the presence of pyruvate malate and rotenone when complex I is at 
maximal stimulation. The reduced release is also seen in reverse flow. 0.5mg/ml of BSA 
was added to all future experiments.  
Membrane potential is dependent on the respiratory states. State III respiration (active 
respiration in the presence of ADP) the membrane potential is lower than that of state 
IV (without active ATP synthesis). Isolated mitochondria should not contain substrates 
for the electron transport chain but residual substrates and ADP may remain in the 
matrix. These residual substrates could be expended during the assay affecting results. 
Residual substrate would be seen in basal levels of H2O2 release. Respiration state II 
occurs with the addition of substrate. Endogenous ADP will result in state III 
respiration as opposed to state II. Oligomycin blocks ATP synthase causing state IV 
respiration. State II and IV are comparable as substrate is present and ATP synthase 
inactive.  
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Figure 3-5 shows that the addition of oligomycin has no effect on H2O2 release from 
brain mitochondria when using pyruvate malate as a substrate. There is a significant 
increase in H2O2 release when succinate is used as a substrate and both succinate and 
rotenone are present. All future experiments contain oligomycin; the addition of 
oligomycin to the assay medium ensures all hydrogen peroxide release is determined 
with respiration is at state IV (Hutter et al., 2004).  
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Figure 3-3:  DMSO at a concentration of 50uM does not change the rate of hydrogen 
peroxide release in brain mitochondria. Brain mitochondria were incubated with 
either PM (A) or Succinate (B), with (right) or without (left) DMSO. Graphs show the 
results from three independent experiments performed on subsequent days. Each day 
is denoted by a lighter purple. Each experiment was performed in three technical 
replicates, and data are mean ± SEM. No significant difference was seen with either a 
complex I (A) or II (B) substrate (paired t test).  
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Figure 3-4: The presence of BSA increases hydrogen peroxide release in the presence 
of both pyruvate malate and succinate. H2O2 release from brain mitochondria in the 
presence of BSA (0.5mg/ml, orange/right) or its absence (blue/left) with a PM (A) and 
succinate (B) as a substrate. The bars show the mean of three mice with the same age, 
strain and treatment. Data is shown as mean ± SEM; * significantly different (t test). 
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Figure 3-5: Oligomycin increases the release of hydrogen peroxide in brain 
mitochondria in the presence of succinate and rotenone. Brain mitochondria 
incubated with pyruvate and malate (A) or succinate (B). The bars display hydrogen 
peroxide release (pmoles H2O2/mg protein/min) in the presence of oligomycin (orange) 
and absence of oligomycin (blue). The bars are the mean from three mice each with 
three technical replicates. Data is shown as mean ± SEM; * significantly different (t-
test).  
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3.2. THE MEASUREMENT OF HYDROGEN PEROXIDE PRODUCTION IN 
PURIFIED LIVER MITOCHONDRIA USING AMPLEX RED 
3.2.1. THE LIVER MITOCHONDRIA FLUORESCE DIFFERENTLY IN THE 
AMPLEX RED METHOD TO BRAIN AND MUSCLE MITOCHONDRIA 
Under basal conditions (i.e. in the absence of a respiration substrate), mitochondrial 
oxygen consumption is negligible and (almost) no superoxide should be produced. This 
is the case in brain and muscle mitochondria (figure 3-6). However, when studying liver 
mitochondria with amplex red in the presence of only the reaction medium, there is 
already a fast increase in fluorescence under ‘basal’ conditions (figure 3-6). When a 
respiration substrate (pyruvate + malate, PM) is added, brain and muscle mitochondria 
generate increased fluorescence in the presence of the catalyst HRP (Figure 3-6), 
indicating release of hydrogen peroxide. Conversely, in the presence of liver 
mitochondria this fluorescence rate is lower when a substrate is added (figure 3-6). 
To identify possible causes of high basal fluorescence in liver mitochondria, the 
following questions were experimentally addressed:  
Does the fluorescence result from hydrogen peroxide? 
Is Amplex red oxidized to resorufin by liver mitochondria? 
Is resorufin instable at high hydrogen peroxide concentrations? 
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Figure 3-6: Basal fluorescence detection of resorufin is higher in liver mitochondria 
than brain and muscle mitochondria. The addition of Pyruvate Malate (PM) causes a 
reduction to the rate of fluorescence Brain, muscle and liver mitochondria are 
incubated with either assay buffer containing HRP (orange) or excluding HRP (blue). 
During the assay ‘basal’ fluorescence was calculated before PM was added. 
*statistically significant from no HRP, +statistically significant from brain basal, 
#statistically significant from muscle basal. (t-test) 
  
0
50
100
150
200
250
Brain
Basal
Liver Muscle Brain
PM
Liver Muscle
R
e
so
ru
fi
n
 F
lu
o
re
sc
e
n
ce
/m
g 
p
ro
te
in
/m
in
u
te
* * * *
+#
46 
 
3.2.2. LIVER MITOCHONDRIA INDUCE STRONG RESORUFIN 
FLUORESCENCE INDEPENDENTLY FROM HYDROGEN PEROXIDE 
UNDER BASAL CONDITIONS  
The resorufin fluorescence maximum occurs at 585nm. Resorufin has a characteristic 
absorption spectrum with the absorption maximum at 571nm. To see whether 
resorufin is generated from amplex red by liver mitochondria, absorption spectra are 
measured over a wavelength scale of 400-700nm. The assay medium is incubated for 
five minutes with hydrogen peroxide, liver or brain mitochondria and in the presence 
or absence of HRP or substrate or both (Figure 3-7). AR with HRP alone or with brain 
mitochondria in the absence of substrate served as negative controls, while AR + HRP + 
98pmoles hydrogen peroxide or brain mitochondria incubated with AR, HRP and 
substrate were used as positive controls.  The absorbance spectra from liver 
mitochondria + AR with or without substrate and/or HRP are the same as that of 
resorufin.  
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Figure 3-7: The amplex red oxidation product generated by liver mitochondria has 
the same absorption spectrum as resorufin. The absorbance across a range of 
wavelengths 400-700nm was measured from amplex red assays using liver and brain 
mitochondria. The wells were incubated for five minutes prior to detection. Blue, light 
blue and green traces contain liver mitochondria with and without substrate or HRP. 
Red, orange and purple traces depict brain mitochondria with and without substrate or 
HRP. The peaks are smaller in brain mitochondria experiments as less resorufin is 
produced. The lilac trace (AR+HRP) shows only the reaction medium (negative control). 
As positive control, 98 nmoles hydrogen peroxide were added to the reaction medium 
(pink labelled trace, AR + HRP + H2O2). 
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If the fluorescence generated by liver mitochondria under basal conditions were 
caused by hydrogen peroxide, it should be inhibitable by catalase added to the 
reaction medium. Therefore fluorescence was compared in the absence and presence 
of 1,000U/ml catalase (Votyakova and Reynolds, 2004). In brain mitochondria, basal 
fluorescence was low, and PM-stimulated fluorescence was strongly suppressed by 
addition of catalase. However the liver mitochondrial basal production is high as 
shown before and PM-stimulated fluorescence is unaffected by catalase (figure 3-8).   
HRP is the catalyst for the amplex red reaction. If HRP is not present hydrogen 
peroxide cannot react with amplex red to produce resorufin therefore fluorescence 
should not occur. The results of which are shown in Figure 3-8. Removing the HRP from 
the reaction medium completely removes the resorufin signal in brain mitochondria. 
Completing the reaction without the HRP only removes a small proportion of the 
fluorescence in liver mitochondria. In liver mitochondria there is no difference in 
fluorescence signal in the experiments with catalase and without HRP. When there is 
no HRP in the reaction medium and there is catalase present with liver mitochondria 
there is no increased suppression with PM addition This suggests that the fluorescence 
signal does not come from hydrogen peroxide release. If amplex red is removed from 
the reaction medium there is no fluorescence signal (not shown) suggesting the 
fluorescence occurs through amplex red by producing resorufin irrespective of 
hydrogen peroxide addition. 
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Figure 3-8: Fluorescence generated by liver mitochondria is independent of both 
catalase and HRP. Liver (A) or brain (B) mitochondria are incubated in assay medium 
either containing 103U/ml (Votyakova and Reynolds, 2004) catalase (orange) or 
excluding catalase (blue). The presence and absence of HRP is denoted on the x axis. 
Furthermore substrate addition occurs during the assay and is denoted on the x axis. 
Results are shown as mean ± SEM calculated from four mice of the same age and 
strain. * significantly different with catalase addition, + significantly different with HRP 
absence. 
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3.2.3. REDUCTION OF RESORUFIN FLUORESCENCE OCCURS IN 
RESPONSE TO SUBSTRATE ADDITION 
To see whether the decrease of fluorescence after substrate addition in liver 
mitochondria could be due to exhaustion of any reaction component, short and long 
term kinetic measurements were compared. The kinetic experiments to measure 
amplex red usually require 30 minutes of measuring time (long term kinetics). Even in 
brain or muscle mitochondria with their lower amplex red oxidation rate, reduced 
reduction can be seen over a 60 minute time frame. In liver mitochondria the additions 
of substrate cause a decreased rate of fluorescence. Mitochondria were incubated 
with all stimulants and inhibitors for two minutes prior to measuring for only five 
minutes total these were short kinetics. Brain and liver mitochondria were compared 
using long and short kinetics in the presence and absence of HRP. Comparing the 
results from both long and short kinetics no significant differences were seen (Figure 3-
9). In the brain there was no amplex red oxidation if HRP was not present. The short 
kinetic data also showed no amplex red oxidation without HRP. The suppression in 
fluorescence rate production is not related to an overall decrease in signal with time. 
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Figure 3-9: Short and long term kinetic data show no difference when measuring 
hydrogen peroxide release in brain and liver mitochondria. Long kinetics (Blue) were 
performed as in the materials and methods section, both with and without HRP. The 
measurements were determined basal, PM only and PM and rotenone. Short kinetics 
(orange) were carried out incubating the mitochondria with all the stimulants and 
inhibitors for two minutes prior to measuring for five minutes. Results show mean of 
three replicates. When comparing the results there are no differences between the 
measurement techniques.  
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3.2.4. RESORUFIN CONSUMERS ARE NOT RESPONSIBLE FOR THE 
LOWER RESORUFIN FLUORESCENCE 
As shown in Figure 3-10, liver mitochondria generate higher amounts of a product with 
fluorescence and absorption characteristics like resorufin from Amplex red even in the 
absence of substrate and HRP. Surprisingly, with substrate addition the resorufin 
fluorescence is suppressed. It is unclear how and why the suppression occurs. 
Resorufin can be reduced into another fluorescent form as well as re-oxidised to 
reform resorufin. Resorufin can also form resazurin, a non-fluorescent compound, as 
shown in figure 3-10. It has been shown that resorufin can be reduced to resazurin by 
high levels of hydrogen peroxide (Towne et al., 2004). In the liver experiments the 
fluorescence is reduced with substrate addition. It is thus possible that energized liver 
mitochondria produce so much hydrogen peroxide that resorufin is reduced to 
resaruzin, resulting in a decrease of fluorescence intensity.  
Changes in resorufin fluorescence with hydrogen peroxide addition are shown in figure 
3-11. Resorufin fluorescence was monitored over one hour with additions of KHE, 
succinate, hydrogen peroxide and HRP. As no mitochondria are present in the assay, 
addition of substrate had no effect. 196pmoles hydrogen peroxide, added at 35 
minutes, reduced resorufin fluorescence only when HRP was present as expected.  
Figure 3-12 shows the response of resorufin fluorescence in the presence of either 
liver or muscle mitochondria. After mitochondrial addition substrate was added to 
determine if mitochondrial release of hydrogen peroxide would result in resorufin 
consumption. However mitochondrial presence suppresses the effect of added 
hydrogen peroxide on resorufin. Consequently the high production of hydrogen 
peroxide has no effect on resorufin fluorescence.  
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Figure 3-10: The oxidation of amplex red and reduction of resorufin. Amplex red is 
oxidised to form resorufin in the presence of hydrogen peroxide. Resorufin can be 
polymerized to form an unknown substance and reduced to form resazurin, a non-
fluorescent product. If this was formed the fluorescence would reduce with time 
without the addition of other stimuli (Towne et al., 2004).   
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Figure 3-11: Hydrogen peroxide consumes resorufin in the presence of HRP. This 
graph shows resorufin fluorescence both in the presence (blue) and absence (red) of 
HRP. At each blue line an addition was made and explained below the traces. 
196pmoles of hydrogen peroxide was the third addition. This is the highest amount of 
hydrogen peroxide the liver mitochondria would produce per minute. This resulted in 
consummation of resorufin in the presence of HRP only.  
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Figure 3-12: Mitochondria have a protective effect on resorufin consumption. 
Resorufin without mitochondria present is consumed with 196 pmoles hydrogen 
peroxide added. Resorufin is incubated with and without HRP. In one trace no 
mitochondria was added blue (A and B). The other trace on each graph has 
mitochondria added at the first blue line. In red (graph A) liver mitochondria was 
added to the assay. In pink (graph B) muscle mitochondria was added to the assay. In 
the presence of 196 pmoles hydrogen peroxide there was no resorufin consummation 
if mitochondria were present. 
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3.2.5. THE FLOURESCENCE DECREASE SEEN WITH SUBSTRATE 
ADDITION IS HRP DEPENDENT 
The oxidation of amplex red in the presence of liver mitochondria occurs irrespective 
of the presence of HRP and substrate. In addition the oxidation is hydrogen peroxide 
independent. However the addition of a substrate reduces the amount of fluorescence 
detected from liver mitochondria with or without the presence of HRP in liver 
mitochondria. In figure 3-13 the HRP was added after substrate addition and compared 
to the rate of production if it was present prior to the addition. In the presence of a 
respiration substrate, addition of HRP increases the rate of amplex red oxidation 
similarly in liver and brain mitochondria. This suggests that the HRP sensitive amplex 
red signal in the presence of respiration substrate indicates the hydrogen peroxide 
released by the mitochondria.  
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Figure 3-13: The presence of HRP increases hydrogen peroxide release in both liver 
(left) and brain mitochondria (right) in the presence of PM. Hydrogen peroxide 
release is measured in basal and substrate only states with and without HRP in liver 
and brain mitochondria. The addition of HRP is made after substrate addition to wells 
without HRP (green bars), while those with HRP from the beginning had an addition of 
KHE made after substrate addition. Results are mean and error bars are standard 
deviation based on three wells.  
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Addition of a substrate suppresses the hydrogen peroxide independent oxidation of 
amplex red. To determine if the suppression is substrate linked, different 
concentrations of PM were added. In figure 3-14 the rate of oxidation is shown as a 
percentage of the individual well’s corresponding basal rate both with and without 
HRP. The percentage of oxidation decreases as the concentration of PM added 
increases. The suppression is higher if there is no HRP in the reaction medium. The 
increased suppression seen when HRP is absent suggests the presence of a HRP 
sensitive amplex red signal. 
Two substrates are used in the main study to obtain details on the hydrogen peroxide 
release from specific sites in the ETC. Succinate and Pyruvate malate are the substrates 
used to dissect these sites out of the ETC. Pyruvate malate and glutamate malate are 
complex I linked substrate. Whereas succinate is a complex II linked substrate. 
Studying the effects of both these substrates and glutamate malate allows for the 
determination of the importance of complex I linked substrates. In figure 3-15 the role 
of each substrate both combined and individually is compared in the presence and 
absence of HRP. Glutamate, Pyruvate, Malate and the combinations of Glutamate 
malate and pyruvate malate show a marked suppression of the signal. Succinate a 
complex II linked substrate does not show the same degree of suppression.  
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Figure 3-14: The suppression of basal signal is higher if the concentration of PM is 
higher. The bars show percentage of basal hydrogen peroxide release from liver 
mitochondria in the presence of HRP (Orange) and absence of HRP (Blue). Four 
concentrations of PM were added 0.01mM, 0.1mM, 1mM and 5mM (optimal). These 
experiments were repeated with 5-7 mice three technical replicates each. Mean is 
shown with error bars denoting standard deviation. 
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Figure 3-15: Complex I substrates cause more suppression than a complex II linked 
substrate. Basal rate of hydrogen peroxide release was calculated and the release in 
the presence of the denoted substrate. These results were used to obtain a 
percentage, denoting release as a percentage of basal release. S, P, M, G, PM and GM 
were added in 5mM. Mean of 4-7 replicates error bars showing standard deviation. 
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Data shown in chapter 3.2.3.3 suggested that the HRP sensitive amplex red signal is 
due to hydrogen peroxide release from the liver mitochondria. To analyse this further, 
the effect of myxathiozol on on Amplex Red fluorescence from liver mitochondria was 
assessed. In the presence of PM, myxathiozol inhibits respiration and oxygen 
consumption (Thierbach and Reichenbach, 1981b; Thierbach and Reichenbach, 1981a; 
Porter and Brand, 1995). When respiration is low, superoxide release is low.  
Accordingly, no HRP sensitive amplex red signal should be produced by liver 
mitochondria treated with myxathiozol. This is shown in Figure 3-16. The detected 
fluorescence is comparable in the experiments without HRP and under low superoxide 
conditions. The rate is significantly higher when HRP and pyruvate malate is present 
and myxathiozol is absent most likely due to superoxide production causing hydrogen 
peroxide release from the mitochondria. 
I conclude that hydrogen peroxide release from liver mitochondria can be measured by 
the Ampled red method as the difference between fluorescence rates with and 
without HRP in the presence of respiration substrate. 
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Figure 3-16: Myxathiozol inhibits the HRP-dependent increase of Amplex Red 
fluorescence from liver mitochondria. On the left the traces show the rate of 
fluorescence increase. Standardized means from four experiments (± SEM) are shown 
on the right in corresponding colour laid out in the key above the graph on the left. 
Measurements were taken with and without HRP, in the presence of a substrate or a 
substrate and myxathiozol. *=significantly different (t-test) 
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3.3. CHANGES IN HYDROGEN PEROXIDE RELEASE DURING AGEING 
AND DIETARY RESTRICTION 
3.3.1. CHANGES IN BRAIN MITOCHONDRIA WITH AGE AND DIETARY 
RESTRICTION 
Hydrogen peroxide release increases with age under both AL and DR conditions. In 
Figure 3-17 an increase with age is seen the presence of PM and rotenone, which 
indicates the maximum capacity of hydrogen peroxide release from complex I. This 
increase is significant between 3 and 24 months of age (figure.3-17).   
The presence of succinate also shows increased hydrogen peroxide release with age 
from complex I (Figure 3-18). In AL brain mitochondria there is a significant increase in 
the presence of succinate between 3 months hydrogen peroxide release and 24 month 
ages. In the presence of succinate and rotenone as well as succinate, rotenone and 
antimycin a 24 and 30 months are significantly higher than that of 3 and 15 months. 
The addition of antimycin a shows the complex III maximal production. These results 
correlate and the succinate and rotenone result could be a result of the increase from 
complex III. Figure 3-19 shows an increase in hydrogen peroxide release from reverse 
flow through complex I between 3 and 15 months, but no further increase with age. 
Reverse flow shows no differences in hydrogen peroxide release from brain 
mitochondria in AL treated mitochondria. There is a tendency for all three parameters 
to improve in the oldest mice. This might be due to a survivor effect. 
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Figure 3-17: Maximum hydrogen peroxide release from complex one in brain 
mitochondria increases with age. These are the individual rate calculations after basal 
subtraction in the presence of PM and PM + Rotenone (rotenone) in AL treated brain 
mitochondria. Hydrogen peroxide release was determined in mice at ages of 3, 15, 24 
and 30 months these are denoted by increasingly paler colours.  Bars show the mean 
from n=4-6, with standard error bars displayed. *significantly different from three 
months (One-way ANOVA).  
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Figure 3-18: The release of hydrogen peroxide from AL brain mitochondria in the 
presence of a complex two-related substrate increases with age. Hydrogen peroxide 
release calculated minus basal from AL brain mitochondria in mice at ages of 3 15, 24 
and 30 months. The release of hydrogen peroxide is measured in the presence of a 
complex II linked substrate, succinate. In succession two inhibitors are added; 
rotenone and antimycin A.. Age is shown in increasingly paler colour. Bars show the 
mean from n=4-6, with standard error bars displayed. *significantly different from 
three months. 
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Figure 3-19:  Hydrogen peroxide  release by reverse flow is only increased between 3 
and 15 months in brain mitochondria. Reverse flow of hydrogen peroxide released 
from AL brain mitochondria in mice at ages of 3 , 15, 24, 30  months. Increasingly paler 
colour denotes age. Bars show the mean from n=4-6, with standard error bars 
displayed. * significantly different from three months. 
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Dietary restriction (to 60% of intake under ad libitum feeding) was induced at 3 
months of age. In general, isolated brain mitochondria from DR treated mice show 
lower hydrogen peroxide release than those from AL mice (figure 3-20, 3-21 and 3-22). 
The AL and DR values are significantly different at 15 and 24 months for both 
maximum release from complex I (Figure 3-20), complex II-linked substrate (Figure 3-
21) and reverse flow (Figure 3-22), however, the only remaining difference at 30 
months of age is in hydrogen peroxide release by reverse flow.  
In brain mitochondria from AL mice the predominant increase is between 3 and 15 
months. 15-30 month old mitochondria show a plateau effect when fed an AL diet. A 
DR diet resulted in improved maintenance of a lower level of hydrogen peroxide 
production up to 24 months of age, although Superoxide release in complex I (Figure 3-
20) and complex II (Figure 3-21) linked respiration begins to increase after 15 months 
of age. The hydrogen peroxide production via reverse flow remains constant up to 30 
months under DR (Figure 3-22). However, in very old DR mice (at 36 months, no AL 
mice were alive at this age) all measured parameters are at least as high as in AL 
mitochondria from 30 months old mice. In conclusion, the data show that the increase 
of hydrogen peroxide release with age from brain mitochondria under AL is postponed 
by DR.   
Considering the plateau effect in brain and liver mitochondria the hydrogen peroxide 
release from complex I in was compared in both groups at 35% survival. 35% survival 
was determined using the lifespan curves in Figure 3-23. Dietary restriction extends 
lifespan in the mice, it also delays the effects of increased hydrogen peroxide release a 
marker of ageing. Mice on an AL diet were at 35% survival at 30 months and therefore 
we have no 36 month time point for this condition. Dietary restricted mice lifespan 
was extended so they were at 35% survival at 36 months. Comparing the hydrogen 
peroxide release in figure 3-24 shows there was no significant difference between 
these two conditions at 35% survival from reverse flow. There was a significant 
increase in DR hydrogen peroxide release in the presence of PM and PM and rotenone. 
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Figure 3-20: Brian mitochondria show decreased hydrogen peroxide release in DR 
from complex I when in the presence of PM and Rotenone. Maximal stimulation of 
complex I, PM + Rotenone (rotenone), hydrogen peroxide release from AL (red) and DR 
(blue) treated brain mitochondria. Hydrogen peroxide release was determined in mice 
at ages of 3, 15, 24, 30 months. Bars show the mean from n=4-6, with standard error 
bars displayed. *DR is significantly different from AL (t test).   
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Figure 3-21: The increase of superoxide release from brain mitochondria with age in 
the presence of the complexII-linked substrate succinate is delayed by DR. In the 
presence of succinate these are the hydrogen peroxide release values from AL (red) 
and DR (blue). Values are the mean from n=4-6, with standard error bars displayed. 
*significantly different from AL. 
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Figure 3-22: There is lower hydrogen peroxide release from reverse flow in DR brain 
mitochondria up to 30 months of age. Hydrogen peroxide production from muscle 
mitochondria as a result of reverse flow. Values are calculated after basal subtraction 
and the mean from n=4-6, with standard error bars displayed. *DR is significantly 
different from AL. 
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Figure 3-23: The lifespan curves of AL fed and DR males. Marked on the graph is the 
line at 35% survival this intersects the AL mice at 30 months and the DR mice at 36 
months. These age the groups  were used to compare the release of hydrogen 
peroxide.  
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Figure 3-24: There is significantly higher hydrogen peroxide production from DR 
brain mitochondria in the presence of PM. Comparison of the release of hydrogen 
peroxide between AL and DR brain mitochondria at the same mouse survival 
percentage. 30 months from AL mice in red, and 36 months from DR mice in blue. 
These ages were determined to be 35% survival in each treatment. The left graph 
display the hydrogen peroxide release from complex I in the presence of PM and after 
the inhibition of complex I with rotenone. The middle graph shows the hydrogen 
peroxide release in the presence of complex II substrate succinate. In this graph, 
rotenone and antimycin A are added as inhibitors. The reverse flow is shown in the 
graph on the right. The condition added to determine each bar is given beneath. There 
were four mice per group and standard error is displayed. No significance was 
determined. 
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3.3.2. CHANGES IN HYDROGEN PEROXIDE RELEASE IN SKELETAL 
MUSCLE MITOCHONDRIA 
Mitochondria isolated from skeletal muscle of the hind legs produced a higher level of 
hydrogen peroxide than isolated brain mitochondria from the same animals (compare 
Figures 3-17, 3-18 and 3-19 with 3-25, 3-26 and 3-27). 24 month old muscle 
mitochondria are not included in the analysis of muscle mitochondria. The 24 month 
old mitochondria were damaged during the isolation process and didn’t return 
consistent results. In the presence of PM and rotenone, 30 month old AL muscle 
mitochondria have significantly higher hydrogen peroxide release than 3 and 15 month 
old ones. In conclusion the complex I linked hydrogen peroxide release from skeletal 
muscle mitochondria increases with age.  
Succinate only stimulation of muscle mitochondria shows a significant increase with 
age between all time-points in AL mitochondria. The presence of rotenone in addition 
to succinate also shows a continuous increase with age in AL mitochondria. Complex III 
hydrogen peroxide release in AL mitochondria is higher in 15 and 30 month than 3 
months (Figure 3-26). Reverse flow is significantly increased with age in muscle 
mitochondria (Figure 3-27). 
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Figure 3-25: There is an increase in hydrogen peroxide release from complex I in AL 
muscle mitochondria with age. Values are calculated after basal subtraction. 
Hydrogen peroxide release was determined in mice at ages of 3, 15, 24 and 30 months. 
Increasing age is shown with increasingly paler colour.  Bars show the mean from n=4-
6, with standard error bars displayed. *significantly different from three months under 
the same conditions.  
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Figure 3-26: Hydrogen peroxide release in the presence of succinate and when both 
rotenone and antimycin A is present increases with age in muscle mitochondria. The 
release of hydrogen peroxide is measured in the presence of a complex II linked 
substrate, succinate. In succession two inhibitors are added rotenone and antimycin a. 
Increasingly paler red shows different  ages; 3, 15, and 30 months. Bars show the mean 
from n=4-6, with standard error bars displayed. * significantly different from three 
months. ¥ significantly different from 15 months. 
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Figure 3-27: Release of hydrogen peroxide via reverse flow increases with age in 
muscle mitochondria.  Hydrogen peroxide release via reverse flow in Al muscle 
mitochondria. Three ages are shown, 3, 15 and 30 months denoted by paler red colour 
as age increases. Bars show the mean from n=4-6, with standard error bars displayed. 
*significantly different from three months and ¥ significantly different from 15 
months. 
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Dietary restriction reduces the hydrogen peroxide release in skeletal muscle 
mitochondria at 15 and 30 months of age, both in terms of maximum capacity of 
complex I (Figure.3-28), under respiration with a complex II linked substrate (Figure 3-
29) and in reverse flow (Figure 3-30). In conclusion there is a higher hydrogen peroxide 
release from complex I in AL mitochondria and DR postpones this age-dependent 
increase.  
The plateau effect seen in the Brain and Liver mitochondria is not observed in the 
skeletal muscle mitochondria. Considering the plateau effect in brain and liver 
mitochondria, the effect was more obvious at 24 and 30 months rather than 15 and 30 
months. Therefore the hydrogen peroxide release from complex I in was compared in 
both groups of skeletal muscle at 35% survival in figure 3-31. Mice at 35% survival 
under DR did show no difference from the AL fed mice at the same percentage 
survival.  
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Figure 3-28: The release of hydrogen peroxide from complex I when it is maximally 
stimulated is significantly lower in DR muscle mitochondria than AL. Maximal 
stimulation of complex I, PM + Rotenone (rotenone), hydrogen peroxide release from 
AL (red) and DR (blue). Values are calculated after basal subtraction and the mean is 
displayed from n=4-6, with standard error bars. *DR is significantly different from AL. 
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Figure 3-29: The release of hydrogen peroxide in the presence of succinate is 
significantly lower in DR muscle mitochondria than AL. In the presence of succinate 
these are the hydrogen peroxide release values from AL (red) and DR (blue). Values are 
the mean minus basal from n=4-6, with standard error bars displayed. *DR is 
significantly different from AL. 
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Figure 3-30: The release of hydrogen peroxide from complex I via reverse flow is 
significantly lower in DR muscle mitochondria than AL muscle mitochondria. Values 
are reverse flow calculated after basal subtraction and shown is the mean from n=4-6, 
with standard error bars displayed. *DR is significantly different from AL. 
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Figure 3-31: There is no significant change between AL and DR at 35% survival. 
Comparison of the kinetic release of hydrogen peroxide between AL and DR muscle 
mitochondria at the same mouse survival percentage. 30 months for AL mice in ligh 
red, and 36 months for DR mice in light blue. These ages were determined to be 35% 
survival in each treatment. Two substrates were added separately, PM in the left 
graph, rotenone added as an inhibitor, and succinate in the middle and right graph. 
Mitochondria in the presence of succinate had two inhibitors added in succession, 
rotenone and antimycin A. There were four mice per group and standard error is 
displayed.  
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3.3.3. THE CHANGE IN HYDROGEN PEROXIDE PRODUCTION IN LIVER 
MITOCHONDRIA 
Hydrogen peroxide release is measured using the corrected method discussed in 
chapter 3.2. The corrected method is the difference between the presence and 
absence of HRP and was only used when measuring 3, 24, 30 and 36 month old 
mitochondria. The liver mitochondria were measured at 15 months but only in the 
presence of HRP. The corrected data is more accurate so the 15 month data is not 
included. The rate of hydrogen peroxide release was measured from isolated liver 
mitochondria from mice fed an AL and a DR diet at 3, 24 and 30 months of age. There 
is no significant change when only PM is present in AL. In the presence of PM and 
rotenone AL mitochondria show no significant change with age. In conclusion the 
complex I linked hydrogen peroxide release doesn’t increase with age in liver 
mitochondria.  
Succinate only stimulation of liver mitochondria shows no significant changes with age 
in AL mitochondria. The presence of rotenone in addition to succinate shows an 
increase with age in AL mitochondria between 3 and 24 months. Between 3 and 30 
months no significant change is seen in liver mitochondria. Complex III hydrogen 
peroxide release in AL mitochondria is higher in 30 month than 3 months. Reverse flow 
is unchanged with age in AL liver mitochondria. Complex III is the only specified site of 
hydrogen peroxide release which is changed with age in liver mitochondria. 
There is a plateau effect seen in AL liver mitochondria similar to the brain. 24 month 
old AL mice have no significant difference to 30 month old AL mice in terms of 
hydrogen peroxide release. The maximum capacity of complex I to produce superoxide 
and the release of hydrogen peroxide in the presence of succinate were not significant. 
This shows the plateau effect of AL fed mice as they are both significantly increased 
compared to 3 month old mice. In Dietary restricted mice these ages are also not 
significantly different and the increase is seen at 36 months which is significantly 
increased rate compared to 24 and 30 months. Comparing both the groups in figure 38 
at 35% survival there is no significant difference between the two conditions. 
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Figure 3-32: The values for corrected release of hydrogen peroxide from liver 
mitochondria. In the presence of PM and PM + Rotenone these are the hydrogen 
peroxide release values from AL Liver mitochondria. Hydrogen peroxide release was 
determined in mice at ages of 3, 24, and 30 months these are denoted by increasingly 
paler colours.  Bars show the mean from n=4-6, with standard error bars displayed. No 
significant changes. 
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Figure 3-33: The values for corrected release of hydrogen peroxide from liver 
mitochondria. These are the hydrogen peroxide release values from AL liver 
mitochondria. Hydrogen peroxide release was determined in the presence of succinate 
from mice at ages of 3, 24, and 30 months these are denoted by increasingly paler 
reds. After the addition of succinate in succession two inhibitors are added rotenone, 
and antimycin a. Bars show the mean from n=4-6, with standard error bars displayed. 
*significantly different from three months.  
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Figure 3-34: The values for corrected reverse flow release of hydrogen peroxide from 
liver mitochondria. The reverse flow hydrogen peroxide release was determined in 
mice at ages of 3, 24 and 30 months these are denoted by increasingly paler colours. 
Bars show the mean from n=4-6, with standard error bars displayed. 
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Dietary restriction in liver mitochondria shows a decrease in hydrogen peroxide 
release after onset at 24 and 30 months of age compared with 3 months. Dietary 
restriction affects liver mitochondria hydrogen peroxide release at 24 and 30 months 
direct comparison shows a reduced level of release. The maximum capacity of complex 
I superoxide release as marked by hydrogen peroxide release shows increased levels of 
production in AL fed mice at both 24 and 30 months (figuren3-35). This is supported by 
complex II linked respiration which shows increased hydrogen peroxide release at 24 
and 30 months in AL (figure 3-36). This increased rate is also predominantly from 
complex I as the reverse flow shows significantly lower rates of hydrogen peroxide 
release from complex I at 24 and 30 months (Figure 3-37). In conclusion the decrease 
in hydrogen peroxide release in DR is a result of complex I changes. 
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Figure 3-35: The release of hydrogen peroxide in the presence of PM and Rotenone is 
significantly lower in DR than AL liver mitochondria up to 30 months of age. Maximal 
stimulation of complex I, PM + Rotenone (rotenone), hydrogen peroxide release from 
AL (red) and DR (blue). Values show the mean with basal subtracted from n=4-6, with 
standard error bars displayed. *DR is significantly different from AL. 
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Figure 3-36: The release of hydrogen peroxide release from liver mitochondria is 
lower in the DR than AL up to 30 months of age. In the presence of succinate these 
are the hydrogen peroxide release values from AL (red) and DR (blue). Values are the 
mean with basal subtracted from n=4-6, with standard error bars displayed. *DR is 
significantly different from AL. 
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Figure 3-37: Up to 30 months of age there is significantly lower hydrogen peroxide 
release as a result of reverse flow from DR liver mitochondria compared to AL. The 
values are the mean with basal subtracted from n=4-6 mice for reverse flow, with 
standard error bars displayed. *DR is significantly different from AL. 
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Figure 3-38: There is no significant difference between the hydrogen peroxide 
release from AL and DR mitochondria at 35% survival. These graphs show the 
comparison of hydrogen peroxide release between AL and DR brain mitochondria at 
the same mouse survival percentage. Hydrogen peroxide release was calculated in the 
presence of PM and rotenone (left), Succinate, rotenone and antimycin A (middle) and 
the reverse flow was calculated in the final graph. 30 months for AL mice in red, and 36 
months for DR mice in blue. These ages were determined to be 35% survival in each 
treatment. There were four mice per group and standard error is displayed. No 
significance was determined. 
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3.3.4. POSTPRANDIAL HYDROGEN PEROXIDE RELEASE IS LOWER THAN 
THAT OF PREPRANDIAL FROM 30 MONTH OLD MITOCHONDRIA 
AFTER LONG TERM DIETARY RESTRICTION 
In the comparison between AL and DR animals the measurements are always taken at 
8am. The DR mice are fed at 8am. Consequently the DR mice haven’t eaten for 24 
hours prior to measurement. Postprandial states have been shown to decrease ROS in 
human cells (Sodre et al., 2011). Fasted DR oxidative stress is higher than fed DR 
oxidative stress (Dani et al., 2010). The differences in oxidative stress suggest fasting 
could mask the dietary restriction changes. The possibility is that the difference 
between AL and DR is affected by the increased time without food. The DR 
mitochondria at 30 months old in this study were compared with DR mitochondria 
measured six hours after feeding (postprandial - PMDR). 30 months old mice have 
been treated with DR for 27 months. Figure 3-39, 3-40 and 3-41 outline the rate of 
hydrogen peroxide production in brain, muscle and liver mitochondria for these 
conditions.  
I have shown in Figure 3-20 that in the presence of only PM normal DR conditions 
result in no significant difference in brain mitochondria. This doesn’t change in PMDR 
brain mitochondria. Maximum capacity of complex I to produce superoxide is equal in 
AL and pre-prandial DR mitochondria, but is decreased only in PMDR. In PMDR 
mitochondria reverse flow is significantly increased compared to DR and is unchanged 
when compared to AL. Complex III is unchanged in AL, DR or PMDR. 
In muscle mitochondria between DR mitochondria showed significantly lower 
hydrogen peroxide release than AL mitochondria in chapter 3.3.2 analysed by t-test. 
The same data is analysed here using an ANOVA due to the presence of PMDR a third 
group. There is no change in AL and DR in the presence of PM only or PM and rotenone 
when analysed by ANOVA to include the third group. PMDR release of hydrogen 
peroxide is significantly lower than both AL and DR when only PM is present. PM and 
rotenone shows a significant decrease in PMDR when compared to AL mitochondria.  
As shown before (Figures 3-35-37), In liver mitochondria there is significantly lower 
hydrogen peroxide release from DR mice compared to AL; this occurs in the presence 
of PM, PM and rotenone and reverse flow. PMDR mitochondria follow the same trend 
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as DR mitochondria. PMDR is only lower in DR liver mitochondria when in the presence 
of PM only. In the presence of PM only, muscle and liver mitochondria have 
significantly lower hydrogen peroxide release from PMDR than both AL and DR. In 
brain and muscle mitochondria maximum complex I hydrogen peroxide release is 
significantly lower from PMDR compared to AL and DR mitochondria. Maximal 
stimulation of complex I in liver PMDR mitochondria is significantly lower than AL 
mitochondria only. In muscle and liver mitochondria,  postprandial complex I hydrogen 
peroxide release is lower than preprandial already under basal conditions.  
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Figure 3-39: PMDR brain mitochondria have significantly lower hydrogen peroxide 
release capacity than both AL and DR brain mitochondria. The rate of hydrogen 
peroxide production in brain mitochondria in the presence of a control diet (AL), a 
dietary restricted diet (DR) and a postprandial DR diet (PMDR). AL (light red) and 
standard DR (light blue) which are culled prior to feeding were compared to post 
prandial mice which were culled six hours after being fed (PMDR, light green). The 
graph shows Pyruvate Malate (PM) as a substrate followed by the further addition of 
rotenone (PM + ROT). The bars are mean of n=4 mice and show standard error bars. * 
significantly different from AL. † significantly different from DR. 
  
0
5
10
15
20
25
30
PM PM + ROT
p
m
o
le
s 
H
2O
2/
 m
in
 /
 m
g 
p
ro
te
in *†
Rotenonee
94 
 
 
Figure 3-40: PMDR muscle mitochondria have significantly lower hydrogen peroxide 
release than AL muscle mitochondria. The rate of hydrogen peroxide production in 
muscle mitochondria in the presence of a control diet (AL) in light red, a dietary 
restricted diet (DR) in light blue and a postprandial DR diet (PMDR) in light green. The 
graph shows Pyruvate Malate (PM) as a substrate followed by the further addition of 
rotenone (PM + ROT). The bars are mean of n=4 mice and show standard error bars. * 
significantly different from AL. † significantly different from DR. 
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Figure 3-41: PMDR liver mitochondria have significantly lower hydrogen peroxide 
release than both AL and DR liver mitochondria. The rate of hydrogen peroxide 
production in liver mitochondria in the presence of a control diet (AL), a dietary 
restricted diet (DR) and a postprandial DR diet (PMDR). The graph shows Pyruvate 
Malate (PM) as a substrate followed by the further addition of rotenone (Rotenone). 
The bars are mean of n=4 mice and show standard error bars. * significantly different 
from AL. † significantly different from DR.(one-way ANOVA) 
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3.4. SHORT-TERM DIETARY RESTRICTION AND SHORT-TERM 
RAPAMYCIN TREATMENT HAVE A SIMILAR EFFECT ON 
HYDROGEN PEROXIDE RELEASE. 
3.4.1. HYDROGEN PEROXIDE RELEASE IS LOWER IN PRE- AND 
POSTPRANDIAL CONDITIONS AFTER SHORT-TERM DIETARY 
RESTRICTION  
Female mice were fed a short-term dietary restricted diet. The diet was imposed at 12 
months and mice were culled and mitochondria obtained at 15 months. The mice 
which were dietary restricted were culled 24 hours post prandial (DR) or 6 hours post 
prandial (PMDR).  
In brain and muscle mitochondria there was no significant change in hydrogen 
peroxide release from complex I as a result of reverse flow shown in figure 3-42 and 
Figure 3-43. When maximum capacity of superoxide release from complex I was 
stimulated the rate of hydrogen peroxide release was different. In both brain and 
muscle mitochondria the capacity was diminished significantly in DR mice, and further 
significantly diminished in PMDR mice.  
In liver mitochondria hydrogen peroxide release was lower in DR and further 
decreased in PMDR when maximum capacity was stimulated shown in Figure 3-44. In 
the situation when reverse electron flow was stimulated the DR effect was still present 
reducing the rate of hydrogen peroxide release but this reduction was not furthered in 
PMDR mitochondria. 
Complex III production is measured in the presence of succinate, rotenone and 
antimycin A. In muscle mitochondria the production from complex III is not 
significantly different under DR compared with AL (Figure 3-43). Complex III hydrogen 
peroxide release is decreased in PMDR muscle mitochondria. In liver mitochondria 
complex III hydrogen peroxide release in decreased under DR and PMDR (Figure 3-44). 
The release is not significantly different depending on the time at which the DR tissues 
were collected. 
The release of hydrogen peroxide from complex II was measured at two sites site f and 
site q. Complex IIq (blue) is the difference between succinate and succinate with ATP. 
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ATP blocks this site and hydrogen peroxide release can be determined from the 
difference. Succinate with malonate calculates the production from site IIf (red).   
(Treberg et al., 2011). There were no significant changes in the release from either site 
in brain mitochondria (figure 3-45). In muscle mitochondria there is less hydrogen 
peroxide release from site q in DR mitochondria compared to AL (figure 3-46). In the 
PMDR animals the release of hydrogen peroxide is lower at both sites. 
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Figure 3-42: The rate of hydrogen peroxide production in brain mitochondria in the 
presence of a control diet (AL) of a dietary restricted diet (DR). Diet was fed to mice 
for three months from the age of 12 months. AL (purple) and DR (red) were also 
compared to post prandial mice which were culled six hours after being fed (green). 
These mice were to show the effect starvation has on the DR mice. The graph is split in 
three sections: The addition of Pyruvate Malate (PM) as a substrate followed by the 
further addition of rotenone; Succinate addition to the mitochondria and the 
subsequent additions of rotenone, antimycin and myxathiozol; finally the calculation of 
reverse flow. Standard error is displayed. * = significantly different. 
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Figure 3-43: The rate of hydrogen peroxide production in muscle mitochondria in the 
presence of a control diet (AL) of a dietary restricted diet (DR). Diet was fed to mice 
for three months from the age of 12 months. AL (purple) and DR (red) were also 
compared to post prandial mice (PMDR) which were culled 6 hours after being fed 
(green). These mice were to show the effect starvation has on the DR mice. The graph 
is split in three sections: The addition of Pyruvate Malate (PM) as a substrate followed 
by the further addition of rotenone; Succinate addition to the mitochondria and the 
subsequent additions of rotenone, antimycin and myxathiozol; Finally the calculation 
of reverse flow. Standard error is displayed. * = significantly different. 
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Figure 3-44: The rate of hydrogen peroxide production in liver mitochondria in the 
presence of a control diet (AL) of a dietary restricted diet (DR). Diet was fed to mice 
for three months from the age of 12 months. AL (purple) and DR (red) were also 
compared to post prandial mice which were culled 6 hours after being fed (green). 
These mice were to show the effect starvation has on the DR mice. The graph is split in 
three sections: The addition of Pyruvate Malate (PM) as a substrate followed by the 
further addition of rotenone; Succinate addition to the mitochondria and the 
subsequent additions of rotenone, antimycin and myxathiozol; Finally, the calculation 
of reverse flow. Standard error is displayed.  
* = significantly different. 
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Figure 3-45: The calculated rate of hydrogen peroxide production in brain 
mitochondria from specific complex II sites. Two sites in complex II had hydrogen 
peroxide release measured when stimulated. Two ages were compared 12 and 15 
months. Start control was measured at 12 months then three different treatments 
were measured after three months. AL (red) on a normal diet, DR (blue) on a 40% 
calorie restricted diet and PMDR (green) on a 40% restricted diet and fed prior to 
tissue collection. Mean values with standard error is displayed.  
* significantly different between IIq and IIf. 
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Figure 3-46: The calculated rate of hydrogen peroxide production in muscle 
mitochondria from specific complex II sites. Hydrogen peroxide release was measured 
from two complex II sites, IIq and IIf. The measurements were taken at 12 months 
(start control purple) and 15 months. 15 month old mice had three groups with a 
different treatment for the three months. AL is normal feeding (red), DR (blue) and 
PMDR (green) were fed a 40% restricted diet for these three months. DR tissues were 
collected 24 hours after feeding and PMDR tissue collected 6 hours after feeding. 
Mean and standard error is displayed.  
* significantly different between IIq and IIf. 
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3.4.2. THREE MONTH RAPAMYCIN FEEDING REDUCES HYDROGEN 
PEROXIDE RELEASE 
Three month rapamycin treatment was studied in both males and females. Female 
mice were given rapamycin at 12 months and mitochondrial hydrogen peroxide 
release was compared at 12 month (prior to treatment) and 15 months. In the brain 
and liver mitochondria no significant difference was seen with rapamycin feeding in 
complex I hydrogen peroxide production in Figure 3-47 and Figure 3-49. In muscle 
mitochondria hydrogen peroxide production was reduced from complex I in figure 3-
48. This was shown in both the maximum capacity of complex I and the reverse flow 
through complex I in the presence of succinate. 
The hydrogen peroxide production from complex II was unchanged with rapamycin 
feeding over three months in both brain and muscle shown in figure 3-50 and figure 3-
51. In the muscle production from complex IIq and IIf were significantly higher than the 
production from the starting point mice in figure 3-51. 
Male mice were fed for three months with rapamycin prior to being culled at 12 
months. Isolated Brain and Liver mitochondria in mice displayed a significantly reduced 
rate of hydrogen peroxide release from complex I (figure 3-52 and figure 3-53). In liver 
using either substrate produced significantly lower levels of hydrogen peroxide 
release. The maximum capacity of complex I to produce superoxide is reduced in both 
tissues in mitochondria treated with rapamycin (figure 3-53). The hydrogen peroxide 
release from complex I via reverse flow was also significantly reduced in mitochondria 
treated with rapamycin. 
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Figure 3-47: The rate of hydrogen peroxide production in brain mitochondria in the 
presence of a control diet or a rapamycin diet. Control mice data were coloured 
orange and rapamycin treated mice were blue. Diet was fed to mice for three months 
from the age of 12 months. The graph is split in three sections: The addition of 
Pyruvate Malate (PM) as a substrate followed by the further addition of rotenone; 
Succinate addition to the mitochondria and the subsequent additions of rotenone, 
antimycin a and myxathiozol; finally the calculation of reverse flow. Standard error is 
displayed. * significantly different. 
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Figure 3-48: The rate of hydrogen peroxide production in muscle mitochondria in the 
presence of a control diet or a rapamycin diet. Diet was fed to mice for three months 
from the age of 12 months.  The graph is split in three sections: The addition of 
Pyruvate Malate (PM) as a substrate followed by the further addition of rotenone; 
Succinate addition to the mitochondria and the subsequent additions of rotenone, 
antimycin and myxathiozol; Finally the calculation of reverse flow. Standard error is 
displayed. * significantly different. 
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Figure 3-49: The rate of hydrogen peroxide production in liver mitochondria in the 
presence of a control diet or a rapamycin diet. Diet was fed to mice for three months 
from the age of 12 months.  The graph is split in three sections: The addition of 
Pyruvate Malate (PM) as a substrate followed by the further addition of rotenone; 
Succinate addition to the mitochondria and the subsequent additions of rotenone, 
antimycin and myxathiozol; Finally the calculation of reverse flow. Standard error is 
displayed. * significantly different. 
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Figure 3-50: The calculated rate of hydrogen peroxide production in brain 
mitochondria from specific complex II sites. Complex IIq (blue) is the difference 
between succinate and succinate with atpenin a5. Malonate causes a further block at 
site IIf the difference seen between succinate with atpenin a5 and succinate with 
malonate calculates the production from site IIf (red).  There are six mouse treatments 
from which mitochondria were taken: SC is start control these were 12 month mice 
prior to the short term treatments given. AL is normal feeding form three months from 
the start control. DR and PF were fed a 40% restricted diet for these three months DR 
being culled 24 hours after feeding and PF culled six hours after feeding. RC and RAPA 
relate to rapamycin treatment (RAPA) and it’s control diet (RC). Standard error is 
displayed. * significantly different. 
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Figure 3-51: The calculated rate of hydrogen peroxide production in muscle 
mitochondria from specific complex II sites. Complex IIq (blue) hydrogen peroxide 
release is measured as well as site IIf (red). There are six mouse treatments from which 
mitochondria were taken: SC is start control these were 12 month mice prior to the 
short term treatments given. AL is normal feeding form three months from the start 
control. DR and PF were fed a 40% restricted diet for these three months DR being 
culled 24 hours after feeding and PF culled 6 hours after feeding. RC and RAPA relate 
to rapamycin treatment (RAPA) and its control diet (RC). Standard error is displayed. * 
significantly different. 
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Figure 3-52: Short-term rapamycin feeding in males decreases complex I hydrogen 
peroxide release from brain mitochondria. On the left measurements in the presence 
of the complex I linked substrate pyruvate/malate are shown. Right: kinetic 
measurements of hydrogen peroxide release in the presence of the complex II linked 
substrate succinate. Mice were fed rapamycin or control diet for 3 months starting at 9 
months of age. Mean of each group with standard error is displayed.  
* significantly different from control. 
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Figure 3-53: In male liver mitochondria treated with rapamycin the hydrogen 
peroxide release from complex I is significantly lower. Mice were fed rapamycin diet 
for three months from 9 months of age, mitochondria were isolated at 12 months. The 
left graph shows the hydrogen peroxide release from mitochondria in the presence of 
PM and rotenone. The right graph indicates hydrogen peroxide release in the presence 
of succinate. Mean and standard error is displayed.  
* = significantly different from control 
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In this study when comparing the changes seen in DR and those seen in rapamycin 
feeding there are no mirroring effects. It was noted that when comparing the studies 
the rapamycin mice were fed a higher fat content in their diet. This could account for 
the much higher levels of production determined in the rapamycin and rapamycin 
control animals than those without these diets. In the experiments shown in Figure 3-
42 and Figure 3-44 complex I changes were noted between AL and DR animals the 
brain and liver respectively. These changes were not present in the rapamycin study in 
brain (figure 3-47) and liver (figure 3-49). In addition the complex II effects in muscle 
were not present in the rapamycin mice in figure 3-46 and 3-51. Although the 
rapamycin control mice had a higher fat content in their diet the rapamycin effect 
could have been diminished. 
When comparing this three month study with the rapamycin feeding seen in the three 
month TERT-/- study the results are more comparable. These studies were done in 
mice of the same age and treatment type but there is no starting point data for those 
in the TERT-/- study. Both brain and liver mitochondria had reduced production of 
hydrogen peroxide from complex I in response to rapamycin (figures 3-56 and 3-57). 
This reduction in complex I production was also seen in the 3 month DR mice in figures 
3-47 and 3-49. 
3.4.3. THE ABSENCE OF TELOMERASE REDUCES HYDROGEN PEROXIDE 
RELEASE 
Telomerase has been shown to have a protective effect of mitochondria reducing 
superoxide levels and increasing antioxidant defences (Ahmed et al., 2008; Haendeler 
et al., 2009; Spilsbury et al., 2015). The changes in superoxide release have not been 
determined from individual sites of the ETC. Here I look at changes in the hydrogen 
peroxide release from different sites. 
Comparing TERT-/- and WT mice shows a lower rate of hydrogen peroxide release 
from isolated brain mitochondria in TERT-/- at eight months (figure 3-54 and 3-55). 
However this effect was not seen in the 15 month old TERT-/- mice there was no 
difference in the release of hydrogen peroxide at complex I maximum capacity shown 
in figure 3-54. TERT-/- brain mitochondria at 15 months have reduced hydrogen 
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peroxide release from complex I produced by reverse flow using a complex II linked 
substrate (figure 3-55).  
There was no change with age in WT mice between 8 and 15 months but there was an 
increase in complex I hydrogen peroxide release in 15 month old mice (figure 3-54). 
These results suggest that at 8 months telomerase presence increases hydrogen 
peroxide release. Short age changes without telomerase cause an increase in hydrogen 
peroxide release which is not seen in WT mitochondria. 
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Figure 3-54: Complex I linked hydrogen peroxide release from isolated brain 
mitochondria from three biological replicates of 8 and 15 month old WT and TERT-/- 
mice.  
* = Significant from TERT-/- 8 months,  
† = Significantly different from WT – 8 months. 
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Figure 3-55: Hydrogen peroxide release from isolated brain mitochondria from WT 
and TERT-/- mice at two different ages using a complex II linked substrate. Mice were 
either 8 or 15 months old when culled three mice were culled per group. 8 month old 
mice were only exposed to Succinate and rotenone.  
* Significantly different from WT – 15 months, 
† significantly different from WT - 8 months.  
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Rapamycin treatment was also studied in WT and TERT-/- mice. WT mice were fed for 
three months with rapamycin prior to being culled at 15 months. Isolated brain 
mitochondria in WT strains of mice displayed a significantly reduced rate of hydrogen 
peroxide release from complex I. In brain mitochondria (figure 3-56) using either 
substrate produced significantly lower levels of hydrogen peroxide release. The 
maximum capacity of complex I to produce superoxide is reduced in both liver and 
brain tissues in mitochondria treated with rapamycin figure 3-56 and figure 3-57. The 
hydrogen peroxide release from complex I via reverse flow was also significantly 
reduced in mitochondria treated with rapamycin. 
TERT-/- mice were also treated with rapamycin (figure 3-56 and figure 3-57), only the 
brain mitochondria were collected from these animals. It was shown that those mice 
which had also been treated with rapamycin for three months had no change in 
hydrogen peroxide release than untreated mitochondria with either substrate. 
Here there is similarity in the change in hydrogen peroxide release of both DR and 
Rapamycin treatment with their respective controls. TERT-/- mice have no change in 
hydrogen peroxide release, therefore TERT is a necessary gene for rapamycin 
suppression of hydrogen peroxide release. 
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Figure 3-56: Complex I linked hydrogen peroxide release from isolated brain 
mitochondria in 15 month old mice. Two conditions and treatments are were 
compared. Isolated brain mitochondria from WT and TERT-/- mice, either on a control 
diet or with 3 month rapamycin treatment.  
* = Significantly different from WT – control. (two-way ANOVA) 
  
0
5
10
15
20
25
PM Rotenone
WT Control
WT Rapamycin
TERT-/- Control
TERT-/- Rapamycin
117 
 
 
Figure 3-57: Complex II linked hydrogen peroxide release in brain mitochondria of 
WT and TERT-/- mice, control and 3 months rapamycin treatment in 15 month mice.  
* = Significantly different from WT – control 
† = Significantly different from WT – rapamycin (two-way ANOVA). 
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3.5. THE INCREASE OF HYDROGEN PEROXIDE RELEASE SEEN WITH 
AGE CAN BE POSTPONED WITH DIETARY RESTRICTION. 
The amplex red method was developed for detecting the hydrogen peroxide release 
from brain, skeletal muscle and liver mitochondria. Amplex red is a commonly used 
method for detecting Superoxide or ROS production by way of hydrogen peroxide 
release from mitochondria. Liver mitochondria were found to respond differently than 
brain and skeletal muscle mitochondria to the amplex red assay. Amplex red is 
oxidised to resorufin in the presence of HRP only in the brain and skeletal muscle 
mitochondria however, in the presence of liver mitochondria resorufin is produced 
independent from HRP. Hydrogen Peroxide release is calculable using the amplex red 
assay by monitoring the difference between with and without HRP.  
The hydrogen peroxide release was measured from brain, skeletal muscle and liver 
mitochondria from mice across multiple ages (3, 15, 24 and 30 months) as a marker for 
superoxide production from the electron transport chain. Hydrogen peroxide was seen 
to increase with age in brain, skeletal muscle and liver mitochondria from both 
complex I and complex III. The effects of long-term dietary restriction was studied in 
the same ages, as well as at 36 months, which is the same survival rate as 30 month AL 
mice (35%). The dietary restricted mitochondria show reduced hydrogen peroxide 
release from complex I at 15 months and 24 months in brain, skeletal muscle and liver 
mitochondria when measured. Dietary restriction has no consistent reduction in 
complex III production. Hydrogen peroxide release at 36 months is not lower in dietary 
restricted mitochondria than AL mitochondria at 30 months as is the trend at matched 
ages. 
Thus, the mitochondrial hydrogen peroxide release is not low throughout the lifespan 
of dietary restricted mice. Hydrogen peroxide release increases with age in dietary 
restricted mice as well as ad libitum fed mice. The increase in hydrogen peroxide 
release from mitochondria with age is delayed in DR mice tissue. The low levels of 
hydrogen peroxide release are maintained for longer in the DR mice tissue compared 
with that of AL mice tissues. Hydrogen peroxide release at the same survival point in 
their respective lifespans shows no differences between AL and DR mitochondria. 
Long-term DR treatment studies mitochondria collected prior to feeding (pre-prandial) 
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and six hours after feeding (post-prandial). When the mitochondria were collected 
post-prandially there was a lower hydrogen peroxide release compared to that of DR 
at 30 months in all tissues. 
Short-term dietary changes also show alterations in hydrogen peroxide release. The 
mitochondria from brain, skeletal muscle and liver show reductions in hydrogen 
peroxide release in response to dietary restriction. The lower release of hydrogen 
peroxide is seen whether the mitochondria were collected pre or post prandially. 
Short-term addition of rapamycin to the diet also causes a reduction in hydrogen 
peroxide release in male 12 month old brain and liver mitochondria. This reduction 
was not replicated in female brain and liver mitochondria but was seen in 15 month 
female skeletal muscle mitochondria.  
Telomerase has been shown to be protective against superoxide release and increase 
antioxidant defences. TERT knockout mice are missing the catalytic unit of telomerase 
reverse transcriptase, yet they show a decreased level of hydrogen peroxide release. 
The addition of rapamycin to the diets of these TERT-/- mice show no additional 
change in hydrogen peroxide release as seen in the controls or earlier rapamycin 
treatment experiments.  
Overall changes to the diet of mice which alter the metabolism of the mice change the 
production of superoxide from the mitochondria. Short and long-term dietary 
restriction are shown to alter the protein abundance in fatty acid and amino acid 
metabolism in Chapter 4, and rapamycin is documented to regulate metabolism. These 
dietary changes both reduce the release of hydrogen peroxide from brain, liver and 
muscle mitochondria. 
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CHAPTER 4: CHANGES IN THE LIVER MITOCHONDRIAL 
PROTEOME REVEAL POSSIBLE CAUSES OF HYDROGEN 
PEROXIDE CHANGES WITH AGE AND DR 
4.1. PROTEOMICS CAN PROVIDE MORE DETAIL AS TO WHAT OCCURS 
TO CAUSE THE CHANGES IN LIVER MITOCHONDRIAL FUNCTION 
SEEN IN AGEING AND DR 
Mitochondria are a major source of superoxide in the eukaryotic cell (Chou et al., 
2011). Superoxide production occurs mainly at the protein complexes I, II and III in the 
electron transport chain (ETC) (St-Pierre et al., 2002; Barja, 2004; Miwa and Brand, 
2005). It is known that superoxide causes damage to proteins (Harman, 1956). It is 
likely there are changes in proteome composition in response to increased oxidative 
stress. The proteome changes occur due to adaptive changes in protein expression in 
response to the degradation and removal of damaged proteins. To understand a cell 
and an organism’s response to oxidative stress, it is therefore logical to investigate the 
cellular proteome. This information can complement and add to the observations of 
changes in superoxide release seen with ageing and dietary restriction (Sohal and 
Weindruch, 1996; Brand, 2000; Mansouri et al., 2006)(Thesis section 3.4). Protein 
changes have been shown to change with DR in protein focused studies (Miwa et al., 
2008; Chen et al., 2014; Miwa et al., 2014) . However, so far, no large scale study of 
the mitochondrial proteome has been performed that would take into account 
different ages, gender and dietary status. In this study I investigate the influence of all 
these independent variables on the composition of the mitochondrial proteome. Here, 
I have analysed the proteome from liver mitochondria of twenty groups of three mice 
each. The liver was chosen as an organ that is rich in mitochondria, central to 
physiological and biochemical adjustments at an organism level and an early detector 
of changes in an organism’s dietary circumstances. Nine of these groups correlate in 
diet, age and sex with those used in chapter three to study hydrogen peroxide release 
from isolated liver mitochondria. There were twenty groups in total. Four dietary 
treatments (AL, DR, PMAL and PMDR) were investigated. The AL proteome was 
determined in ages 3, 15, 24 and 30 months in males and females. The DR proteome 
was determined in ages 15, 24 and 30 in both male and female mice, 36 months in 
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only male DR mice. PMAL and PMDR are postprandial dietary restriction. Mouse 
samples were collected 24 hours post-prandially; in alternate day feeding experiments 
this caused differences in superoxide production (Dani et al., 2010). Here we look at 
the protein changes in mouse liver mitochondria 24 hours after feeding and 6 hours 
after feeding. At 15 months in both male and female mice PMAL and PMDR and at 30 
months only male PMDR mitochondrial proteomes were investigated.  
4.1.1. THE PROTEOMICS METHODOLOGY 
Stable Isotope Labelling with Amino Acids in Cell Culture (SILAC) was developed in the 
centre for Experimental Bioinformatics (CEBI), at the University of Southern Denmark 
(Ong et al., 2002). Typical SILAC is the biosynthetic labelling of a cell line with heavy 
amino acids (Mann 2006) followed by a direct relative comparison of peptide peak 
intensities and subsequently protein concentrations in two samples, one of which is 
labelled with heavy isotopes and the other one is not. Spike in SILAC (Geiger et al., 
2011) requires a biosynthetically heavy labelled complex standard that can be added 
to multiple samples. A SILAC spike-in method was used to compare a large number of 
mouse liver mitochondrial samples. We chose the addition of a labelled mouse liver 
carcinoma mitochondria lysate as an internal standard. 
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Figure 4-1: Workflows used to produce the figures presented in the proteomics 
chapter of this thesis. Red parallelograms denote file names. Purple rectangles with 
rounded ends represent figures in the thesis. Orange rectangles denote 
computational processes completed in excel or sigma plot unless noted.  
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4.2. DATA PROCESSING AND NORMALISATION 
Data processing and normalisation followed the scheme outlined in Figure 4-1.  
4.2.1. QUALITY CONTROL OF THE LCMS DATA 
Altogether, just over 1200 proteins were identified in 60 mouse liver mitochondrial 
samples. To gain a first-hand impression of the overall quality of the dataset, the file 
sizes of the 60 raw LCMS datasets were compared (Figure 4-2) and found to be roughly 
equal. 
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Figure 4-2:  Raw data file sizes of all mouse mitochondrial proteomics samples 
analysed. The y – axis denotes the file size in Gb, whereas the x axis denotes sample 
ID (Table 6-2) 
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4.2.2. PROTEIN IDENTIFICATION 
Subsequently, proteins were identified using the search engine Andromeda (part of 
the MaxQuant environment). Prior to counting identified proteins, contaminant 
proteins (proteins that were of non-murine origin and proteins that did not at all 
contain heavy isotope standard-labelled peptides) were removed. All samples 
contained a similar number of proteins (between 342 and 755 proteins per sample). 
Three samples stand out as having a particularly low number of identified proteins 
(sample 23 (30m M AL 2, 427 proteins), 35 (30m M PFDR 1, 445 proteins) and 40 (15m 
M DR 2, 342 proteins)) 
This is reflected at the peptide level, where variability is much more pronounced than 
at the protein level, due to the redundancy of the contribution of peptide 
identifications to specific proteins. The same three samples stand out as having 
particularly low numbers of identified peptides ((sample 24 (30m M AL 2, 1003 
peptides), 35 (30m M PFDR 1, 933 peptides) and 40 (15m M DR 2, 704 peptides)).  
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Figure 4-3: Proteins identified in each of the mouse liver mitochondrial samples 
analysed. Samples 24 and 40 have the lowest number of proteins identified; mouse 
sample 40 (15m Male DR) had only 342 proteins identified. The y-axis is the number 
of proteins identified in each mouse sample using the Andromeda search engine at a 
peptide level FDR rate of 1%. The x axis denotes the sample ID (Table 6-2).  
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Figure 4-4:  Peptides identified in each of the mouse liver mitochondrial samples 
analysed. There is a range of numbers peptides from 900 in sample 40 to 5000 in 
sample 12. The mouse sample ID is denoted on the x axis. Peptides were identified 
using the Andromeda Search engine (FDR rate %1). The x axis denotes the sample ID 
(Table 6-2). 
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4.2.3. PROTEIN QUANTITATION 
Assessing the result of the protein quantitation indicated that on average in all 
samples the amount of internal standard proteins was lower than the amount of 
mouse liver mitochondrial proteins (Figure 4-5). There was considerable variability in 
the ratio of internal standard protein concentration to sample protein concentrations, 
in particular samples 34-48 contain lower concentrations of the internal standard. This 
indicated variation in the amount of internal standard added to the samples and 
resulted in the necessity of data normalisation as a remedial measure (see section 
4.2.4).  
The overall reproducibility of the data was assessed by investigating the variability of 
the ratio of proteins in the carcinoma cell line standard (Heavy) to the same proteins in 
the liver mitochondrial samples (Light) (H/L ratio, Figure 4-6). It is to be noted that 
many of the proteins in this figure were only quantifiable in a small number of 
samples.  
Following this, a list of quantifiable proteins was compiled that contains only proteins 
that were quantifiable  in at least two thirds of all samples in the dataset, to ensure 
that only high quality data entered the quantitative analysis stage of this dataset 
(Table 6-6 (appendix A)). This list of quantifiable proteins (from here onwards referred 
to as quantifiable proteins) contained 305 proteins, 232 (76%) of which were found in 
the mitochondria using at least two methods according to the database mitominer 
(Smith and Robinson, 2009; Smith et al., 2012) and therefore classed as being 
mitochondrial. I used the cell part gene ontology (GO) terms to confirm this and 227 of 
the 305 proteins where labelled with mitochondrion (Ashburner et al., 2000) The other 
proteins were nevertheless included in the analysis of the dataset, as they co-purified 
reproducibly with the mitochondrial preparation used in my study.  
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Figure 4-5: Variation in the median log2 H/L ratio of all quantifiable proteins in 
mouse liver mitochondria samples. The x axis corresponds to the sample ID (table 6-
2). On the y-axis log2 H/L ratio was denoted. The main cause for the observed 
variability of the log2 H/L ratios are differences in the amount of internal standard 
(heavy labelled mouse hepatocarcinoma proteins) added.  
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Figure 4-6: The ratio of amount of quantifiable protein in the mouse liver 
mitochondrial samples to the amount of the same protein in the mouse 
hepatocarcinoma mitochondria varies over about one order of magnitude but is 
quite constant for each individual protein in all the mouse samples where it was 
quantifiable. Median protein concentrations are diamonds and the error bars are the 
standard deviations of the H/L ratios of the 60 samples. Proteins (on the x axis) are 
sorted by the H/L (hepatocarcinoma / liver tissue) ratio. The y-axis is the log2H/L 
ratio for the proteins. 860 proteins were quantifiable in at least two out of 60 
samples and were included in this graph. 
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4.2.4. DATA NORMALISATION 
To account for the variable amounts of internal standard that were added to each 
sample, the H/L ratios of the 305 quantifiable proteins in each sample were divided by 
the median H/L ratio for the quantifiable proteins in this sample (Figure 4-7). This 
normalisation step removes the dependency of the quantitative readout on the 
amount of internal standard added.  
The result of the first transformation is a list of quantifiable proteins for each sample 
with the H/L ratio indicating the difference between the protein amount in this sample 
and the amount for the same protein in the internal mouse liver carcinoma cell line 
mitochondria standard. However, for the purpose of this investigation, it is not 
interesting, if a protein has been selected for or against in this laboratory cell line. To 
remove the dependency of the quantitative readout on the internal standard, the H/L 
ratios after the first transformation for each protein in each sample were divided by 
the median H/C ratio for this protein in all samples (Figure 4-8). The 2 base log of the 
resulting value, which will from here onwards be referred to as Relative Abundance 
After Transformation (RAAT value) is solely indicative of a particular mitochondrial 
protein or peptide’s tendency to be more or less abundant in a specific sample when 
compared to the average of this protein or peptide’s abundance in all samples.  
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Figure 4-7: The first data normalisation step removes the bias in the data that is 
caused by the varying amounts of internal standard (mouse hepatocarcinoma 
mitochondria) added. Blue diamonds represent the median of the H/L ratio (amount 
of protein in mouse hepatocarcinoma mitochondria divided by the amount of 
protein in mouse liver mitochondria) for each individual, quantifiable protein in 
sample 3 (3m Male AL). The 312 proteins that were included in this graph were 
quantifiable in at least 2/3 of all samples. The same normalisation was carried out 
for the other 59 samples. Red squares represent the H/L ratios following this 
transformation step.  
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Figure 4-8: The second normalisation step removes the dependence of the 
quantitation on the internal standard (mouse hepatocarcinoma mitochondria). Blue 
diamonds represent the median protein H/L ratio for the protein prohibitin 2 (Phb2) 
in each of 60 individual mouse samples (after the first transformation). Mouse 
samples are sorted by increasing H/L ratios. Red squares represent RAAT values 
(Relative Abundance After Transformation) for this protein in each sample. This 
transformation step was carried out for each individual protein out of 305 
quantifiable proteins, resulting in a RAAT value for this protein in all samples where 
it was quantifiable.  
  
-5
-4
-3
-2
-1
0
1
2
3
4
R
A
A
T 
V
al
u
e
Median 
134 
 
4.3. ANALYSIS OF THE DATA AT THE PROTEOME LEVEL 
4.3.1. DIFFERENCES OF RELATIVE PROTEIN AMOUNTS (RAAT VALUES) 
BETWEEN GROUPS INDICATE THAT THE LARGE SCALE 
PROTEOMICS EXPERIMENT CONTAINS BIOLOGICALLY RELEVANT 
INFORMATION 
Each mouse group comprises three biological replicates. Mouse groups differ by 
nutritional status (AL, DR or Post-Prandial), age and sex (see section 1.3.5 for 
experimental design). The variability of the determination of RAAT values for each 
individual protein can be assessed by calculating the standard deviation of the RAAT 
values for this particular protein in one mouse group. The average of these standard 
deviations over the 20 mouse groups is an overall indicator of the experimental 
variability of the determination of the RAAT value and will henceforth be referred to as 
the triplicate standard deviation (Equation 1).  
 
In order to check, if the protein concentration variability between samples is caused by 
biological effects or by random fluctuation only, I decided to investigate the random 
variability in the complete dataset. To do this, the 60 mouse samples were shuffled to 
create 20 random triplicate groupings. This was followed by the same procedure that 
was used to calculate the triplicate standard deviation, but the resulting standard 
deviations (referred to hence as total standard deviation) are calculated from the 
average of standard deviations for each protein in 20 completely random mouse 
groups. As a result, it represents the random variability of each protein in the dataset.  
Equation 1. Calculation of the triplicate standard deviation (SDtriplicate). σi represents 
the standard deviation of the RAAT values of one specific protein in mouse group i 
prior to shuffling.  
𝑺𝑫𝒕𝒓𝒊𝒑𝒍𝒊𝒄𝒂𝒕𝒆 =
∑ (𝝈𝒊)
𝟐𝟎
𝒊=𝟏
𝟐𝟎
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The triplicate standard deviation SDtriplicate is a measure for the reliability of the 
measurement of the RAAT values permits to assess various aspects of the general 
reliability of the dataset. When SDtriplicate  is plotted against the average spectral count 
for each protein in all mouse groups (Figure 9), it becomes apparent that the reliability 
of the determination of RAAT values increases with protein concentration (it is 
generally acknowledged that spectral counts are an approximate measure of protein 
concentration, (Arike and Peil, 2014)). Two proteins do not conform to this trend 
(highlighted with red circles in Figure 9). When the identity of these two proteins is 
checked it turns out that both of them are keratins (keratin 8 and keratin 18) and that 
the high variability of determination of their concentration is likely to be due to 
contamination of the samples with human keratins (producing peptides that are 
identical in sequence to the corresponding murine keratins).  
If the variability of the data that were acquired for this study could be entirely 
explained by random experimental variability, then a plot of the triplicate standard 
deviations SDtriplicate versus the total standard deviations SDtotal would result in a cloud 
of points that could be summarised with a regression line with a slope of 1. To test 
this, one representative random set of SDtotal  was plotted against SDtriplicate (Figure 10). 
Clearly, the slope of a regression curve through the resulting cloud of points deviates 
from 1, indicating that the dataset contains variability that can only be explained by 
the grouping of the mouse samples in biological replicates.  
To test, if this would be only due to one particular random set of SDtotal, a Monte Carlo 
model was employed. SDtotal was calculated for 1000 randomisation sets derived from 
the existing dataset and the results of this analysis are shown in the kernel density plot 
displayed in Figure 11 (the R script employed to do this is in Appendix A). The median 
slope obtained for all 1000 linear regressions is 1.065 and the probability of obtaining a 
slope of 1 based on the present data was calculated to be 4.19e-7. This implies that the 
Equation 2: Calculation of the total standard deviation (SDtotal). σj represents the 
standard deviation of the RAAT values of one specific protein in random mouse group 
j.  
𝑺𝑫𝒕𝒐𝒕𝒂𝒍 =
∑ (𝝈𝒋)
𝟐𝟎
𝒋=𝟏
𝟐𝟎
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distribution of RAAT values in the dataset differs from a random distribution in a 
statistically highly significant manner.  
  
137 
 
 
Figure 4-9: Highly abundant proteins yield less noisy quantitation results. Proteins 
with high peptide counts (highly abundant proteins) have a lower standard deviation 
of the RAAT value than less abundant proteins (with a lower peptide count). The x- 
axis represents the median peptide cound for each of 312 quantifiable proteins. The 
y-axis represents the average standard deviation of the RAAT value for this protein in 
a group of three biological replicates (mice that received the same treatment).Circled 
in red are two proteins that don’t fit the trend these are keretins 8 and 19.  
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Figure 4-10: Triplicate standard deviation is lower than proteins comparative total 
standard deviation. On the x axis in triplicate standard deviation determined by 
avaraging the standard deviation from each of the biological replicate groups. On the 
y-axis is the total standard deviation determined by averaging twenty randomised 
groups of three. The proteins displayed an exponential trendline. In the absence of 
any biological effect, one would expect the two standard deviations to be very 
similar (black diagonal line). Lower abundant proteins appear to change significantly 
depending on biological treatment. Peptide count is represented by the shading of 
the diamonds, a high peptide count having a darker shade of red. Abundant proteins 
(dark diamonds) tend to have lower triplicate and total standard deviations.  
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Figure 4-11: The relationship between triplicate SD and total SD has a slope higher 
than 1 when 1000 randomisations of total standard deviation are completed. This 
suggests there are significant changes in protein RAAT values with age and treatment 
within the dataset. This histogram shows the slope from 1000 trend lines. The trend 
lines are determined from different randomisations of the groupings for calculating 
total standard deviation. The slope is determined from y=mx, the intercept is set at 
zero and the slope (m) is calculated for the linear regression trend line which best fits 
the data (r script in Appendix A). 
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4.3.2. COMPARISON OF THE INDIVIDUAL SAMPLES 
Mice that are very similar to each other are likely to have very similar RAAT values for 
all of their quantifiable proteins. Biological replicates are therefore likely to have very 
similar RAAT values and sample groups where ageing or nutritional status have 
changed the animals’ physiology are likely to differ in the RAAT values of the proteins 
that represent the observed physiological changes.  
To see, if the measured RAAT levels reflect the relative concentrations of the proteins 
and therefore also reflect the physiological status of the individual samples, I have 
performed to different multivariate statistical analyses to see, if related mouse groups 
would cluster. The two methods that were chosen here are clustering based on 
Pearson’s correlation coefficients and Principal Component Analysis (Massart, 1997).  
The Pearson Correlation Clustering (Figure 4-12) shows that mouse samples can indeed 
be grouped into clusters that indicate that the distance between individual samples is 
at least partially determined by biological differences. 60 samples were used in the 
Pearson correlation clustering. The proteins which weren’t determined to be 
mitochondrial in mitominer (Smith et al., 2012) were excluded for this clustering as 
they cluster closely and affect the sample clustering. The proteins measured in this 
study are from isolated mitochondria. None mitochondrial proteins may not be 
isolated with the mitochondria every time. 
Clustering used on the mouse samples show which groups have similar protein RAAT 
values. Clustering of the samples in figure 4-12 produces an overall trend from young 
mouse samples on the right to old mouse samples on the left of the right hand side 
cluster. This cluster also contains high proportion of DR samples on the left. The right 
hand side of this heatmap has more AL samples. Within these AL samples on the right 
there is a separation of male (left) and female (right) mice which isn’t seen in the other 
sections of the graph. The post-prandial (PF) mouse samples cluster of opposing sides 
of the heatmap. It is noticeable that one cluster is essentially formed by samples 
where a relatively large number of proteins were not quantifiable. This sample cluster 
is mainly composed of old mice of both sexes on the AL diet. It also contains male mice 
from the post-prandial (PF) experiment. Six of the samples are 30 months old.  
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Principle component analysis (PCA) requires a minimum number of non-missing values. 
Missing values are customary in proteomics research. The missing values can cause 
problems during data analysis. When calculating the PCA results for this data the 
missing values became a problem. PCA analysis requires at least two samples which 
have no missing values, this does not occur in my dataset. As a solution to the missing 
value problem I would have to exclude many proteins from the analysis. However, 
missing values are not indicative of an absent protein but can be due to low levels of 
the protein which weren’t measured. In Perseus missing values can be produced to 
ease the analysis process. The missing values are filled with a random value generated 
by Perseus for each mouse sample RAAT values (Geiger et al., 2013). These are not 
used throughout the study as they are not transformed raw data. PCA is an important 
mathematical tool which requires a more complete dataset and so was used in PCA 
analysis only. 
The sample PCA scores plots in figure 4-13 shows four groups which cluster closely. 
The mouse samples which are biological replicates should group together. In figure 4-
13, not all the biologically analogous mouse samples group together. I coloured the 
samples by sex (figure 4-13-B), Nutrition separating PMAL and PMDR (figure 4-13-C) 
and age. There is no grouping seen between male and female mouse samples. The 
post-prandial mice cluster on the left of component one. Component 2 and 3 remove 
this grouping. Age is the only condition which shows any grouping within the three 
components of the principle component analysis. This grouping is seen in the older 
mouse samples. Samples of 30 and 36 month old group closely together.  
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Figure 4-12: Clustering of the individual samples based on the RAAT values for each 
protein. Individual proteins are coloured red to black to green based on the RAAT 
value from low to high. Biological replicates which don’t cluster closely together 
suggest a tendency for those groups to have a large triplicate standard deviation. 
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A: B:  
C: D:  
Figure 4-13: PCA shows three distinct groups within the data which are separated by 
nutrition and age not sex. Principle component analysis scores plot of the 60 samples 
comparing components 1, 2 and 3. Panel A shows the eiganvalues for each component 
explaining the cause of data variation. Panel B is coloured to show male in black, and 
female in red. Panel C is coloured to show AL (black), DR (red), PMAL (green) and 
PMDR (blue). Panel D is coloured to show age, 3 months (black), 15 months (red), 24 
months (blue), 30 months (green) and 36 months (light blue). 
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4.4. INDIVIDUAL METABOLISM PATHWAY CHANGE WITH AGE AND 
NUTRITION 
The pearson correlation clustering of the proteins was analysed using DAVID (Huang et 
al., 2007a; Huang et al., 2007b) and uniprot (The UniProt, 2014; UniProt, 2014). The 
analysis was carried out on protein groupings which have the same heatmap trends in 
figure 4-12. The groupings were analysed in DAVID against a background of the 305 
quantifiable proteins which were in the clustering. Using the annotation clustering 
offered by DAVID I discovered groupings containing fatty acid enriched clusters and 
enrichment of branched-chain amino acid degradation. Enrichment of glycolysis was 
seen in some clusters and was included in further analysis. These pathways were 
looked at in detail below. 
4.4.1. RELATIVE PROTEIN CONCENTRATION OF PROTEINS INVOLVED IN 
FATTY ACID BIOSYNTHESIS AND CATABOLISM ARE INCREASED 
WITH AGE 
Proteins involved in fatty acid biosynthesis, either from acetyl CoA or triglyeride. Acyl-
CoA synthetase family member 2 (Acsf1),2,4-dienoyl-CoA reductase (Decr1),Enoyl-CoA 
hydratase domain-containing protein 2 (Echdc2),3-ketoacyl-CoA thiolase 
(Acaa2),Peroxisomal trans-2-enoyl-CoA reductase (Pecr). Protein abundance changes 
with age as they relate to 3 month old mice are shown in figure 4-14-A. These changes 
show an increase Echdc2 with age but a decrease in Acsf2. When separating the ageing 
mice into the two nutritions we see four of the five proteins are increased with age. 
The proteins increased with age in AL mitochondria are Acaa2, Echdc2, Decr1 and Pecr. 
Acsf2 is decreased with age. These proteins are unchanged in DR mitochondria (figure 
4-14-C) however in Acsf2 is decreased with age in DR mice. DR feeding prevents this 
increase in Acaa2, Echdc2, Decr1 and Pecr. There are no changes in average RAAT 
value with the fatty acid biosynthesis pathway between nutrition, collection time and 
sex irrespective of any other condition.  
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Figure 4-14: The protein concentration of fatty acid biosynthesis proteins is increased 
with age in AL mice. The change in protein abundance of five quantified proteins 
which are involved in fatty acid biosynthesis are displayed in the above graph. These 
proteins are acetyl CoA or triglyeride. Acyl-CoA synthetase family member 2 
(Acsf1),2,4-dienoyl-CoA reductase (Decr1),Enoyl-CoA hydratase domain-containing 
protein 2 (Echdc2),3-ketoacyl-CoA thiolase (Acaa2),Peroxisomal trans-2-enoyl-CoA 
reductase (Pecr). Panel A, B and C display the same proteins for combined age (in grey, 
panel A) in red for AL (panel B) and blue for DR (panel C). Panel A has the abundance 
change from 3 months for each protein at each age without nutrition, collection time 
or sex differentiation. Panel B and C is the abundance change from 3 months for each 
protein at each age point B is with AL nutrition, and C is with DR nutrition, from any 
collection time and either sex. Panel D to F compares the average RAAT value for all 
four proteins comparing AL and DR (D), pre and post-prandial (E) and male and female 
(F) irrespective of all other conditions. 
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Beta-oxidation of fatty acids is the degradation of fatty acids to obtain acetyl CoA for 
used of the TCA cycle and production of substrate for the electron transport chain. 
Enoyl-CoA hydratase (Echs1), Carnitine O-palmitoyltransferase 2 (Cpt2), Hydroxyacyl-
coenzyme A dehydrogenase (Hadh), Long-chain specific acyl-CoA dehydrogenase 
(Acadl), Short-chain specific acyl-CoA dehydrogenase (Acads), 3-ketoacyl-CoA thiolase 
(Hadhb),Very long-chain specific acyl-CoA dehydrogenase (Acadvl), Long-chain-fatty-
acid—CoA ligase (Acsl1), Long-chain-fatty-acid--CoA ligase 1 (Acadm) Delta(3,5)-
Delta(2,4)-dienoyl-CoA isomerase (Ech1), are the proteins quantified in this study 
which are involved in this process.  
The abundance of the ten proteins linked to beta-oxidation has no strong trend in 
changes with ageing independent of other conditions. Ageing in AL mitochondria has 
only one protein with a consistent increase with age (Echs1). In DR mitochondria there 
is an early decrease in abundance in four of the proteins between 3 and 15 months. 
These four proteins show an protein abundance then increases with age to 30 months 
after this initial decrease (Echs1, Acadl, Acadm, and Hadhb). Then there is a drop in the 
abundance of these four proteins. Acadvl doesn’t follow this trend it has a low 
concentration with age in DR mitochondria. 
Fatty-acid beta-oxidation protein abundance is unchanged between colletion time and 
sex of the mitochondria. Nutritional change causes a change in average RAAT value 
irrespective of age, collection time or sex.AL mitochondria have a higher protein 
concentration than DR mitochondria. AL mice weigh more than DR mice; in addition 
they have a higher amount of fat. DR mitochondria don’t have this available resource 
reducing the use of this pathway. 
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Figure 4-15: The protein concentration of fatty acid beta-oxidation proteins are 
decreased in DR liver mitochondrial proteomes. The change in protein abundance of 
fourteen quantified proteins which are involved in fatty acid beta-oxidation are 
displayed in the above graph. These proteins include: Enoyl-CoA hydratase (Echs1, 
dark squares), Carnitine O-palmitoyltransferase 2 (Cpt2, dark crosses) Hydroxyacyl-
coenzyme A dehydrogenase (Hadh, dark crosses), Long-chain specific acyl-CoA 
dehydrogenase (Acadl, dark stars), Short-chain specific acyl-CoA dehydrogenase 
(Acads, dark pluses), Trifunctional enzyme subunit beta (Hadhb, dark dashes), Very 
long-chain specific acyl-CoA dehydrogenase (Acadvl, light diamonds), 3-ketoacyl-CoA 
thiolase B (Acaa1b, light squares), Medium-chain specific acyl-CoA dehydrogenase 
(Acadm, light triangles), Long-chain-fatty-acid--CoA ligase 1 (Acsl1, light crosses). Panel 
A, B and C display the same proteins for combined age (in grey, panel A) in red for AL 
(panel B) and blue for DR (panel C). Panel A has the abundance change from 3 months 
for each protein at each age without nutrition, collection time or sex differentiation. 
Panel B and C is the abundance change from 3 months for each protein at each age 
point B is with AL nutrition, and C is with DR nutrition, from any collection time and 
either sex. Panel D to F compares the average RAAT value for all four proteins 
comparing AL and DR (D), pre and post-prandial (E) and male and female (F) 
irrespective of all other conditions.  
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Ketone bodies are produced by the liver from fatty acids when food intake is low. 
Three ketone bodies are produced as an alternative to glucose, acetone, acetoacetic 
acid and beta-hydroxybutaric acid. Four proteins were quantifiable from the synthesis 
and degradation of ketone bodies pathway in this dataset. These were Acetyl-CoA 
acetyltransferase (Acat1),D-beta-hydroxybutyrate dehydrogenase 
(Bdh1),Hydroxymethylglutaryl-CoA lyase (Hmgcl), and Hydroxymethylglutaryl-CoA 
synthase(Hmgcs2).  
The four proteins are compared between AL and DR, pre- and post-prandial and male 
and female. There was no difference between any of these comparisons. In aging there 
is no change in three of the proteins however Bdh1 increases with age. When 
separating age into AL and DR nutritions, Hmgcl is unchanged with age. The other 
proteins all follow a close trend with an increase in protein abundance with respect to 
the 3 month concentration between 15 to 30 months. In dietary restricted 
mitochondrial proteomes the change in protein abundance is only increased in Bdh1. 
Dietary restriction appears to prevent the ageing increase of three of the ketone 
bodies but not Bdh1.  
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Figure 4-16: The protein concentration of D-beta-hydroxybutyrate dehydrogenase 
increases with age independent of other conditions. The abundance change in four 
proteins involved in ketone synthesis and degradation, including for four ketone body 
synthesis or degradation proteins quantified in this dataset, these were Acetyl-CoA 
acetyltransferase (Acat1), D-beta-hydroxybutyrate dehydrogenase (Bdh1), 
Hydroxymethylglutaryl-CoA lyase (Hmgcl), and Hydroxymethylglutaryl-CoA synthase 
(Hmgcs2). Panel A,B and C display the same proteins in red for AL (panel B) and blue 
for DR (panel C). Panel A has the Log2 abundance change from 3 months for each 
protein at each age without nutrition, collection time or sex differentiation. Panel B is 
the Log2 abundance change from 3 months for each protein at each age point for AL 
nutrition, any collection time and either sex. Panel C is the same Log2 abundance 
change from 3 months for each protein at each age point for DR nutrition, all collection 
times and sexes. Panel D compares the average RAAT value for all three proteins for AL 
(red) and DR (blue) from all ages and sexes. Panel E compares the average RAAT value 
from the three proteins for pre- (red) and post-prandial (green) treatments and Panel F 
shows the average RAAT value from the three proteins for male (blue) and female 
(red) mice irrespective of age, nutrition or collection. 
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4.4.2. CHANGES SEEN IN DIFFERENT AREAS OF AMINO ACID 
METABOLISM WITH DIFFERENT DIETARY TREATMENTS 
Groups of amino acids are synthesised using different pathways. Branched chain 
amino acids, aromatic and nucleophilic amino acids have separate synthesis pathways. 
The other amino acids are produced with crossover points between individual 
pathways including the urea cycle, aspartate and asparagine metabolism and glycine, 
glutamate and histidine metabolism.  
Eight amino acid biosynthesis proteins are quantifiable within the urea cycle and 
glutamate metabolism. These proteins including, Ornithine aminotransferase (Oat), 
Aspartate aminotransferase (Got2), Glutamate dehydrogenase 1 (Glud1), Glutathione 
S-transferase kappa 1 (Gstk1) and Amine oxidase (Maob). Three proteins as part of the 
urea cycle include Argininosuccinate synthase (Ass), Carbamoyl-phosphate synthase 
(Cps), and Ornithine carbamoyltransferase (Otc). The concentration of the urea cycle 
proteins increases at 24 months with age independent of nutrition, collection time and 
sex. There is no change in the other proteins with age. In the urea proteins in AL 
mitochondria, Ass1 has a large increase with age until 30 months. In the DR 
mitochondria with age all urea proteins are increased at 24 months and decreased by 
30 months of age.  
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Figure 4-17: The protein concentration of urea amino acid biosynthesis proteins is 
increased with age. The change in protein abundance of ten quantified proteins which 
are involved in amino acid biosynthese are displayed in the above graph. Ornithine 
aminotransferase (Oat), Aspartate aminotransferase (Got2), Glutamate dehydrogenase 
1 (Glud1), Glutathione S-transferase kappa 1 (Gstk1), Alpha-aminoadipic semialdehyde 
dehydrogenase (Aldh7a1) and Amine oxidase (Maob). Three proteins as part of the 
urea cycle include Argininosuccinate synthase (Ass), Carbamoyl-phosphate synthase 
(Cps), and Ornithine carbamoyltransferase (Otc) are the quantifiable proteins detected 
in amino acid biosynthesis. Panel A, B and C display the same proteins for combined 
age (in grey, panel A) in red for AL (panel B) and blue for DR (panel C). Panel A has the 
abundance change from 3 months for each protein at each age without nutrition, 
collection time or sex differentiation. Panel B and C is the abundance change from 3 
months for each protein at each age point B is with AL nutrition, and C is with DR 
nutrition, from any collection time and either sex. Panel D to F compares the average 
RAAT value for all four proteins comparing AL and DR (D), pre and post-prandial (E) and 
male and female (F) irrespective of all other conditions. 
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Branched amino acid degradation proteins were grouped in the clustering. The six 
proteins in this pathways which have quantifiable results are: 3-mercaptopyruvate 
sulfurtransferase (Mpst), Protein disulfide-isomerase (P4hb) 3-hydroxyisobutyrate 
dehydrogenase (Hibadh), 3-hydroxyisobutyryl-CoA hydrolase (Hibch), Methylmalonyl-
CoA mutase (Mut), Methylcrotonoyl-CoA carboxylase subunit alpha (Mccc1).  
Four of the proteins involved in branched chain amino acid degradation are decreased 
with age. Three of these are specific to valine degradation. Mccc1 involved in Leucine 
degradation has no change with age. Mccc1 has no change in AL or DR mitochondria 
with age. Whereas the other proteins decrease with age in AL mitochondria, in DR 
mitochondria there is a decrease with age for Mut, Mpst and Hibach. In DR 
mitochondria P4hb doesn’t decrease with age. This is the only protein which has 
different outcomes between AL and DR. 
These proteins have the same average RAAT value in AL and DR mitochondria. There is 
a lower average RAAT value for the proteins, involved in branched amino acid 
degradation, if the mitochondria were collected post-prandially. The proteins have a 
high turnover if they are changed between these two groups. This is the only pathway 
which has a difference between male and female mice. Female mitochondria have a 
lower average RAAT value than the male mitochondria. 
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Figure 4-18: The protein concentration of amino acid catabolism proteins is lower in 
post-prandial mitochondria and female mitochondria irrespective of other 
conditions. The change in protein abundance of six quantified proteins which are 
involved in amino acid catabolism are displayed in the above graph. 3-
mercaptopyruvate sulfurtransferase (Mpst), Protein disulfide-isomerase (P4hb) 3-
hydroxyisobutyrate dehydrogenase (Hibadh), 3-hydroxyisobutyryl-CoA hydrolase 
(Hibch), Methylmalonyl-CoA mutase (Mut), Methylcrotonoyl-CoA carboxylase subunit 
alpha (Mccc1) are the quantifiable proteins detected in amino acid catabolism. Panel 
A, B and C display the same proteins for combined age (in grey, panel A) in red for AL 
(panel B) and blue for DR (panel C). Panel A has the abundance change from 3 months 
for each protein at each age without nutrition, collection time or sex differentiation. 
Panel B and C is the abundance change from 3 months for each protein at each age 
point B is with AL nutrition, and C is with DR nutrition, from any collection time and 
either sex. Panel D to F compares the average RAAT value for all four proteins 
comparing AL and DR (D), pre and post-prandial (E) and male and female (F) 
irrespective of all other conditions. 
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4.4.3. PYRUVATE METABOLISM PROTEINS HAVE LOWER 
CONCENTRATIONS IN POSTPRANDIAL COLLECTED 
MITOCHONDRIA 
Pyruvate metabolism has four proteins which were quantifiable in this study. Three of 
these proteins are dihydrolipoyl dehydrogenase (Dld) and pyruvate dehydrogenase E1 
components (Pdha1 and Pdhb), these proteins are involved in changing pyruvate to 
acetyl Co A or the reverse. The fourth protein is pyruvate carboxylase (Pcx) which 
produces oxaloacetate from pyruvate as part of the gluconeogenesis pathway.  
Proteins involved in producing acetyl CoA from pyruvate follow a similar trend in 
figures 4-22-A-C. Ageing changes irrespective of any other condition results in no 
change with age in these proteins. Separating ageing changes by nutrition produces 
the same pattern of age changes in both AL and DR. In AL there is decrease in protein 
abundance compared to 3 month abundance with age in Dld and Pdhb at 15 and 24 
months. In DR there is the same abundance change at 15, 24 and 36 months. 
Pcx has a different trend to the other three proteins. This protein concentration 
increases with age irrespective of nutrition, collection time or sex. In AL mitochondria 
15 and 24 month old mice have higher Pcx abundance compared to 3 month old 
mitochondria. In DR mitochondria higher Pcx abundance is seen in 24 and 36 month 
old mice compared to 3 month old mice. Pcx abundance increases earlier in AL 
mitochondria, it is higher in 15 month old mice than DR abundance of Pcx, DR 
abundance doesn’t increase until 24 months nutritional restriction delays the 
abundance increase. 
When comparing the conditions directly there is no change within the proteins 
between AL and DR and male and female. Comparing the pre- and post-prandial 
conditions reveals these four proteins were reduced in post-prandially collected tissue 
when compared to pre-prandially collected tissue. 
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Figure 4-19: The protein concentration of pyruvate metabolism proteins is lower in 
post-prandial mitochondria. The change in protein abundance of four quantified 
proteins which are involved in pyruvate metabolism are displayed in the above graph. 
Dihydrolipoyl dehydrogenase (Dld, Dark diamonds), pyruvate carboxylase (Pcx, dark 
stars), and two pyruvate dehydrogenase E1 components (Pdha1 (light X) and Pdhb 
(light circles)) are the quantifiable proteins detected in pyruvate metabolism. Panel A, 
B and C display the same proteins for combined age (in grey, panel A) in red for AL 
(panel B) and blue for DR (panel C). Panel A has the abundance change from 3 months 
for each protein at each age without nutrition, collection time or sex differentiation. 
Panel B and C is the abundance change from 3 months for each protein at each age 
point B is with AL nutrition, and C is with DR nutrition, from any collection time and 
either sex. Panel D to F compares the average RAAT value for all four proteins 
comparing AL and DR (D), pre and post-prandial (E) and male and female (F) 
irrespective of all other conditions. 
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4.4.4. PROTEINS WHICH PROTECT AGAINST SUPEROXIDE HAVE A 
HIGHER CONCENTRATION IN OLDER AND DIETARY RESTRICTED 
MICE 
Three proteins, mitochondrial superoxide dismutase (Sod2), glutathione peroxidase 
(Gpx1), and catalase (cat) are involved in clearing superoxide, forming hydrogen 
peroxide and preventing damage to the cell macromolecules. Glutathione peroxidase 
and catalase reduce hydrogen peroxide to water. Glutathione peroxidase abundance is 
unchanged with both age and nutrition. (Mavelli et al., 1982) 
Catalase remains unchanged with age independent of nutrition. However, catalase has 
an increased abundance with age in both AL and DR nutrition, independent of sex and 
collection time. There is an increased concentration of catalase between 3 and 30 
months of age in the AL mitochondrial proteome (Figure 4-20-B). In addition there is 
an increase in catalase concentration in DR mitochondrial proteomes between 3 and 
30 months of age with a decrease in the later 36 month age point (Figure 4-20-C).  
The comparisons in panels D-F (Figure 4-20) show there are no independent changes in 
the three proteins between collection time and sex. The three protein do have an 
increase in DR mitochondria independent of age, collection time or sex. This change is 
predominantly in catalase. There is a higher concentration of catalase in DR 
mitochondria than AL at 15, 24 and 30 month age points in panels B and C of figure 4-
20.  
Superoxide dismutase removes the radical superoxide by producing hydrogen peroxide 
(McCord and Fridovich, 1969b). The abundance of the protein doesn’t change 
independently with age, nutrition, collection time or sex. In panel c of figure 4-20 there 
is a decrease with age between 3 and 36 months. Catalase is the only protein changed 
which is involved with free radical clearance that is changed with age and nutrition. 
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Figure 4-20: The protein concentration of catalase increases with age dependent on 
nutrition. There is a higher abundance of catalase in DR mitochondria at 15, 24 and 
30 months. These panels display the RAAT values for three superoxide clearance 
proteins quantified in this dataset, catalase (Cat, Dark diamonds), glutathione 
peroxidase 1 (Gpx1, light squares) and mitochondrial superoxide dismutase (Sod2, 
Triangles). Panel A and B display the same proteins in red for AL (panel B) and blue for 
DR (panel C). Panel A has the average RAAT values for each protein at each age 
without nutrition, collection time or sex differentiation. Panel B is the average RAAT 
value for each protein at each age point for AL nutrition, any collection time and either 
sex. Panel C is the same average RAAT value for each protein at each age point for DR 
nutrition, all collection times and sexes. Panel D compares the average RAAT value for 
all three proteins for AL (red) and DR (blue) from all ages and sexes. Panel E compares 
the average RAAT value from the three proteins for pre- (red) and post-prandial 
(green) treatments and Panel F shows the average RAAT value from the three proteins 
for male (blue) and female (red) mice irrespective of age, nutrition or collection. 
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4.5. MITOCHONDRIAL PROTEOME IS ALTERED WITH DIETARY 
INTERVENTION 
Proteomics is a fast developing field which can give a vast amount of information. This 
study focused on the mitochondrial proteome to better understand the role of ageing 
and dietary restriction as a lifespan extension model. Four different effects were 
compared including; sex, age, dietary restriction and tissue collection time (Figure 1-3). 
The different methodologies accessible for this project determined a spiked SILAC 
standard in each tissue to be the best method to compare the 60 samples.  
A heavy labelled standard was ‘spiked in’ to 60 samples allowed comparisons to be 
made between the mouse groups for each protein. Comparisons cannot however be 
made between levels of the proteins with one sample. Data analysis of proteomics 
typically involves complicated statistics, and the large amounts of data require the 
proteins to have very low p-values to achieve statistical significance. The SILAC method 
used will allow for direct comparisons for all proteins between all samples. The mass 
spectrometry equipment is not infallible, it may not always detect every peptide. The 
most abundant peptides are the primary target of the instrument and consequently 
peptides of lower abundance are not always detected.  
The SILAC method required two transformation steps. The first removed any variation 
of the concentration heavy labelled standard which was added to each sample. The 
second removed the influence of the mouse carcinoma cell line on the ratio 
determined by MaxQuant. This resulted in Relative Abundance After Transformation or 
RAAT values which were directly comparable between samples.  
Analysis was started on particular protein functional groups, specific focus was paid to 
the metabolism pathways as these were the interesting pathways with regard to 
dietary changes. Proteins were grouped based on type of metabolism and compared 
between mouse groups. Mouse groups were simplified to compare sex, ageing, diet 
and collection time effects on protein abundance. 
Ageing trends showed that fatty acid metabolism protein abundance was seen to 
increase with age irrespective of other factors. This trend appears stronger in AL fed 
mice than DR mice. On the contrary amino acid metabolism decreases with age 
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irrespective of other factors. Superoxide clearance proteins were shown to increase 
with age irrespective of any other factors. These proteins also show increased 
abundance in DR fed mice compared with AL irrespective of age. The abundance of 
catalase is increased in DR between 15 and 30 months of age yet abundance falls at 36 
months. Collection time effects the RAAT values of proteins involved in the amino acid 
and pyruvate metabolism pathways. When tissues were collected post-prandially 
amino acid catabolism proteins were lower in abundance irrespective of any other 
factors. In addition pyruvate metabolism proteins show a decreased abundance when 
post prandial tissues are collected. Metabolism is altered with age and dietary 
restriction. 
 
162 
 
CHAPTER 5: DISCUSSION 
5.1. AIMS OF THIS THESIS 
Amplex red fluorescence from isolated mitochondria was used to measure hydrogen 
peroxide release from sites within the electron transport chain. These measurements 
examined changes with age, under normal and lifespan extension influences including 
dietary restriction, rapamycin and telomerase presence. The mitochondrial liver 
proteome was measured under four conditions. These are outlined in section 1.8, 
figure 1-3 and included ageing, nutrition, sex and time of tissue collection (pre vs post-
prandial). The results from these measurements hopefully enlighten us to potential 
protein changes which cause the functional changes we see with ageing.  
Hydrogen peroxide production and proteome composition were measured from up to 
five age points in isolated mice mitochondria. This is a greater comprehensive 
coverage of age than has been seen in other studies (Lass et al., 1998; Barja, 2002; 
Barja, 2004; Ash and Merry, 2011). The first four ageing points were measured with 
only AL mitochondria (3, 15, 24, and 30 months). Long term dietary restriction was 
started at 3 months and measured from 15 months until the fifth age point (36 
months) which was only reached by the DR mice. AL mice don’t survive until 36 
months and cannot be measured in 36 months. However we can compare the 
differences between 30 month AL and 36 month DR mitochondrial hydrogen peroxide 
release these are the ages when both groups are at 35% survival.  
Post-prandial mitochondria will give us an understanding of which proteins have a high 
turnover. The proteome was measured at 15 and 30 months of age (PMDR), these 
mitochondria were measured six hours post DR feeding. A control for this group at 15 
months was measured PMAL, these mitochondria were measured at 7hrs into the day 
light cycle. The 30 month old post-prandial mitochondria also used to obtain hydrogen 
peroxide release from isolated mitochondria. Females have a longer life extension with 
DR feeding thought to be due to lower oxidant generation (Borras et al., 2007) by 
looking at the proteome compositional differences between the sexes we might find a 
reason for the difference in life extension.  
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5.2. LIVER MITOCHONDRIA REQUIRED AN ALTERED METHOD OF 
HYDROGEN PEROXIDE DETECTION 
Liver mitochondria were measured by a slightly different method to the brain and 
muscle section 2.3. The brain, muscle and liver mitochondria hydrogen peroxide 
release are all measured using amplex red. The brain and muscle mitochondria were 
measured using the traditional method. Liver mitochondria were measured in a slightly 
different method. The hydrogen peroxide release was measured using amplex red 
both in and without the presence of HRP. The difference between these values was 
determined to be the release of hydrogen peroxide from the mitochondria. This 
method was developed due to a high oxidation of amplex red when no stimulation was 
presented. This doesn’t occur in brain and muscle mitochondria. 
Liver mitochondria have a large rate of basal hydrogen peroxide release from 
mitochondria. These basal levels were measured in the 15 month old AL and DR mice. 
There was a significantly lower release of H2O2 from DR mitochondria at basal levels. 
This significant reduction is maintained after the addition of substrate and the addition 
of rotenone and AA. I know from parallel respiration studies that there is no oxygen 
consumption when there is no substrate present (unpublished data, Satomi Miwa). If 
there is no oxygen consumption there is no respiratory chain activity. Without 
respiratory chain activity there is no superoxide production and therefore no hydrogen 
peroxide release.  
The basal fluorescence response in liver mitochondria is complex. The signal is high 
and in 15 month old male liver mitochondria the addition of a substrate causes a 
decrease in fluorescence (figure 3-6 and figure 3-13). This decrease implies there is less 
hydrogen peroxide present to cause fluorescence. The signal would be expected to 
increase with the substrate addition as in brain mitochondria (figure 3-13). Substrate 
would activate the electron transport chain and produce superoxide. The production 
of superoxide would increase the prevalence of hydrogen peroxide increasing 
fluorescence. The kinetic addition of substrate didn’t alter the responses (figure 3-9). 
The response to substrate occurs irrespective of when the substrate is added. The 
decrease after substrate addition is the crux of the problem. This removes the ability 
to subtract the basal level and measure the increase seen after substrate addition. 
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In liver mitochondrial studies using amplex red this problem is not discussed. Basal 
(state 1) hydrogen peroxide generation is rarely published as generally this is a 
negligible value due to the absence of a substrate. The results published for hydrogen 
peroxide measured by amplex red in mouse liver mimic those I detected without the 
consideration of the high basal levels (Lopez-Torres et al., 2002). The possibility is 
these high ‘basal’ levels are both tissue specific and animal specific.  
5.2.1. THE DETECTED FLUORESCENCE IS IN RESPONSE TO RESORUFIN 
BUT NOT IN RESPONSE TO HYDROGEN PEROXIDE RELEASE 
Catalase breaks down hydrogen peroxide into water (Mavelli et al., 1982; Schriner et 
al., 2005). Catalase reacts with hydrogen peroxide to produce water so hydrogen 
peroxide can form resorufin and fluorescence. In brain mitochondria catalase almost 
completely removes the resorufin signal. In liver mitochondria addition of catalase has 
very little removal of the signal suggesting the signal is not linked to hydrogen peroxide 
release (figure 3-8). HRP absence removes the catalyst to the amplex red reaction. HRP 
absence in the amplex red assay with brain mitochondria irradicates the signal 
completely. Removal of HRP in liver mitochondria has very little effect on the liver 
hydrogen peroxide release. It is unlikely to be different peroxidases acting as a catalyst 
as using catalase to remove the hydrogen peroxide should still remove the signal 
(Votyakova and Reynolds, 2004).  
The signal detected in the amplex red assay is resorufin. However the fluorescence 
signal detected could be another product in the mitochondria which fluoresces in the 
same area of the spectrum. The absorbance of the fluorescence product in the 
presence of liver and brain mitochondria occurs in the same range. Both absorbances 
show a peak at 590nm, the absorbance is higher in the liver mitochondria due to the 
intensity of the signal (figure 3-7). The addition of hydrogen peroxide to the liver 
mitochondria well returned a smooth absorbance graph with no second peak so the 
absorbance is aligned. The fluorescence of hydrogen peroxide only also gives a peak at 
590nm further supporting the theory that the basal fluorescence in liver mitochondria 
is resorufin.  
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5.2.2. THE SUPPRESSION OF THE FLUORESCENCE IS DEPENDANT ON 
THE SUBSTRATE AND IT ’S CONCENTRATION 
Investigating the substrate effect proved that there is a response which occurs in 
proportion to the addition made. The suppression is dependent on substrate type, and 
concentration. 5mM of pyruvate malate and 4mM succinate are the optimal 
concentration for the amplex red assay (figure 3-14 and 3-15). The suppression of 
hydrogen peroxide release in liver mitochondria is not proportional between with and 
without HRP. There is greater suppression when HRP is not present. This greater 
suppression is concluded to be a result of the substrate addition producing superoxide 
and consequently hydrogen peroxide and resorufin. The type of substrate is also 
significant. Succinate, a type II linked substrate, has less of a suppressive effect then 
Complex I linked substrates, pyruvate malate for example.  
5.2.3. THE SUPPRESSION OF HYDROGEN PEROXIDE RELEASE FROM 
MITOCHONDRIA IN THE PRESENCE OF HRP MIMICS THE RESULTS 
IF HRP IS NOT PRESENT 
The difference between with and without HRP is how I have determined hydrogen 
peroxide release. Addition of a complex I substrate, rotenone and myxathiozol 
minimises the electron transport chain activity and consequently superoxide 
production. Figure 3-16 shows an increase in the rate of hydrogen peroxide release 
when HRP and substrate is present. Suppression of superoxide production results by 
myxathiozol removes the difference between presence and absence HRP. In addition 
the suppressed hydrogen peroxide release in equal to the release with substrate but in 
the absence of HRP. The best method available to determine liver mitochondria 
superoxide release is to measure the difference in amplex red production from 
mitochondria with and without the presence of amplex red. 
5.3. INCREASED HYDROGEN PEROXIDE RELEASE IS SEEN IN AGEING 
TISSUES 
Hydrogen peroxide production was measured at up to four ages in three tissues in AL 
mice. This is a much more in depth study of age and oxidative damage. Current studies 
show an increase in ROS production and superoxide production with age (Sohal et al., 
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1994; Lass et al., 1998; Dkhar and Sharma, 2010). Complex I superoxide release occurs 
from two different sites (lambert 2008). Complex I hydrogen peroxide release is 
increased in both brain and muscle mitochondria with age (section 3.3.1 and 3.3.2).  
In the brain it was seen that the function of complex I and III was altered with age. The 
increase in hydrogen peroxide release which was detected was predominantly from 
complex I. The maximum capacity of complex I to produce superoxide increased with 
age. There was also an increase in complex I superoxide release with age under 
electron reverse flow. The complex III production was increased in the later age points, 
24 and 30 months not at 15 months.  
Muscle mitochondrial hydrogen peroxide release increases with age form complexes I 
and III. Increases in hydrogen peroxide release from complex I were seen in both 
forward and reverse flow with age. The increased reverse flow level is reflected in the 
higher release of hydrogen peroxide release seen when succinate is present. Complex 
III maximum capacity was higher in 15 and 30 months.  
Liver mitochondria show no increase in hydrogen peroxide production with age as 
seen in brain and muscle mitochondria. Tissue specificity has been shown in other 
publications (Tahara et al., 2009). There is no information for the 15 month age group 
as the problem detected had not shown its full complexity.  The hydrogen peroxide 
release is higher in 24 and 30 months old mice compared with 3 month old mice. This 
increase was only significant in both maximal complex I stimulated release. This 
increase in complex I hydrogen peroxide release is not apparent in reverse flow. The 
age related increase of complex III is in all tissues, however complex I increase is tissue 
specific to brain and muscle. 
5.4. HYDROGEN PEROXIDE RELEASE IS LOWER IN DIETARY 
RESTRCTED MICE COMPARED WITH AD LIBITUM FED MICE 
Dietary restriction is well documented to have lower superoxide than AL fed mice 
(Sohal et al., 1994; Lass et al., 1998). DR reduced the release of hydrogen peroxide 
from the mitochondria. This ageing effect seen in AL mice tissues was delayed with 
dietary restriction. The 15 month old mice show no significant difference in hydrogen 
peroxide release when compared with 3 month old animals. This suppression is seen in 
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brain mitochondria. Forward flow complex I release is not significantly different with 
then of 3 month old animals. Reverse flow from complex I maintains low levels 
comparative to 3 month old release up until 30 months of age.  This effect is also seen 
in complex III release and is maintained until 24 months old. The same effect does not 
occur in muscle mitochondria from complex I. At 15 months the release of hydrogen 
peroxide is significantly higher than that produced at 3 months when forward and 
reverse flow is occuring. This level of release is significantly lower than that released at 
30 and 36 months. This pattern follows complex III production also. The release at 3 
months is significantly lower than the DR animal at greater ages. Complex III release 
also does not increase with age as seen in the brain mitochondria.  
Liver mitochondria used a different method this resulted in only uncorrected 15 month 
old data. The pattern is maintained here at 24 and 30 months of age the release of 
hydrogen peroxide from complex I, with flow in either direction, is not significantly 
different than at 3 months old. 
A decreased level of ROS production in DR mice has been shown in muscle, heart and 
liver tissues (Lopez-Torres et al., 2002; Drew et al., 2003). This study looks at older age 
ranges in DR animals than have been seen previously, so comparisons could be drawn 
between hydrogen peroxide release at similar survival percentages. Decreased 
hydrogen peroxide release as a marker of superoxide production in DR mice has been 
seen in mice up to the age of 30 months, as seen here in liver mitochondria. Most 
studies compared ageing at two ages, young (3-8 months) and old (24 months). Few 
studies go up to 30 months old, the data available show an increase in age supporting 
this data. The effects of DR have also been shown at these ages to be lower than AL 
mice, with more than two ages to compare a more comprehensive understanding of 
how the release of hydrogen peroxide changes with age (Lopez-Torres et al., 2002; 
Drew et al., 2003). Loss of the difference between AL and DR mice at 30months and at 
30% survival suggests that the effects of DR are reduced over long term restriction. 
The dysfunction of complex I can avoided using dietary restriction until 24 months 
when there is no improvement compared to AL mice. At 30% survival the mice had 
similar levels of superoxide production from complex I via reverse flow, though 
maximum capacity from forward flow was increased in DR brain mitochondria.  In 
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muscle mitochondria the differences in between AL and DR lasted longer. Complex I 
maximum capacity was increased with age, dietary restriction at ages 15 and 24 
months resulted in lower maximum capacities. The data from reverse flow reflected 
these changes in complex I with age and DR. 
Liver mitochondria show the effects of DR most predominantly. There is a large 
decrease in the hydrogen peroxide release from complex I at 24 and 30 months DR 
compared with 3 months. At 36 months DR the is a large increase so there is little 
difference in hydrogen peroxide release at 30% survival in the liver of AL and DR mice. 
Again the decrease in hydrogen peroxide release in DR and increase with age was seen 
mainly in complex I production.  
The 30 month old mice were compared for AL, DR and PMDR treatments. Dani et al 
showed that fasted DR (my DR treatment) have higher superoxide levels than fed DR 
rats (my PMDR treatment –post-prandial) liver mitochondria (Dani et al., 2010). In this 
study there is a decrease in liver mouse mitochondria from maximal complex I 
production. Brain and muscle also have significantly lower post-prandial hydrogen 
peroxide release than pre-prandial hydrogen peroxide release (figure 3-39, 3-40, 3-41).  
This comprehensive detail of this study allows the visualisation the delay in ageing 
which occurs in the DR mice. Again this supports the theory that increased superoxide 
is linked to complex I dysfunction, and maintained at a lower level for longer with a DR 
diet. This data was published in Miwa et al (Miwa et al., 2014). 
5.4.1. SHORT-TERM DIETARY RESTRICTION 
The short term age changes are seen between 12 and 15 months. In the brain as in the 
main study there is a large increase in both complex I and III hydrogen peroxide release 
in brain and muscle mitochondria. This increase is not seen in complex I in the liver 
mitochondria, but there is the increase seen in complex III which agrees with the 
results seen in the main study. Complex II release has not been measured in relation to 
age, DR or rapamycin treatment before. This release is most affected in muscle 
mitochondria with age. There is an increase of superoxide production in both sites of 
production from complex II (Quinlan et al., 2012).  
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Short term dietary restriction has been done in late stages of life and shown to extend 
lifespan (Cameron et al., 2011). In all studied mitochondria complex I hydrogen 
peroxide release in decreased with DR treatment. These levels show further reduction 
in the post-fed mice when pyruvate malate is used as a substrate. Liver mitochondria 
only show the same effect in the reverse flow of mitochondria. These sites of 
production have different locations in complex one and or sensitive to different 
conditions which may not be present in short term DR but are with a longer treatment. 
Complex III is unchanged between AL and DR in all tissues. In liver and muscle the 
release of hydrogen peroxide is lower in post fed mice only. Muscle mitochondria also 
show changes in complex II release of hydrogen peroxide at site q. There is a decrease 
in the release of hydrogen peroxide with DR treatment which is further decreased in 
the mice are culled six hours after feeding. Site f shows no difference in release 
between AL and DR treatments but there is significantly lower release in the post-fed 
animals (figure 3-46). This has been shown in other studies 
5.4.2. SHORT-TERM RAPAMYCIN FEEDING 
Rapamycin has been shown to extend lifespan in mice (Anisimov et al., 2011; Chen et 
al., 2009; Harrison et al., 2009; Miller et al., 2011).  Mice treated with rapamycin have 
also been shown to have less ROS (Tunon et al., 2003). However the breakdown of the 
site of superoxide production has not been determined. In this study rapamycin 
reduced the amount of hydrogen peroxide release from complex I in only muscle 
mitochondria. In liver and brain this is shown in the maximum capacity on complex I 
and the reverse flow via complex I.  
There is no comparison with the effects of DR in liver mitochondria at 15 months. This 
comparison can be drawn in liver showing that they reflect those in AL and DR mice of 
the same age. Differences between the WT control and AL mice are seen, these are 
likely to be due to differences in strain of the mice. Comparing the results from the 
TERT-/- mice which were treated with rapamycin there was no effect of rapamycin on 
hydrogen peroxide release on mice.  
Only short term feeding of rapamycin have comparable results to those seen in the 
short term DR treatment. These mice were all obtained from one background and fed 
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different treatments. The RC and RAPA group were fed a diet with a similar nutritional 
make up to that of the AL food, with one containing rapamycin and one without. The 
rapamycin control animals have increased hydrogen peroxide release from complex I 
in brain and muscle mitochondria. In all three tissues there was an increased hydrogen 
peroxide release from complex III. There was no change in complex II production. This 
means while the DR results cannot be directly compared with the rapamycin results 
the relationship between AL and DR can be compared with that of RC and RAPA 
treatment. The predominant changes seen with DR treatment are a reduction in 
complex I release. Only muscle mitochondria replicate these complex I results in both 
forward and reverse flow. There is an increase in hydrogen production as a result of 
liver complex I reverse flow with in rapamycin treatment. There is no significant 
change seen in complex III production in both DR and RAPA when compared with their 
respective controls. 
5.4.3. TERT-/- MICE HAVE LOWER HYDROGEN PEROXIDE RELEASE AT A 
YOUNG AGE BUT A HIGHER INCREASE WITH AGE 
TERT-/- showed a decrease in hydrogen peroxide release at 8 months compared to 
WT. This decrease was seen in complex I production from both forward and reverse 
flow of electrons. Looking at the same conditions at 15 months of age there is only a 
decrease hydrogen peroxide release via reverse flow in TERT-/-. Complex I superoxide 
release occurs from different sites in the complex for reverse flow compared to 
forward flow (figure 3-54, 3-55). These differences in release at 15 months could be 
linked to this. In succinate linked hydrogen peroxide release there is also a decrease 
with age in the mitochondria. This is not seen in PM linked hydrogen peroxide release.  
Rapamycin treatment decreases hydrogen peroxide release in WT mice. In mice 
without catalytic telomerase the hydrogen peroxide release is unchanged. This 
suggests rapamycin requires telomerase to cause the hydrogen peroxide release seen 
with rapamycin treatment (figure 3-56, 3-57). 
5.5. OLD AND DIETARY RESTRCTED LIVER SHOW DIFFERENCES IN 
FUNCTION AND PROTEOME COMPOSITION WHEN COMPARED TO 
TISSUES FROM YOUNG CONTROLS 
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Proteome changes were monitored in mouse liver mitochondria from five different age 
groups. The liver has been seen to have the most changed proteins in a tissue 
comparative study (Chang et al., 2007). All the groups had male animals and nine of 
the groups have female animals. 15, 24 and 30 month old mice were either fed a 
dietary restricted diet (DR) or with unrestricted access to food (AL). This resulted in a 
very large multidimensional dataset that was mined for differences in the abundance 
of classes of mitochondrial proteins between different nutritional states and/or during 
the ageing process (figure 1-3). 
5.5.1. FATTY ACID SYNTHESIS AND BETA OXIDATION HAVE NO CHANGE 
WITH NUTRITION BUT HAVE HIGH TURNOVER OF PROTEINS. 
Fatty acids are a source of nutrient. The mitochondria can catabolise the fatty acids to 
produce acetyl CoA which feeds into the TCA cycle (Alberts et al., 2008). There are two 
metabolism pathways which synthesize and catabolise fatty acids there is overlap in 
these proteins. The catabolism pathway for fatty acids is called beta-oxidation, which 
breaks down fatty acids into acetyl CoA for use in the TCA cycle.  
Proteins involved in fatty acid biosynthesis, either from acetyl CoA or triglyeride. There 
is no change in the total protein abundance between nutrition, tissue collection time 
and gender differences. In ageing there is a steady increase in Decr1, Pecr and Echdc2. 
Acaa2 increases at 24 months AL. Acsf2 decreased in both AL and DR with age, this 
protein is part of an enzyme group which this is the first catalyst in fatty acid 
metabolism (figure 4-14).  
Beta-oxidation of fatty acids is the degradation of fatty acids to obtain acetyl CoA for 
used of the TCA cycle and production of substrate for the electron transport chain. The 
abundance of these fatty acid beta oxidation proteins are unchanged with age. Fatty-
acid beta-oxidation protein abundance is lower in DR mitochondrial proteomes 
compared with AL independent of age, collection time or sex (figure 4-15). This has 
been seen in an early liver proteome study with high significance (Chang et al., 2007). 
There is no change between protein abundance of fatty acids at different tissue 
collection times and genders. 
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Ketone bodies are produced by the liver from fatty acids when food intake is low. The 
abundance of these enzymes is unchanged between AL and DR, pre- and post-prandial 
feeding and gender. The four enzymes involved in the synthesis and degradation of 
ketone bodies act in parallel trends with age in AL mice an initial decrease from 3 to 15 
months is highly reproducible with an increase of abundance with age in three of the 
proteins. In DR ageing only Bdh1 is increased with age (figure 4-16). Fatty acids are 
increasing used with age in the AL mice,  
5.5.2. PROTEINS LINKED TO PYRUVATE METABOLISM HAVE INCREASED 
ABUNDANCE IN DIETARY RESTRICTED MITOCHONDRIAL 
PROTEOMES. 
Pyruvate metabolism occurs in the mitochondria Pyruvate metabolism proteins have 
no clear ageing trend between them, even when separated into AL and DR. The 
protein abundance is unchanged between AL and DR and gender differences. However 
in post-prandial mitochondria the protein abundance is lower than pre-prandial 
abundance (figure 4-19). 
5.5.3. AMINO ACID METABOLISM  
Different groups of amino acids are synthesised using different pathways. Branched 
chain amino acids, aromatic and nucleophilic amino acids have separate synthesis 
pathways. The other amino acids are produced with crossover points between 
individual pathways including the urea cycle, aspartate and asparagine metabolism 
and glycine, glutamate and histidine metabolism.  
There is no change between the protein abundance of enzymes involved in amino acid 
biosynthesis between AL and DR nutrition (figure 4-17). Post-prandial amino acid 
biosynthesis proteins have a no change in abundance between pre- and post-prandial 
protein concentration. Gender shows no abundance change between amino acid 
proteins either. Proteins involved in the urea cycle are changed with age. In AL and DR 
mitochondria at 24 months the abundance is higher than 3 months.  
A decrease is seen in the protein abundance of branched amino acid catabolism 
proteins with age in AL mitochondria (figure 4-18). These proteins have a lower 
abundance in older DR mitochondria. The change is a gradual decrease with age. 
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Branched chain protein abundance in post-prandial protein mitochondria is lower than 
that of pre-prandial protein abundance. These proteins are likely to have a high 
turnover if six hour changes cause alteration of the protein abundance. Gender also 
has a role in amino acid catabolism protein abundance the protein abundance is lower 
in female mice irrespective of age, diet and collection time. 
5.5.4. THE ABUNDANCE OF REACTIVE OXYGEN SPECIES CLEARING 
PROTEINS INCREASES WITH AGE ONLY IN AD LIBITUM ANIMALS, 
INDEPENDENT OF SEX 
Superoxide dismutase, glutathione peroxidase, and catalase are quantified proteins in 
this dataset which are involved in superoxide clearance. Post-prandial feeding and 
gender have no change in superoxide clearance protein abundance (McCord and 
Fridovich, 1969b; Mavelli et al., 1982; Schriner et al., 2005). 
Increase in the three superoxide clearance proteins with age in the AL mitochondria in 
both males and females (figure 4-20-B). In DR mice with age and overall age 
independent of sex, DR and collection time only catalase increases with age (figure 4-
20A,C). There is no increase in hydrogen peroxide release from complex I in older liver 
mitochondria. The increased catalase abundance with age may prevent the hydrogen 
peroxide increase with age seen in brain and muscle.  
Catalase abundance is increased in mitochondria from DR fed mice comparing figures 
4-20B and C. In addition there is an increase in superoxide clearance proteins in DR 
mice compared to AL mice independent of sex, age or tissue collection time. The 
increase in superoxide clearing proteins in the DR animals correlates with the decrease 
in hydrogen peroxide release from liver mitochondria which have been dietary 
restricted. These proteins have been shown to increase with age in brain tissues (Sohal 
et al., 1994). Catalase overexpression has increases lifespan possibly by a similar 
mechanism (Schriner et al., 2005). SOD overexpression has reduced superoxide levels 
in other models (Lee et al., 2009) 
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CHAPTER 6: APPENDIX A 
6.1. TABLES 
Age 
(months) 
Nutritio
n 
Mouse 
ID 
Weight 
(g) 
Pathology 
Assay Completed  
Reason Assay 
not completed 
Brai
n 
Liver 
Skeletal 
Muscle 
3 AL 
Young 
1 
   YES YES YES 
 
3 AL 
Young 
2 
   YES YES YES 
 
3 AL 
Young 
3 
   YES YES YES 
 
3 AL 
Young 
4 
   YES YES YES 
 
15 AL 
F4164 
NN 
49.4   YES NO YES 
Liver method 
uneffective 
15 AL 
F4164 
BN 
49.7 
Liver 
Growth 
YES NO YES 
Pathology 
excludes assays  
15 AL 
F4164 
LN 
47.4 
Pancreatic 
growth 
NO NO YES 
Pathology 
altered 
nutrition 
15 AL 
F4164 
RN 
41.1   YES NO YES 
Liver method 
uneffective 
15 AL 
F4164 
2RN 
40.6   YES NO YES 
Liver method 
uneffective 
15 AL 
F5228 
LN 
41.5   YES NO YES 
Liver method 
uneffective 
15 AL 
F5228 
NN 
31.2   YES NO YES 
Liver method 
uneffective 
15 AL 
F5228 
RN 
37.3   YES NO YES 
Liver method 
uneffective 
15 DR 
F4165 
NN 
23.3   YES NO YES 
Liver method 
uneffective 
15 DR 
F4165 
BN 
25.2   YES NO YES 
Liver method 
uneffective 
15 DR 
F4165 
LN 
26.2   YES NO YES 
Liver method 
uneffective 
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15 DR 
F4165 
RN 
24.7   YES NO YES 
Liver method 
uneffective 
15 DR 
F4165 
2RN 
27.8   YES NO YES 
Liver method 
uneffective 
15 DR 
F5230 
BN 
22.5   YES NO YES 
Liver method 
uneffective 
15 DR 
F5230 
NN 
21.3   YES NO YES 
Liver method 
uneffective 
15 DR 
F5230 
RN 
22.5   YES NO YES 
Liver method 
uneffective 
15 DR 
F5230 
LN 
24.2   YES NO YES 
Liver method 
uneffective 
24 AL 
F2921 
NN 
43.8   YES YES YES 
 
24 AL 
F2921 
RN 
37.2   YES YES YES 
 
24 AL 
F2921 
BN 
37.2   YES YES YES 
 
24 AL 
F2921 
2RN 
39.1  YES NO NO 
Problem in 
liver assay and 
muscle 
preparation 
24 AL 
F2921 
2LN 
33.1 
Enlarged 
Spleen 
YES YES YES 
 
24 DR 
F2907 
2RN 
22.5 Prolapse YES YES YES 
 
24 DR 
F2907 
2LN 
24.7   YES YES YES 
 
24 DR 
F2908 
2RN 
21.9 
Blocked 
gut. 
Enlarged 
spleen 
and 
kidneys. 
Dark 
pancreas 
YES YES YES 
 
24 DR 
F2910 
BN 
26.8   YES NO NO 
Experimental 
error 
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24 DR 
F2910 
2LN 
22.4 
Blocked 
gut 
YES YES YES 
 
30 AL 
F1656 
BN  
39.88 
Seminal 
Duct 
abnormal 
YES YES NO 
Low muscle 
mitochondrial 
concentration 
30 AL 
F1657 
RN 
40.5 
Lung 
Growth 
YES NO YES 
Experimental 
error 
30 AL 
F1660 
2LN 
33.31 
Growth 
under skin 
YES YES YES 
 
30 AL 
F1660 
BN 
36.69 
 Liver 
Fibrosis 
YES YES YES 
 
30 AL 
F1659 
BN 
24.64   YES YES YES 
 
30 PMDR 
F1639 
RN 
26.3   YES YES YES 
 
30 PMDR 
F1639 
LN 
23.2   YES YES YES 
 
30 PMDR 
F1639 
2LN 
27.2   YES YES YES 
 
30 PMDR 
F1639 
2RN 
26.6   YES YES YES 
 
30 DR 
F1640 
NN  
20.3 
Liver 
Fibrosis 
YES YES NO 
Problem in 
muscle 
preparation 
30 DR 
F1640 
LN 
26.7   YES YES YES 
 
30 DR 
F1640 
BN  
20 
Liver 
Fibrosis 
YES YES YES 
 
30 DR 
F1640 
2LN 
24   YES YES NO 
Problem in 
muscle 
preparation 
30 DR 
F1640 
2RN 
24.6   YES YES YES 
 
36 DR 
F1639 
RN 
25.8   YES YES YES 
 
36 DR 
F1639 
LN 
26.4   YES YES YES 
 
36 DR 
F1639 
2LN 
22.1   YES YES YES 
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36 DR 
F1639 
2RN 
23.2   YES YES YES 
 
Table 6-1: Mice used to measure mitochondrial hydrogen peroxide release by the 
Amplex Red method from the ageing and dietary restriction study. The table includes 
the mouse age, treatment and body weight at death. It also notes any pathology which 
could have been the cause of not obtaining or not using the data from particular tissue 
assays. The table also indicates in which tissues the assay was not performed or not 
completed (columns on the right).   
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Name Fraction Experiment 
AJ-Sample1  3M M AL 1 
AJ-Sample2  3M M AL 2 
AJ-Sample3  3M M AL 3 
AJ-Sample4  15M M AL 1 
AJ-Sample5  15M M AL 2 
AJ-Sample6  15M M AL 3 
AJ-Sample7  15M M DR 1 
AJ-Sample8  15M F AL 1 
AJ-Sample9  15M F AL 2 
AJ-Sample10  15M F DR 1 
AJ-Sample11  15M F DR 2 
AJ-Sample12  15M F AL 3 
AJ-Sample13  15M F DR 3 
AJ-Sample14  24M M AL 1 
AJ-Sample15  24M M DR 1 
AJ-Sample16  24M M DR 2 
AJ-Sample17  24M M DR 3 
AJ-Sample18  24M F AL 1 
AJ-Sample19  24M F AL 2 
AJ-Sample20  24M F DR 1 
AJ-Sample21  24M F DR 2 
AJ-Sample22  24M F DR 3 
AJ-Sample23  30M M AL 1 
AJ-Sample24  30M M AL 2 
AJ-Sample25  36M M DR 1 
AJ-Sample26  36M M DR 2 
AJ-Sample27  36M M DR 3 
AJ-Sample28  30M M AL 3 
AJ-Sample29  30M M DR 1 
AJ-Sample30  30M M DR 2 
AJ-Sample31  30M M DR 3 
AJ-Sample32  30M F AL 1 
AJ-Sample33  30M F AL 2 
AJ-Sample34  30M F DR 1 
AJ-Sample35  30M M PFDR 1 
AJ-Sample36  30M M PFDR 2 
AJ-Sample37  30M M PFDR 3 
AJ-Sample38  15M M PFAL 1 
AJ-Sample39  15M M PFAL 2 
AJ-Sample40  15M M DR 2 
AJ-Sample41  15M M PFDR 1 
AJ-Sample42  15M M PFDR 2 
AJ-Sample43  15M M PFDR 3 
AJ-Sample44  15M F PFAL 1 
AJ-Sample45  15M F PFAL 2 
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AJ-Sample46  15M F PFAL 3 
AJ-Sample47  15M F PFDR 1 
AJ-Sample48  15M F PFDR 2 
AJ-Sample49  15M F PFDR 3 
AJ-Sample50  15M M DR 3 
AJ-Sample51  30M F DR 2 
AJ-Sample52  30M F DR 3 
AJ-Sample53  30M F AL 3 
AJ-Sample54  24M F AL 3 
AJ-Sample55  24M M AL 2 
AJ-Sample56  24M M AL 3 
AJ-Sample57  3M F AL 1 
AJ-Sample58  3M F AL 2 
AJ-Sample59  15M M PFAL 3 
AJ-Sample60  3M F AL 3 
Table 6-2: The MaxQuant template denoting the sample ID for each sample number. 
Fractions were not used on these samples, individual samples were analysed on a 
long gradient. 
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Age 
(months) 
Nutrition Sex Sample ID Mouse ID Pathology 
3 AL M 3M M AL 1 YOUNG 1  
3 AL M 3M M AL 2 YOUNG 2  
3 AL M 3M M AL 3 YOUNG 3  
15 AL M 15M M AL 1 2637 LN  
15 AL M 15M M AL 2 2637 2RN  
15 AL M 15M M AL 3 2637 NN  
15 DR M 15M M DR 1 2630 RN  
15 DR M 15M M DR 2 2630 LN  
15 DR M 15M M DR 3 2630 NN  
15 PMAL M 15M M PFAL 1 2639 2RN  
15 PMAL M 15M M PFAL 2 2639 LN  
15 PMAL M 15M M PFAL 3 2639 RN  
15 PMDR M 15M M PFDR 1 2631 NN  
15 PMDR M 15M M PFDR 2 2631 LN  
15 PMDR M 15M M PFDR 3 2631 BN  
24 AL M 24M M AL 1 2916 2LN fibrotic liver, cysts on s.gut 
24 AL M 24M M AL 2 2917 BN 
cyst on lung. Ingrown teeth so 
DR phenotype 
24 AL M 24M M AL 3 2917 2RN   
24 DR M 24M M DR 1 2906 BN   
24 DR M 24M M DR 2 2906 NN pancreatic absess 
24 DR M 24M M DR 3 2908 RN  
30 AL M 30M M AL 1 1646 RN small lymphoma 
30 AL M 30M M AL 2 1647 2RN   
30 AL M 30M M AL 3 1649 2LN calcium deposit in s.int 
30 DR M 30M M DR 1 1642 NN   
30 DR M 30M M DR 2 1642 2RN   
30 DR M 30M M DR 3 1642 BN   
30 PMDR M 30M M PFDR 1 1654 BN   
30 PMDR M 30M M PFDR 2 1654 2RN   
30 PMDR M 30M M PFDR 3 1654 2LN   
36 DR M 36M M DR 1 1666 NN   
36 DR M 36M M DR 2 1666 BN   
36 DR M 36M M DR 3 1666 2LN   
3 AL F 3M F AL 1 YOUNG 1    
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3 AL F 3M F AL 2 YOUNG 2   
3 AL F 3M F AL 3 YOUNG 3   
15 AL F 15M F AL 1 2657 LN   
15 AL F 15M F AL 2 2657 NN   
15 AL F 15M F AL 3 2657 RN   
15 DR F 15M F DR 1 2643 2LN   
15 DR F 15M F DR 2 2643 2RN   
15 DR F 15M F DR 3 2649 NN   
15 PMAL F 15M F PFAL 1 2650 NN   
15 PMAL F 15M F PFAL 2 2650 LN   
15 PMAL F 15M F PFAL 3 2650 RN   
15 PMDR F 15M F PFDR 1 2645 NN   
15 PMDR F 15M F PFDR 2 2645 RN   
15 PMDR F 15M F PFDR 3 2645 LN   
24 AL F 24M F AL 1 3104 NN pancreatic tumour 
24 AL F 24M F AL 2 3104 RN   
24 AL F 24M F AL 3 3104 BN cyst on ovary  
24 DR F 24M F DR 1 3093 LN   
24 DR F 24M F DR 2 3093 RN couldn't find one ovary 
24 DR F 24M F DR 3 3093 NN   
30 AL F 30M F AL 1 1695 2LN   
30 AL F 30M F AL 2 1695 LN lymphoma 
30 AL F 30M F AL 3 1695 BN   
30 DR F 30M F DR 1 1698 2RN lymphoma and kidney tumours 
30 DR F 30M F DR 2 1698 LN   
30 DR F 30M F DR 3 1698 BN lymphoma, advanced 
Table 6-3: List of mice used in the proteomics ageing and dietary restriction study. 
The table includes the mouse age, treatment, sex, mouse ID and sample ID.  
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Parameter Value 
Version 1.3.0.5 
Fixed modifications Carbamidomethyl (C) 
Randomize FALSE 
Special AAs KR 
Include contaminants TRUE 
MS/MS tol. (FTMS) 20 ppm 
Top MS/MS peaks per 100 Da. (FTMS) 10 
MS/MS deisotoping (FTMS) TRUE 
MS/MS tol. (ITMS) 0.5 Da 
Top MS/MS peaks per 100 Da. (ITMS) 6 
MS/MS deisotoping (ITMS) FALSE 
MS/MS tol. (TOF) 0.1 Da 
Top MS/MS peaks per 100 Da. (TOF) 10 
MS/MS deisotoping (TOF) TRUE 
MS/MS tol. (Unknown) 0.5 Da 
Top MS/MS peaks per 100 Da. (Unknown) 6 
MS/MS deisotoping (Unknown) FALSE 
Peptide FDR 0.01 
Max. peptide PEP 1 
Protein FDR 0.01 
Site FDR 0.01 
Use Normalized Ratios For Occupancy TRUE 
Apply site FDR separately TRUE 
Min. peptide Length 7 
Min. score 0 
Min. unique peptides 0 
Min. razor peptides 1 
Min. peptides 1 
Use only unmodified peptides and TRUE 
Modifications included in protein quantification Oxidation (M);Acetyl (Protein N-term) 
Peptides used for protein quantification Razor 
Discard unmodified counterpart peptides TRUE 
Min. ratio count 2 
Lfq min. ratio count 2 
Site quantification Use least modified peptide 
Re-quantify TRUE 
Keep low-scoring versions of identified peptides Also between groups 
Label-free protein quantification FALSE 
iBAQ FALSE 
iBAQ log fit TRUE 
MS/MS recalibration FALSE 
Match between runs TRUE 
Time window [min] 2 
Find dependent peptides FALSE 
Fasta file C:\Mass Spec Amy\uniprot_mouse_2013_07.fasta 
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Labeled amino acid filtering TRUE 
Site tables Oxidation (M)Sites.txt 
Cut peaks TRUE 
Randomize FALSE 
Special AAs KR 
Include contaminants TRUE 
RT shift FALSE 
Advanced ratios FALSE 
AIF correlation 0.8 
First pass AIF correlation 0.8 
AIF topx 50 
AIF min mass 0 
AIF SIL weight 4 
AIF ISO weight 2 
AIF iterative FALSE 
AIF threshold FDR 0.01 
Table 6-4: The parameters used by MaxQuant to generate protein SILAC data for 
individual samples from the .RAW file output by the mass spectrometer. 
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Chemical Company 
Amplex Red Thermo Fisher Scientific 
Sucrose Sigma 
Tris Base Sigma 
EDTA Sigma 
Ficoll Sigma 
EGTA Sigma 
Percoll Sigma 
KCl Sigma 
ATP Sigma 
MgCl2 Sigma 
BSA - Bovine Serum Albumin Sigma 
Protease Type VIII Subtilisin A Sigma 
Resorufin Invitrogen 
Hepes Sigma 
SOD Sigma 
Oligomycin Sigma 
DMSO Sigma 
Catalase Sigma 
HRP Sigma 
Pyruvate Sigma 
Malate Sigma 
Succinate Sigma 
Antimycin A Sigma 
Hydrogen peroxide Sigma 
Myxothiazol Sigma 
Atpenin A5 Sigma 
Malonate Sigma 
DMEM/F12 Media Sigma 
Insulin Sigma 
Transferrin Sigma 
Selenium Sigma 
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Dexamethasone Sigma 
L-Lysine-2HCl (K8) Cambridge Isotope Lab 
L-Arginine-HCl (R8) Cambridge Isotope Lab 
FBS Sigma 
Coomassie Blue Sigma 
DTT Applichem 
Iodoacetamide Applichem 
Acetonitrile Sigma 
Trypsin Promega 
Ammonium Bicarbonate Sigma 
Calcium Chloride Sigma 
TFA - Trifluoroacetic acid Sigma 
Urea Sigma 
Table 6-5: List of chemicals used in this studay and company that they were supplied 
from. 
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Protein IDs Protein names Gene names 
Q99K67 Alpha-aminoadipic semialdehyde synthase, 
mitochondrial;Lysine ketoglutarate 
reductase;Saccharopine dehydrogenase 
Aass 
P61922 4-aminobutyrate aminotransferase, mitochondrial Abat 
Q8VCH0 3-ketoacyl-CoA thiolase B, peroxisomal Acaa1b 
Q8BWT1 3-ketoacyl-CoA thiolase, mitochondrial Acaa2 
Q8K370 Acyl-CoA dehydrogenase family member 10 Acad10 
P51174 Long-chain specific acyl-CoA dehydrogenase, 
mitochondrial 
Acadl 
P45952 Medium-chain specific acyl-CoA dehydrogenase, 
mitochondrial 
Acadm 
Q07417 Short-chain specific acyl-CoA dehydrogenase, 
mitochondrial 
Acads 
Q9DBL1 Short/branched chain specific acyl-CoA 
dehydrogenase, mitochondrial 
Acadsb 
P50544 Very long-chain specific acyl-CoA dehydrogenase, 
mitochondrial 
Acadvl 
Q8QZT1 Acetyl-CoA acetyltransferase, mitochondrial Acat1 
Q99KI0 Aconitate hydratase, mitochondrial Aco2 
Q9QYR9 Acyl-coenzyme A thioesterase 2, mitochondrial Acot2 
Q9R0H0 Peroxisomal acyl-coenzyme A oxidase 1 Acox1 
Q9QXD1 Peroxisomal acyl-coenzyme A oxidase 2 Acox2 
Q8VCW8 Acyl-CoA synthetase family member 2, 
mitochondrial 
Acsf2 
D3Z041 Long-chain-fatty-acid--CoA ligase 1 Acsl1 
Q91VA0 Acyl-coenzyme A synthetase ACSM1, mitochondrial Acsm1 
Q8BGA8 Acyl-coenzyme A synthetase ACSM5, mitochondrial Acsm5 
Q7TPR4 Alpha-actinin-1 Actn1 
Q8R0N6 Hydroxyacid-oxoacid transhydrogenase, 
mitochondrial 
Adhfe1 
A2AS89 Agmatinase, mitochondrial Agmat 
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Q3UEG6 Alanine--glyoxylate aminotransferase 2, 
mitochondrial 
Agxt2 
Q9Z0X1 Apoptosis-inducing factor 1, mitochondrial Aifm1 
Q9WTP6 Adenylate kinase 2, mitochondrial Ak2 
Q9WTP7 GTP:AMP phosphotransferase, mitochondrial Ak3 
Q9WUR9 Adenylate kinase isoenzyme 4, mitochondrial Ak4 
Q8CG76 Aflatoxin B1 aldehyde reductase member 2 Akr7a2 
Q9CZS1 Aldehyde dehydrogenase X, mitochondrial Aldh1b1 
P47738 Aldehyde dehydrogenase, mitochondrial Aldh2 
Q8CHT0 Delta-1-pyrroline-5-carboxylate dehydrogenase, 
mitochondrial 
Aldh4a1 
Q8BWF0 Succinate-semialdehyde dehydrogenase, 
mitochondrial 
Aldh5a1 
Q9EQ20 Methylmalonate-semialdehyde dehydrogenase 
[acylating], mitochondrial 
Aldh6a1 
Q9DBF1 Alpha-aminoadipic semialdehyde dehydrogenase Aldh7a1 
Q3U367 4-trimethylaminobutyraldehyde dehydrogenase Aldh9a1 
Q91Y97 Fructose-bisphosphate aldolase B Aldob 
O09174 Alpha-methylacyl-CoA racemase Amacr 
P07356 Annexin A2;Annexin Anxa2 
P16460 Argininosuccinate synthase Ass1 
Q925I1 ATPase family AAA domain-containing protein 3 Atad3 
Q8VDN2 Sodium/potassium-transporting ATPase subunit 
alpha-1 
Atp1a1 
O55143 Sarcoplasmic/endoplasmic reticulum calcium 
ATPase 2 
Atp2a2 
Q03265 ATP synthase subunit alpha, mitochondrial;ATP 
synthase subunit alpha 
Atp5a1 
P56480 ATP synthase subunit beta, mitochondrial Atp5b 
Q91VR2 ATP synthase subunit gamma, mitochondrial;ATP 
synthase gamma chain 
Atp5c1 
Q9D3D9 ATP synthase subunit delta, mitochondrial Atp5d 
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P56382 ATP synthase subunit epsilon, mitochondrial Atp5e 
Q9CQQ7 ATP synthase subunit b, mitochondrial Atp5f1 
Q9DCX2 ATP synthase subunit d, mitochondrial Atp5h;Gm102
50 
Q06185 ATP synthase subunit e, mitochondrial Atp5i 
P97450 ATP synthase-coupling factor 6, mitochondrial Atp5j 
P56135 ATP synthase subunit f, mitochondrial Atp5j2 
Q9CPQ8 ATP synthase subunit g, mitochondrial Atp5l 
Q9DB20 ATP synthase subunit O, mitochondrial Atp5o 
Q3U3J1 2-oxoisovalerate dehydrogenase subunit alpha, 
mitochondrial 
Bckdha 
Q6P3A8 2-oxoisovalerate dehydrogenase subunit beta, 
mitochondrial 
Bckdhb 
Q80XN0 D-beta-hydroxybutyrate dehydrogenase, 
mitochondrial 
Bdh1 
Q8R164 Valacyclovir hydrolase Bphl 
P14211 Calreticulin Calr 
P24270 Catalase Cat 
Q91VT4 Carbonyl reductase family member 4 Cbr4 
Q8VCT4 Carboxylesterase 1D Ces1d 
Q9CRB9 Coiled-coil-helix-coiled-coil-helix domain-containing 
protein 3, mitochondrial 
Chchd3 
Q8BJ64 Choline dehydrogenase, mitochondrial Chdh 
Q91WS0 CDGSH iron-sulfur domain-containing protein 1 Cisd1 
Q5SXR6 Clathrin heavy chain 1 Cltc 
Q8R4N0 Citrate lyase subunit beta-like protein, 
mitochondrial 
Clybl 
Q9QXT0 Protein canopy homolog 2 Cnpy2 
P19783 Cytochrome c oxidase subunit 4 isoform 1, 
mitochondrial 
Cox4i1 
P12787 Cytochrome c oxidase subunit 5A, mitochondrial Cox5a 
Q9D881 Cytochrome c oxidase subunit 5B, mitochondrial Cox5b 
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Q9DCW5 Cytochrome c oxidase subunit 6A, 
mitochondrial;Cytochrome c oxidase subunit 6A1, 
mitochondrial 
Cox6a1 
P56391 Cytochrome c oxidase subunit 6B1 Cox6b1 
Q9CPQ1 Cytochrome c oxidase subunit 6C Cox6c 
P36552 Coproporphyrinogen-III oxidase, mitochondrial Cpox 
Q8C196 Carbamoyl-phosphate synthase [ammonia], 
mitochondrial 
Cps1 
P52825 Carnitine O-palmitoyltransferase 2, mitochondrial Cpt2 
Q9CZU6 Citrate synthase, mitochondrial Cs 
Q02248 Catenin beta-1 Ctnnb1 
E9Q8Z8 Catenin delta-1 Ctnnd1 
P18242 Cathepsin D Ctsd 
P56395 Cytochrome b5 Cyb5a;Cyb5 
Q9CQX2 Cytochrome b5 type B Cyb5b 
F2Z456 NADH-cytochrome b5 reductase 3;NADH-
cytochrome b5 reductase 3 membrane-bound 
form;NADH-cytochrome b5 reductase 3 soluble 
form 
Cyb5r3 
Q9D0M3 Cytochrome c1, heme protein, mitochondrial Cyc1 
Q9DBG1 Sterol 26-hydroxylase, mitochondrial Cyp27a1 
Q9D172 ES1 protein homolog, mitochondrial D10Jhu81e 
P53395 Lipoamide acyltransferase component of branched-
chain alpha-keto acid dehydrogenase complex, 
mitochondrial 
Dbt 
O54734 Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase 48 kDa subunit 
Ddost 
Q8BTS0 Probable ATP-dependent RNA helicase DDX5 Ddx5 
Q9CQ62 2,4-dienoyl-CoA reductase, mitochondrial Decr1 
Q99LB2 Dehydrogenase/reductase SDR family member 4 Dhrs4 
E9QNN1 ATP-dependent RNA helicase A Dhx9 
190 
 
Q8BMF4 Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex, 
mitochondrial 
Dlat 
O08749 Dihydrolipoyl dehydrogenase, mitochondrial Dld 
Q9D2G2 Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
Dlst 
Q9DBT9 Dimethylglycine dehydrogenase, mitochondrial Dmgdh 
P70245 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase Ebp 
O35459 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, 
mitochondrial 
Ech1 
Q3TLP5 Enoyl-CoA hydratase domain-containing protein 2, 
mitochondrial 
Echdc2 
Q8BH95 Enoyl-CoA hydratase, mitochondrial Echs1 
P42125 Enoyl-CoA delta isomerase 1, mitochondrial Eci1 
Q9WUR2 Enoyl-CoA delta isomerase 2, mitochondrial Eci2 
P10126 Elongation factor 1-alpha 1 Eef1a1 
G5E8D6  Efemp2 
Q9DBM2 Peroxisomal bifunctional enzyme;Enoyl-CoA 
hydratase/3,2-trans-enoyl-CoA isomerase;3-
hydroxyacyl-CoA dehydrogenase 
Ehhadh 
P34914 Epoxide hydrolase 2 Ephx2 
Q99LC5 Electron transfer flavoprotein subunit alpha, 
mitochondrial 
Etfa 
Q9DCW4 Electron transfer flavoprotein subunit beta Etfb 
Q921G7 Electron transfer flavoprotein-ubiquinone 
oxidoreductase, mitochondrial 
Etfdh 
Q9DCM0 Protein ETHE1, mitochondrial Ethe1 
Q9CR98 Protein FAM136A Fam136a 
P35550 rRNA 2-O-methyltransferase fibrillarin Fbl 
P46656 Adrenodoxin, mitochondrial Fdx1 
Q61578 NADPH:adrenodoxin oxidoreductase, mitochondrial Fdxr 
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P97807 Fumarate hydratase, mitochondrial Fh 
P29391 Ferritin light chain 1;Ferritin light chain 2;Ferritin Ftl1;Ftl2 
Q8BHN3-2 Neutral alpha-glucosidase AB Ganab 
O88986 2-amino-3-ketobutyrate coenzyme A ligase, 
mitochondrial 
Gcat 
Q60759 Glutaryl-CoA dehydrogenase, mitochondrial Gcdh 
Q91W43 Glycine dehydrogenase [decarboxylating], 
mitochondrial 
Gldc 
Q80Y14 Glutaredoxin-related protein 5, mitochondrial Glrx5 
Q571F8 Glutaminase liver isoform, mitochondrial Gls2 
P26443 Glutamate dehydrogenase 1, mitochondrial Glud1 
Q91XE0 Glycine N-acyltransferase Glyat 
E9QAZ2 Ribosomal protein L15;60S ribosomal protein L15 Rpl15 
G3UWG1 Cytochrome c, somatic Cycs 
Q5FW57 Glycine N-acyltransferase-like protein Gm4952 
D3YVN7 Elongation factor Tu;Elongation factor Tu, 
mitochondrial 
Tufm 
P08752 Guanine nucleotide-binding protein G(i) subunit 
alpha-2 
Gnai2 
E9QKR0 Guanine nucleotide-binding protein G(I)/G(S)/G(T) 
subunit beta-2 
Gnb2 
P05202 Aspartate aminotransferase, mitochondrial Got2 
Q64521 Glycerol-3-phosphate dehydrogenase, 
mitochondrial 
Gpd2 
P11352 Glutathione peroxidase 1 Gpx1 
Q99LP6 GrpE protein homolog 1, mitochondrial Grpel1 
Q9DCM2 Glutathione S-transferase kappa 1 Gstk1 
P27661 Histone H2A.x H2afx 
Q9QXE0 2-hydroxyacyl-CoA lyase 1 Hacl1 
Q61425 Hydroxyacyl-coenzyme A dehydrogenase, 
mitochondrial 
Hadh 
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Q8BMS1 Trifunctional enzyme subunit alpha, 
mitochondrial;Long-chain enoyl-CoA hydratase;Long 
chain 3-hydroxyacyl-CoA dehydrogenase 
Hadha 
Q99JY0 Trifunctional enzyme subunit beta, mitochondrial;3-
ketoacyl-CoA thiolase 
Hadhb 
Q99L13 3-hydroxyisobutyrate dehydrogenase, mitochondrial Hibadh 
Q8QZS1 3-hydroxyisobutyryl-CoA hydrolase, mitochondrial Hibch 
Q9D0S9 Histidine triad nucleotide-binding protein 2, 
mitochondrial 
Hint2 
P43277 Histone H1.3 Hist1h1d 
P22752 Histone H2A type 1 Hist1h2ab 
Q8CGP2-2 Histone H2B type 1-F/J/L Hist1h2bf 
P68433 Histone H3.1 Hist1h3a 
P62806 Histone H4 Hist1h4a 
P38060 Hydroxymethylglutaryl-CoA lyase, mitochondrial Hmgcl 
P54869 Hydroxymethylglutaryl-CoA synthase, mitochondrial Hmgcs2 
O88569 Heterogeneous nuclear ribonucleoproteins A2/B1 Hnrnpa2b1 
Q9DCU9 Probable 4-hydroxy-2-oxoglutarate aldolase, 
mitochondrial 
Hoga1 
P52760 Ribonuclease UK114 Hrsp12 
Q99N15 3-hydroxyacyl-CoA dehydrogenase type-2 Hsd17b10 
P51660 Peroxisomal multifunctional enzyme type 2;(3R)-
hydroxyacyl-CoA dehydrogenase;Enoyl-CoA 
hydratase 2 
Hsd17b4 
P50171-2 Estradiol 17-beta-dehydrogenase 8 Hsd17b8;H2-
Ke6 
P11499 Heat shock protein HSP 90-beta Hsp90ab1 
P08113 Endoplasmin Hsp90b1 
P20029 78 kDa glucose-regulated protein Hspa5 
P63017 Heat shock cognate 71 kDa protein Hspa8 
P38647 Stress-70 protein, mitochondrial Hspa9 
P63038 60 kDa heat shock protein, mitochondrial Hspd1 
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Q64433 10 kDa heat shock protein, mitochondrial Hspe1 
Q8BIJ6 Isoleucine--tRNA ligase, mitochondrial Iars2 
P54071 Isocitrate dehydrogenase [NADP], mitochondrial Idh2 
Q9D6R2 Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
Idh3a 
Q8CAQ8-2 Mitochondrial inner membrane protein Immt 
P85094 Isochorismatase domain-containing protein 2A, 
mitochondrial 
Isoc2a 
Q9JHI5 Isovaleryl-CoA dehydrogenase, mitochondrial Ivd 
Q8CC88 Uncharacterized protein KIAA0564 homolog Kiaa0564 
Q9CPY7 Cytosol aminopeptidase Lap3 
Q7TNG8 Probable D-lactate dehydrogenase, mitochondrial Ldhd 
P48678 Prelamin-A/C;Lamin-A/C Lmna 
P14733 Lamin-B1 Lmnb1 
F6TFN2 Lmo7 
Q8CGK3 Lon protease homolog, mitochondrial Lonp1 
Q6PB66 Leucine-rich PPR motif-containing protein, 
mitochondrial 
Lrpprc 
Q922Q8 Leucine-rich repeat-containing protein 59 Lrrc59 
Q64133 Amine oxidase [flavin-containing] A Maoa 
Q8BW75 Amine oxidase [flavin-containing] B Maob 
Q922Q1 MOSC domain-containing protein 2, mitochondrial Marc2;Mosc2 
Q99MR8 Methylcrotonoyl-CoA carboxylase subunit alpha, 
mitochondrial 
Mccc1 
Q3ULD5 Methylcrotonoyl-CoA carboxylase beta chain, 
mitochondrial 
Mccc2 
P08249 Malate dehydrogenase, mitochondrial Mdh2 
E9QJW0 Microsomal glutathione S-transferase 1 Mgst1 
Q3UW66 Sulfurtransferase;3-mercaptopyruvate 
sulfurtransferase 
Mpst 
Q791V5 Mitochondrial carrier homolog 2 Mtch2 
P00405 Cytochrome c oxidase subunit 2 Mtco2;mt-Co2 
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P16332 Methylmalonyl-CoA mutase, mitochondrial Mut 
Q8VDD5 Myosin-9 Myh9 
Q9WTI7 Unconventional myosin-Ic Myo1c 
E9Q390 Myoferlin Myof 
Q99LC3 NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 10, mitochondrial 
Ndufa10 
Q9ERS2 NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 13 
Ndufa13 
Q9CQ75 NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 2 
Ndufa2 
Q62425 NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 4 
Ndufa4 
Q9CPP6 NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 5 
Ndufa5 
Q9CQZ5 NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 6 
Ndufa6 
Q9DCJ5 NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 8 
Ndufa8 
Q9DC69 NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 9, mitochondrial 
Ndufa9 
Q9CQC7 NADH dehydrogenase [ubiquinone] 1 beta 
subcomplex subunit 4 
Ndufb4 
Q91VD9 NADH-ubiquinone oxidoreductase 75 kDa subunit, 
mitochondrial 
Ndufs1 
Q9DCT2 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
Ndufs3 
P52503 NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 6, mitochondrial 
Ndufs6 
Q91YT0 NADH dehydrogenase [ubiquinone] flavoprotein 1, 
mitochondrial 
Ndufv1 
Q9D6J6 NADH dehydrogenase [ubiquinone] flavoprotein 2, 
mitochondrial 
Ndufv2 
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Q8C6I5 Cysteine desulfurase, mitochondrial Nfs1 
O55125 Protein NipSnap homolog 1 Nipsnap1 
Q61941 NAD(P) transhydrogenase, mitochondrial Nnt 
E9Q5C9  Nolc1 
Q9D6Z1 Nucleolar protein 56 Nop56 
E9Q7G0  Numa1 
P29758 Ornithine aminotransferase, mitochondrial Oat 
Q60597 2-oxoglutarate dehydrogenase, mitochondrial Ogdh 
P11725 Ornithine carbamoyltransferase, mitochondrial Otc 
P09103 Protein disulfide-isomerase P4hb 
P60335 Poly(rC)-binding protein 1 Pcbp1 
Q91ZA3 Propionyl-CoA carboxylase alpha chain, 
mitochondrial 
Pcca 
Q99MN9 Propionyl-CoA carboxylase beta chain, 
mitochondrial 
Pccb 
Q8BH04 Phosphoenolpyruvate carboxykinase [GTP], 
mitochondrial 
Pck2 
E9QPD7 Pyruvate carboxylase, mitochondrial Pcx;Pc 
P35486 Pyruvate dehydrogenase E1 component subunit 
alpha, somatic form, mitochondrial 
Pdha1 
Q9D051 Pyruvate dehydrogenase E1 component subunit 
beta, mitochondrial 
Pdhb 
P27773 Protein disulfide-isomerase A3 Pdia3 
Q922R8 Protein disulfide-isomerase A6 Pdia6 
Q99MZ7 Peroxisomal trans-2-enoyl-CoA reductase Pecr 
O55022 Membrane-associated progesterone receptor 
component 1 
Pgrmc1 
P67778 Prohibitin Phb 
O35129 Prohibitin-2 Phb2 
P52480 Pyruvate kinase isozymes M1/M2 Pkm2 
E9QMZ5 Plectin Plec 
Q91VA6 Polymerase delta-interacting protein 2 Poldip2 
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P37040 NADPH--cytochrome P450 reductase Por 
Q91VM9 Inorganic pyrophosphatase 2, mitochondrial Ppa2 
P20108 Thioredoxin-dependent peroxide reductase, 
mitochondrial 
Prdx3 
P99029 Peroxiredoxin-5, mitochondrial Prdx5 
Q922Q4 Pyrroline-5-carboxylate reductase 2;Pyrroline-5-
carboxylate reductase 1, mitochondrial 
Pycr2;Pycr1 
P61027 Ras-related protein Rab-10 Rab10 
P51150 Ras-related protein Rab-7a Rab7a 
Q5XJF6 Ribosomal protein;60S ribosomal protein L10a Rpl10a 
P47963 60S ribosomal protein L13 Rpl13;Rpl13-
ps3 
P35980 60S ribosomal protein L18 Rpl18 
Q9D8E6 60S ribosomal protein L4 Rpl4 
P47911 60S ribosomal protein L6 Rpl6 
P14148 60S ribosomal protein L7 Rpl7 
D3YU93 60S ribosomal protein L7a Rpl7a-ps3 
Q91YQ5 Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 1 
Rpn1 
Q99PL5 Ribosome-binding protein 1 Rrbp1 
Q9EP69 Phosphatidylinositide phosphatase SAC1 Sacm1l 
Q8BGH2 Sorting and assembly machinery component 50 
homolog 
Samm50 
Q99LB7 Sarcosine dehydrogenase, mitochondrial Sardh 
P32020 Non-specific lipid-transfer protein Scp2 
Q8K2B3 Succinate dehydrogenase [ubiquinone] flavoprotein 
subunit, mitochondrial 
Sdha 
Q9CQA3 Succinate dehydrogenase [ubiquinone] iron-sulfur 
subunit, mitochondrial 
Sdhb 
Q8VIJ6 Splicing factor, proline- and glutamine-rich Sfpq 
Q99JR1 Sideroflexin-1 Sfxn1 
Q91V61 Sideroflexin-3 Sfxn3 
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Q9CZN7 Serine hydroxymethyltransferase Shmt2 
Q9QZD8 Mitochondrial dicarboxylate carrier Slc25a10 
Q9QXX4 Calcium-binding mitochondrial carrier protein 
Aralar2 
Slc25a13 
Q8VEM8 Phosphate carrier protein, mitochondrial Slc25a3 
P48962 ADP/ATP translocase 1 Slc25a4 
P51881 ADP/ATP translocase 2 Slc25a5 
Q9D8T7 SRA stem-loop-interacting RNA-binding protein, 
mitochondrial 
Slirp;1810035L
17Rik 
Q6P4T2  Snrnp200 
P09671 Superoxide dismutase [Mn], mitochondrial Sod2 
E9Q447 Spectrin alpha chain, brain Spna2;Sptan1 
Q62261-2 Spectrin beta chain, brain 1 Sptbn1 
Q9R112 Sulfide:quinone oxidoreductase, mitochondrial Sqrdl 
Q8R2K3 Single-stranded DNA-binding protein, mitochondrial Ssbp1 
Q9D8L3 Translocon-associated protein subunit delta Ssr4 
Q99JB2 Stomatin-like protein 2 Stoml2 
Q9Z2I9 Succinyl-CoA ligase [ADP-forming] subunit beta, 
mitochondrial 
Sucla2 
Q9WUM5 Succinyl-CoA ligase [ADP/GDP-forming] subunit 
alpha, mitochondrial 
Suclg1 
Q9Z2I8 Succinyl-CoA ligase [GDP-forming] subunit beta, 
mitochondrial 
Suclg2 
Q8R086 Sulfite oxidase, mitochondrial Suox 
Q921I1 Serotransferrin Tf;Gm20425 
P62075 Mitochondrial import inner membrane translocase 
subunit Tim13 
Timm13 
Q9D880 Mitochondrial import inner membrane translocase 
subunit TIM50 
Timm50 
Q9WVA2 Mitochondrial import inner membrane translocase 
subunit Tim8 A 
Timm8a1 
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P62077 Mitochondrial import inner membrane translocase 
subunit Tim8 B 
Timm8b 
P39447 Tight junction protein ZO-1 Tjp1 
Q61029 Lamina-associated polypeptide 2, isoforms 
beta/delta/epsilon/gamma 
Tmpo 
E9Q7Q3 Tpm3;Tpm3-rs7 
Q9CQN1 Heat shock protein 75 kDa, mitochondrial Trap1 
P52196 Thiosulfate sulfurtransferase Tst 
P68373 Tubulin alpha-1C chain Tuba1c 
P99024 Tubulin beta-5 chain Tubb5 
P0CG50 Polyubiquitin-C Ubc 
Q63886 UDP-glucuronosyltransferase 1-1 Ugt1a1 
P25688 Uricase Uox 
Q9CQB4 Cytochrome b-c1 complex subunit 7 Uqcrb 
Q9CZ13 Cytochrome b-c1 complex subunit 1, mitochondrial Uqcrc1 
Q9DB77 Cytochrome b-c1 complex subunit 2, mitochondrial Uqcrc2 
Q9CR68 Cytochrome b-c1 complex subunit Rieske, 
mitochondrial 
Uqcrfs1 
P99028 Cytochrome b-c1 complex subunit 6, mitochondrial Uqcrh 
Q9CQ69 Cytochrome b-c1 complex subunit 8 Uqcrq 
Q60932 Voltage-dependent anion-selective channel protein 
1 
Vdac1 
Q60930 Voltage-dependent anion-selective channel protein 
2 
Vdac2 
P20152 Vimentin Vim 
Table 6-6: A list of the 305 quantifiable proteins identified in the whole dataset. The 
proteins were found in two thirds of samples and used for the normalisation of the 
dataset. Protein ID, Protein Name and the related Gene Name is included as 
information about the protein. 
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6.2. R SCRIPTS 
6.2.1. GENERATING SLOPES FROM TRIPLICATE AND TOTAL STANDARD 
DEVIATIONS 
Calculating either the triplicate standard deviation of the individual protein or the total 
standard deviation uses the following r script. 
calcProteinSD.01 <- function(protein, triplicate=TRUE){ 
#  This function calculates the triplicate standard deviation if triplicate = TRUE (default 
setting) for 60 samples from a dataset.If triplicate is false it randomly orders the 
samples to generate total standard deviation for a 60 sample dataset.  
     SC <- 12 
#First 11 columns  
     resultVec <- numeric(0) 
     if(triplicate){ 
          proteinVec <- 1:60 
#If triplicate is TRUE ensures the columns are ordered 1-60 in groups of biological 
replicates     } else { 
          proteinVec <- sample(1:60,60,replace=F) 
#This function randomly orders the 60 samples if triplicate is false 
     } 
     for(mouse in seq(1,60, by=3)){ 
          RAAT <- sapply(protein, function(x){as.numeric(x[1])}) 
          RAAT1 <- RAAT[sC+proteinVec[mouse]] 
          RAAT2 <- RAAT[sC+proteinVec[mouse]+1] 
          RAAT3 <- RAAT[sC+proteinVec[mouse]+2] 
#Standard deviation is calculated if each group has three RAAT values for the protein 
otherwise no standard deviation for the group is calculated  
          if(!is.na(RAAT1)){ 
               if(!is.na(RAAT2)){ 
                    if(!is.na(RAAT3)){ 
                         sampErr <- sd(c(RAAT1,RAAT2,RAAT3)) 
                         resultVec <- append(resultVec, sampErr) 
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                         } 
               } 
          } 
      
     } 
     proteinTripSD <- mean(resultVec) 
#The standard deviations are averaged to obtain one for each protein 
     proteinTripSD 
} 
The following script generates a vector of each proteins standard deviaition (either 
total or triplicate) for all the proteins.  
makeProtSDVec <- function(data,triplicate){ 
# This script generates a vector containing the average standard 
deviation for each protein in the dataset using the 
calcProteinSD.01 script.  
     resultVec <- numeric(0) 
     for(i in (c(1:310))){ 
# In the data each protein is a row and there are 310 proteins, 
this function produces the standard deviation for each protein. 
          a <- calcProteinSD.01(data[i,],triplicate) 
          resultVec <- append(resultVec,a) 
# The vector is appended for each row so the final vector has 
310 values 
     } 
     resultVec 
} 
The following script generates 1000 iterations of a slope comparison to compare final 
values. 
get1000slopes <- function(data){ 
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# This script generates 1000 values for the slope of the 
trendline, if the intercept is zero, when triplicate standard 
deviation and total standard deviation are plotted as a 
scattergraph.   
     print("calculating triplicate SDs") 
     protein_tripl <- makeProtSDVec(data, triplicate = TRUE) 
# This section generates a vector of the triplicate standard 
deviation (samples grouped as biological replicates) for each 
protein.  
     resultVec <- numeric(0) 
     for(i in 1:1000){ 
# Generates the following section 1000 times 
          sprintf("Calculating total SD %d",i) 
          protein_total <- makeProtSDVec(data, triplicate = 
FALSE) 
# This section generates a vector of the total standard 
deviation (samples grouped randomly) for each protein. Random 
grouping changes in each i iteration 
          slope <- 
getProtSDVecSlope(protein_tripl,protein_total) 
# Generates the slope when the triplicate vector and this i’s 
total vector is compared. 
          resultVec <- append(resultVec, slope) 
# Appends the slope vector with the additional slope after each 
iteration so the final vector contains 1000 values 
     } 
     resultVec 
} 
This generates a single slope from a triplicate vector and a random total vector. 
getProtSDVecSlope <- function(protein_tripl,protein_total){ 
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#This script finds the slope of the linear regression of a 
scattergraph of triplicate standard deviation compared with 
total standard deviation when the intercept is zero. 
     model <- lm(protein_total ~ 0 + protein_tripl) 
     slope <- as.numeric(model[1][1]) 
     slope 
} 
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